<!DOCTYPE html>
<html class="client-nojs vector-feature-language-in-header-enabled vector-feature-language-in-main-page-header-disabled vector-feature-sticky-header-disabled vector-feature-page-tools-pinned-disabled vector-feature-toc-pinned-enabled vector-feature-main-menu-pinned-disabled vector-feature-limited-width-enabled vector-feature-limited-width-content-enabled vector-feature-zebra-design-disabled" lang="en" dir="ltr">
<head>
<meta charset="UTF-8">
<title>Guillain–Barré syndrome - Wikipedia</title>
<script>document.documentElement.className="client-js vector-feature-language-in-header-enabled vector-feature-language-in-main-page-header-disabled vector-feature-sticky-header-disabled vector-feature-page-tools-pinned-disabled vector-feature-toc-pinned-enabled vector-feature-main-menu-pinned-disabled vector-feature-limited-width-enabled vector-feature-limited-width-content-enabled vector-feature-zebra-design-disabled";(function(){var cookie=document.cookie.match(/(?:^|; )enwikimwclientprefs=([^;]+)/);if(cookie){var featureName=cookie[1];document.documentElement.className=document.documentElement.className.replace(featureName+'-enabled',featureName+'-disabled');}}());RLCONF={"wgBreakFrames":false,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"27cf676a-2ffb-438a-8369-704d84f8e8b6","wgCSPNonce":false,
"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Guillain–Barré_syndrome","wgTitle":"Guillain–Barré syndrome","wgCurRevisionId":1160020717,"wgRevisionId":1160020717,"wgArticleId":12800708,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["CS1: long volume value","CS1 errors: missing periodical","CS1 French-language sources (fr)","Articles with short description","Short description is different from Wikidata","Good articles","Wikipedia medicine articles ready to translate","Wikipedia neurology articles ready to translate","1976 health disasters","Autoimmune diseases","Cytomegalovirus-associated diseases","Medical triads","Myelin disorders","Peripheral nervous system disorders","Syndromes affecting the nervous system","Diseases named for discoverer"],"wgPageViewLanguage":"en","wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":
"Guillain–Barré_syndrome","wgRelevantArticleId":12800708,"wgIsProbablyEditable":true,"wgRelevantPageIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgFlaggedRevsParams":{"tags":{"status":{"levels":1}}},"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"wgMFDisplayWikibaseDescriptions":{"search":true,"watchlist":true,"tagline":false,"nearby":true},"wgWMESchemaEditAttemptStepOversample":false,"wgWMEPageLength":60000,"wgNoticeProject":"wikipedia","wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wgPopupsFlags":10,"wgULSCurrentAutonym":"English","wgEditSubmitButtonLabelPublish":true,"wgCentralAuthMobileDomain":false,"wgULSPosition":"interlanguage","wgULSisCompactLinksEnabled":true,"wgULSisLanguageSelectorEmpty":false,"wgWikibaseItemId":"Q205214","GEHomepageSuggestedEditsEnableTopics":true,"wgGETopicsMatchModeEnabled":false,"wgGEStructuredTaskRejectionReasonTextInputEnabled":false,
"wgGELevelingUpEnabledForUser":false};RLSTATE={"skins.vector.user.styles":"ready","ext.globalCssJs.user.styles":"ready","site.styles":"ready","user.styles":"ready","skins.vector.user":"ready","ext.globalCssJs.user":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","codex-search-styles":"ready","skins.vector.styles":"ready","skins.vector.icons":"ready","jquery.makeCollapsible.styles":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.wikimediaBadges":"ready","ext.uls.interlanguage":"ready","wikibase.client.init":"ready"};RLPAGEMODULES=["ext.cite.ux-enhancements","site","mediawiki.page.ready","jquery.makeCollapsible","mediawiki.toc","skins.vector.js","mmv.head","mmv.bootstrap.autostart","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","ext.cx.eventlogging.campaigns","ext.quicksurveys.init","ext.centralNotice.geoIP","ext.centralNotice.startUp",
"ext.gadget.ReferenceTooltips","ext.gadget.charinsert","ext.gadget.extra-toolbar-buttons","ext.gadget.switcher","ext.centralauth.centralautologin","ext.popups","ext.echo.centralauth","ext.uls.compactlinks","ext.uls.interface","ext.cx.uls.quick.actions","wikibase.client.vector-2022","ext.growthExperiments.SuggestedEditSession"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@12s5i",function($,jQuery,require,module){mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=codex-search-styles%7Cext.cite.styles%7Cext.uls.interlanguage%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediaBadges%7Cjquery.makeCollapsible.styles%7Cskins.vector.icons%2Cstyles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector-2022">
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=vector-2022"></script>
<meta name="ResourceLoaderDynamicStyles" content="">
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=vector-2022">
<meta name="generator" content="MediaWiki 1.41.0-wmf.13">
<meta name="referrer" content="origin">
<meta name="referrer" content="origin-when-crossorigin">
<meta name="referrer" content="origin-when-cross-origin">
<meta name="robots" content="max-image-preview:standard">
<meta name="format-detection" content="telephone=no">
<meta name="viewport" content="width=1000">
<meta property="og:title" content="Guillain–Barré syndrome - Wikipedia">
<meta property="og:type" content="website">
<link rel="preconnect" href="//upload.wikimedia.org">
<link rel="alternate" media="only screen and (max-width: 720px)" href="//en.m.wikipedia.org/wiki/Guillain%E2%80%93Barr%C3%A9_syndrome">
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=edit">
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png">
<link rel="icon" href="/static/favicon/wikipedia.ico">
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)">
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd">
<link rel="canonical" href="https://en.wikipedia.org/wiki/Guillain%E2%80%93Barr%C3%A9_syndrome">
<link rel="license" href="https://creativecommons.org/licenses/by-sa/4.0/deed.en">
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom">
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<link rel="dns-prefetch" href="//login.wikimedia.org">
</head>
<body class="skin-vector skin-vector-search-vue mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-Guillain–Barré_syndrome rootpage-Guillain–Barré_syndrome skin-vector-2022 action-view"><a class="mw-jump-link" href="#bodyContent">Jump to content</a>
<div class="vector-header-container">
	<header class="vector-header mw-header">
		<div class="vector-header-start">
			<nav class="vector-main-menu-landmark" aria-label="Site" role="navigation">
				
<div id="vector-main-menu-dropdown" class="vector-menu vector-dropdown vector-menu-dropdown vector-main-menu-dropdown vector-button-flush-left vector-button-flush-right"  >
	<input type="checkbox"
		id="vector-main-menu-dropdown-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-vector-main-menu-dropdown"
		class="vector-menu-checkbox "
		
		aria-label="Main menu"
		
	/>
	<label
		id="vector-main-menu-dropdown-label"
		for="vector-main-menu-dropdown-checkbox"
		class="vector-menu-heading cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only "
		aria-hidden="true"
		
	>
		<span class="vector-icon mw-ui-icon-menu mw-ui-icon-wikimedia-menu"></span>


		<span class="vector-menu-heading-label">Main menu</span>
	</label>
	<div class="vector-menu-content vector-dropdown-content">


				<div id="vector-main-menu-unpinned-container" class="vector-unpinned-container">
		
<div id="vector-main-menu" class="vector-main-menu vector-pinnable-element">
	<div
	class="vector-pinnable-header vector-main-menu-pinnable-header vector-pinnable-header-unpinned"
	data-feature-name="main-menu-pinned"
	data-pinnable-element-id="vector-main-menu"
	data-pinned-container-id="vector-main-menu-pinned-container"
	data-unpinned-container-id="vector-main-menu-unpinned-container"
>
	<div class="vector-pinnable-header-label">Main menu</div>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-main-menu.pin">move to sidebar</button>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-main-menu.unpin">hide</button>
</div>

	
<div id="p-navigation" class="vector-menu mw-portlet mw-portlet-navigation"  >
	<div class="vector-menu-heading">
		Navigation
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="n-mainpage-description" class="mw-list-item"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"><span>Main page</span></a></li><li id="n-contents" class="mw-list-item"><a href="/wiki/Wikipedia:Contents" title="Guides to browsing Wikipedia"><span>Contents</span></a></li><li id="n-currentevents" class="mw-list-item"><a href="/wiki/Portal:Current_events" title="Articles related to current events"><span>Current events</span></a></li><li id="n-randompage" class="mw-list-item"><a href="/wiki/Special:Random" title="Visit a randomly selected article [x]" accesskey="x"><span>Random article</span></a></li><li id="n-aboutsite" class="mw-list-item"><a href="/wiki/Wikipedia:About" title="Learn about Wikipedia and how it works"><span>About Wikipedia</span></a></li><li id="n-contactpage" class="mw-list-item"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia"><span>Contact us</span></a></li><li id="n-sitesupport" class="mw-list-item"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us by donating to the Wikimedia Foundation"><span>Donate</span></a></li></ul>
		
	</div>
</div>

	
	
<div id="p-interaction" class="vector-menu mw-portlet mw-portlet-interaction"  >
	<div class="vector-menu-heading">
		Contribute
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="n-help" class="mw-list-item"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia"><span>Help</span></a></li><li id="n-introduction" class="mw-list-item"><a href="/wiki/Help:Introduction" title="Learn how to edit Wikipedia"><span>Learn to edit</span></a></li><li id="n-portal" class="mw-list-item"><a href="/wiki/Wikipedia:Community_portal" title="The hub for editors"><span>Community portal</span></a></li><li id="n-recentchanges" class="mw-list-item"><a href="/wiki/Special:RecentChanges" title="A list of recent changes to Wikipedia [r]" accesskey="r"><span>Recent changes</span></a></li><li id="n-upload" class="mw-list-item"><a href="/wiki/Wikipedia:File_upload_wizard" title="Add images or other media for use on Wikipedia"><span>Upload file</span></a></li></ul>
		
	</div>
</div>

	
<div class="vector-main-menu-action vector-main-menu-action-lang-alert">
	<div class="vector-main-menu-action-item">
		<div class="vector-main-menu-action-heading vector-menu-heading">Languages</div>
		<div class="vector-main-menu-action-content vector-menu-content">
			<div class="mw-message-box-notice vector-language-sidebar-alert mw-message-box">Language links are at the top of the page across from the title.</div>
		</div>
	</div>
</div>

</div>

				</div>

	</div>
</div>
		</nav>
			
<a href="/wiki/Main_Page" class="mw-logo">
	<img class="mw-logo-icon" src="/static/images/icons/wikipedia.png" alt=""
		aria-hidden="true" height="50" width="50">
	<span class="mw-logo-container">
		<img class="mw-logo-wordmark" alt="Wikipedia"
			src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" style="width: 7.5em; height: 1.125em;">
		<img class="mw-logo-tagline"
			alt="The Free Encyclopedia"
			src="/static/images/mobile/copyright/wikipedia-tagline-en.svg" width="117" height="13" style="width: 7.3125em; height: 0.8125em;">
	</span>
</a>

		</div>
		<div class="vector-header-end">
			
<div id="p-search" role="search" class="vector-search-box-vue  vector-search-box-collapses vector-search-box-show-thumbnail vector-search-box-auto-expand-width vector-search-box">
	<a href="/wiki/Special:Search"
	
		id=""
		class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only search-toggle"
		title="Search Wikipedia [f]"accesskey="f"><span class="vector-icon mw-ui-icon-search mw-ui-icon-wikimedia-search"></span>

<span>Search</span>
	</a>
	
	<div class="vector-typeahead-search-container">
		<div class="cdx-typeahead-search cdx-typeahead-search--show-thumbnail cdx-typeahead-search--auto-expand-width">
			<form action="/w/index.php" id="searchform" class="cdx-search-input cdx-search-input--has-end-button">
				<div id="simpleSearch" class="cdx-search-input__input-wrapper"  data-search-loc="header-moved">
					<div class="cdx-text-input cdx-text-input--has-start-icon">
						<input
							class="cdx-text-input__input"
							 type="search" name="search" placeholder="Search Wikipedia" aria-label="Search Wikipedia" autocapitalize="sentences" title="Search Wikipedia [f]" accesskey="f" id="searchInput"
							
						>
						<span class="cdx-text-input__icon cdx-text-input__start-icon"></span>
					</div>
					<input type="hidden" name="title" value="Special:Search">
				</div>
				<button class="cdx-button cdx-search-input__end-button">Search</button>
			</form>
		</div>
	</div>
</div>

			<nav class="vector-user-links" aria-label="Personal tools" role="navigation" >
	
<div id="p-vector-user-menu-overflow" class="vector-menu mw-portlet mw-portlet-vector-user-menu-overflow"  >
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="pt-createaccount-2" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=Guillain%E2%80%93Barr%C3%A9+syndrome" title="You are encouraged to create an account and log in; however, it is not mandatory"><span>Create account</span></a></li><li id="pt-login-2" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Guillain%E2%80%93Barr%C3%A9+syndrome" title="You&#039;re encouraged to log in; however, it&#039;s not mandatory. [o]" accesskey="o"><span>Log in</span></a></li></ul>
		
	</div>
</div>

	
<div id="vector-user-links-dropdown" class="vector-menu vector-dropdown vector-menu-dropdown vector-user-menu vector-button-flush-right vector-user-menu-logged-out"  title="Log in and more options" >
	<input type="checkbox"
		id="vector-user-links-dropdown-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-vector-user-links-dropdown"
		class="vector-menu-checkbox "
		
		aria-label="Personal tools"
		
	/>
	<label
		id="vector-user-links-dropdown-label"
		for="vector-user-links-dropdown-checkbox"
		class="vector-menu-heading cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only "
		aria-hidden="true"
		
	>
		<span class="vector-icon mw-ui-icon-ellipsis mw-ui-icon-wikimedia-ellipsis"></span>


		<span class="vector-menu-heading-label">Personal tools</span>
	</label>
	<div class="vector-menu-content vector-dropdown-content">


		
<div id="p-personal" class="vector-menu mw-portlet mw-portlet-personal user-links-collapsible-item"  title="User menu" >
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="pt-createaccount" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=Guillain%E2%80%93Barr%C3%A9+syndrome" title="You are encouraged to create an account and log in; however, it is not mandatory"><span class="vector-icon mw-ui-icon-userAdd mw-ui-icon-wikimedia-userAdd"></span> <span>Create account</span></a></li><li id="pt-login" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Guillain%E2%80%93Barr%C3%A9+syndrome" title="You&#039;re encouraged to log in; however, it&#039;s not mandatory. [o]" accesskey="o"><span class="vector-icon mw-ui-icon-logIn mw-ui-icon-wikimedia-logIn"></span> <span>Log in</span></a></li></ul>
		
	</div>
</div>

<div id="p-user-menu-anon-editor" class="vector-menu mw-portlet mw-portlet-user-menu-anon-editor"  >
	<div class="vector-menu-heading">
		Pages for logged out editors <a href="/wiki/Help:Introduction" aria-label="Learn more about editing"><span>learn more</span></a>
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="pt-anoncontribs" class="mw-list-item"><a href="/wiki/Special:MyContributions" title="A list of edits made from this IP address [y]" accesskey="y"><span>Contributions</span></a></li><li id="pt-anontalk" class="mw-list-item"><a href="/wiki/Special:MyTalk" title="Discussion about edits from this IP address [n]" accesskey="n"><span>Talk</span></a></li></ul>
		
	</div>
</div>

	
	</div>
</div>
</nav>

		</div>
	</header>
</div>
<div class="mw-page-container">
	<div class="mw-page-container-inner">
		<div class="vector-main-menu-container ">
			<div id="mw-navigation">
				<nav id="mw-panel" class="vector-main-menu-landmark" aria-label="Site" role="navigation">
					<div id="vector-main-menu-pinned-container" class="vector-pinned-container">
				
					</div>
		</nav>
			</div>
		</div>
		<div class="vector-sitenotice-container">
			<div id="siteNotice"><!-- CentralNotice --></div>
		</div>
		<input type="checkbox" id="vector-toc-collapsed-checkbox" class="vector-menu-checkbox">
		<nav id="mw-panel-toc" role="navigation" aria-label="Contents" data-event-name="ui.sidebar-toc" class="mw-table-of-contents-container vector-toc-landmark vector-sticky-pinned-container">
			<div id="vector-toc-pinned-container" class="vector-pinned-container">
					<div id="vector-toc" class="vector-toc vector-pinnable-element">
	<div
	class="vector-pinnable-header vector-toc-pinnable-header vector-pinnable-header-pinned"
	data-feature-name="toc-pinned"
	data-pinnable-element-id="vector-toc"
	
	
>
	<h2 class="vector-pinnable-header-label">Contents</h2>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-toc.pin">move to sidebar</button>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-toc.unpin">hide</button>
</div>


	<ul class="vector-toc-contents" id="mw-panel-toc-list">
		<li id="toc-mw-content-text"
			class="vector-toc-list-item vector-toc-level-1">
			<a href="#" class="vector-toc-link">
				<div class="vector-toc-text">(Top)</div>
			</a>
		</li>
		<li id="toc-Signs_and_symptoms"
		class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded">
		<a class="vector-toc-link" href="#Signs_and_symptoms">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">1</span>Signs and symptoms</div>
		</a>
		
			<button aria-controls="toc-Signs_and_symptoms-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Signs and symptoms subsection</span>
			</button>
		
		<ul id="toc-Signs_and_symptoms-sublist" class="vector-toc-list">
			<li id="toc-Respiratory_failure"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Respiratory_failure">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">1.1</span>Respiratory failure</div>
			</a>
			
			<ul id="toc-Respiratory_failure-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Autonomic_dysfunction"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Autonomic_dysfunction">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">1.2</span>Autonomic dysfunction</div>
			</a>
			
			<ul id="toc-Autonomic_dysfunction-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Causes"
		class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded">
		<a class="vector-toc-link" href="#Causes">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">2</span>Causes</div>
		</a>
		
			<button aria-controls="toc-Causes-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Causes subsection</span>
			</button>
		
		<ul id="toc-Causes-sublist" class="vector-toc-list">
			<li id="toc-Infection_onset"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Infection_onset">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">2.1</span>Infection onset</div>
			</a>
			
			<ul id="toc-Infection_onset-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Vaccine_onset"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Vaccine_onset">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">2.2</span>Vaccine onset</div>
			</a>
			
			<ul id="toc-Vaccine_onset-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-COVID-19_infection_or_vaccine_related"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#COVID-19_infection_or_vaccine_related">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">2.3</span>COVID-19 infection or vaccine related</div>
			</a>
			
			<ul id="toc-COVID-19_infection_or_vaccine_related-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Drug_induced"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Drug_induced">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">2.4</span>Drug induced</div>
			</a>
			
			<ul id="toc-Drug_induced-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Pathophysiology"
		class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded">
		<a class="vector-toc-link" href="#Pathophysiology">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">3</span>Pathophysiology</div>
		</a>
		
		<ul id="toc-Pathophysiology-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-Diagnosis"
		class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded">
		<a class="vector-toc-link" href="#Diagnosis">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">4</span>Diagnosis</div>
		</a>
		
			<button aria-controls="toc-Diagnosis-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Diagnosis subsection</span>
			</button>
		
		<ul id="toc-Diagnosis-sublist" class="vector-toc-list">
			<li id="toc-Spinal_fluid"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Spinal_fluid">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">4.1</span>Spinal fluid</div>
			</a>
			
			<ul id="toc-Spinal_fluid-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Neurophysiology"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Neurophysiology">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">4.2</span>Neurophysiology</div>
			</a>
			
			<ul id="toc-Neurophysiology-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Clinical_subtypes"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Clinical_subtypes">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">4.3</span>Clinical subtypes</div>
			</a>
			
			<ul id="toc-Clinical_subtypes-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Treatment"
		class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded">
		<a class="vector-toc-link" href="#Treatment">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">5</span>Treatment</div>
		</a>
		
			<button aria-controls="toc-Treatment-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Treatment subsection</span>
			</button>
		
		<ul id="toc-Treatment-sublist" class="vector-toc-list">
			<li id="toc-Immunotherapy"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Immunotherapy">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">5.1</span>Immunotherapy</div>
			</a>
			
			<ul id="toc-Immunotherapy-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Respiratory_failure_2"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Respiratory_failure_2">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">5.2</span>Respiratory failure</div>
			</a>
			
			<ul id="toc-Respiratory_failure_2-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Pain"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Pain">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">5.3</span>Pain</div>
			</a>
			
			<ul id="toc-Pain-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Rehabilitation"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Rehabilitation">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">5.4</span>Rehabilitation</div>
			</a>
			
			<ul id="toc-Rehabilitation-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Prognosis"
		class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded">
		<a class="vector-toc-link" href="#Prognosis">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">6</span>Prognosis</div>
		</a>
		
		<ul id="toc-Prognosis-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-Epidemiology"
		class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded">
		<a class="vector-toc-link" href="#Epidemiology">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">7</span>Epidemiology</div>
		</a>
		
		<ul id="toc-Epidemiology-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-History"
		class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded">
		<a class="vector-toc-link" href="#History">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">8</span>History</div>
		</a>
		
		<ul id="toc-History-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-Research_directions"
		class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded">
		<a class="vector-toc-link" href="#Research_directions">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">9</span>Research directions</div>
		</a>
		
		<ul id="toc-Research_directions-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-References"
		class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded">
		<a class="vector-toc-link" href="#References">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">10</span>References</div>
		</a>
		
		<ul id="toc-References-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-Further_reading"
		class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded">
		<a class="vector-toc-link" href="#Further_reading">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">11</span>Further reading</div>
		</a>
		
		<ul id="toc-Further_reading-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-External_links"
		class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded">
		<a class="vector-toc-link" href="#External_links">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">12</span>External links</div>
		</a>
		
		<ul id="toc-External_links-sublist" class="vector-toc-list">
		</ul>
	</li>
</ul>
</div>

			</div>
		</nav>
		<div class="mw-content-container">
			<main id="content" class="mw-body" role="main">
				<header class="mw-body-header vector-page-titlebar">
					<label
						id="vector-toc-collapsed-button"
						class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet vector-button-flush-left cdx-button--icon-only"
						for="vector-toc-collapsed-checkbox"
						role="button"
						aria-controls="vector-toc"
						tabindex="0"
						title="Table of Contents">
						<span class="vector-icon mw-ui-icon-wikimedia-listBullet"></span>
						<span>Toggle the table of contents</span>
					</label>
				
					<nav role="navigation" aria-label="Contents" class="vector-toc-landmark">
						
<div id="vector-page-titlebar-toc" class="vector-menu vector-dropdown vector-menu-dropdown vector-page-titlebar-toc vector-button-flush-left"  >
	<input type="checkbox"
		id="vector-page-titlebar-toc-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-vector-page-titlebar-toc"
		class="vector-menu-checkbox "
		
		aria-label="Toggle the table of contents"
		
	/>
	<label
		id="vector-page-titlebar-toc-label"
		for="vector-page-titlebar-toc-checkbox"
		class="vector-menu-heading cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only "
		aria-hidden="true"
		
	>
		<span class="vector-icon mw-ui-icon-listBullet mw-ui-icon-wikimedia-listBullet"></span>


		<span class="vector-menu-heading-label">Toggle the table of contents</span>
	</label>
	<div class="vector-menu-content vector-dropdown-content">


							<div id="vector-page-titlebar-toc-unpinned-container" class="vector-unpinned-container">
			</div>
		
	</div>
</div>
					</nav>
					<h1 id="firstHeading" class="firstHeading mw-first-heading"><span class="mw-page-title-main">Guillain–Barré syndrome</span></h1>
				
							
<div id="p-lang-btn" class="vector-menu vector-dropdown vector-menu-dropdown mw-portlet mw-portlet-lang"  >
	<input type="checkbox"
		id="p-lang-btn-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-p-lang-btn"
		class="vector-menu-checkbox mw-interlanguage-selector"
		aria-label="Go to an article in another language. Available in 55 languages"
		
		
	/>
	<label
		id="p-lang-btn-label"
		for="p-lang-btn-checkbox"
		class="vector-menu-heading cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--action-progressive mw-portlet-lang-heading-55"
		aria-hidden="true"
		
	>
		<span class="vector-icon mw-ui-icon-language-progressive mw-ui-icon-wikimedia-language-progressive"></span>


		<span class="vector-menu-heading-label">55 languages</span>
	</label>
	<div class="vector-menu-content vector-dropdown-content">

		<div class="vector-menu-content">
			
			<ul class="vector-menu-content-list"><li class="interlanguage-link interwiki-af mw-list-item"><a href="https://af.wikipedia.org/wiki/Guillain-Barr%C3%A9-sindroom" title="Guillain-Barré-sindroom – Afrikaans" lang="af" hreflang="af" class="interlanguage-link-target"><span>Afrikaans</span></a></li><li class="interlanguage-link interwiki-ar badge-Q17437798 badge-goodarticle mw-list-item" title="good article badge"><a href="https://ar.wikipedia.org/wiki/%D9%85%D8%AA%D9%84%D8%A7%D8%B2%D9%85%D8%A9_%D8%BA%D9%8A%D9%84%D8%A7%D9%86_%D8%A8%D8%A7%D8%B1%D9%8A%D9%87" title="متلازمة غيلان باريه – Arabic" lang="ar" hreflang="ar" class="interlanguage-link-target"><span>العربية</span></a></li><li class="interlanguage-link interwiki-ast mw-list-item"><a href="https://ast.wikipedia.org/wiki/S%C3%ADndrome_de_Guillain-Barr%C3%A9" title="Síndrome de Guillain-Barré – Asturian" lang="ast" hreflang="ast" class="interlanguage-link-target"><span>Asturianu</span></a></li><li class="interlanguage-link interwiki-az mw-list-item"><a href="https://az.wikipedia.org/wiki/Guillain_Barre_sindromu" title="Guillain Barre sindromu – Azerbaijani" lang="az" hreflang="az" class="interlanguage-link-target"><span>Azərbaycanca</span></a></li><li class="interlanguage-link interwiki-bn mw-list-item"><a href="https://bn.wikipedia.org/wiki/%E0%A6%97%E0%A7%81%E0%A6%B2%E0%A7%87%E0%A6%A8_%E0%A6%AC%E0%A6%BE%E0%A6%B0%E0%A6%BF_%E0%A6%B8%E0%A6%BF%E0%A6%A8%E0%A6%A1%E0%A7%8D%E0%A6%B0%E0%A7%8B%E0%A6%AE" title="গুলেন বারি সিনড্রোম – Bangla" lang="bn" hreflang="bn" class="interlanguage-link-target"><span>বাংলা</span></a></li><li class="interlanguage-link interwiki-bg mw-list-item"><a href="https://bg.wikipedia.org/wiki/%D0%A1%D0%B8%D0%BD%D0%B4%D1%80%D0%BE%D0%BC_%D0%BD%D0%B0_%D0%93%D0%B8%D0%BB%D0%B5%D0%BD-%D0%91%D0%B0%D1%80%D0%B5" title="Синдром на Гилен-Баре – Bulgarian" lang="bg" hreflang="bg" class="interlanguage-link-target"><span>Български</span></a></li><li class="interlanguage-link interwiki-bs mw-list-item"><a href="https://bs.wikipedia.org/wiki/Guillain-Barr%C3%A9ov_sindrom" title="Guillain-Barréov sindrom – Bosnian" lang="bs" hreflang="bs" class="interlanguage-link-target"><span>Bosanski</span></a></li><li class="interlanguage-link interwiki-ca mw-list-item"><a href="https://ca.wikipedia.org/wiki/S%C3%ADndrome_de_Guillain-Barr%C3%A9" title="Síndrome de Guillain-Barré – Catalan" lang="ca" hreflang="ca" class="interlanguage-link-target"><span>Català</span></a></li><li class="interlanguage-link interwiki-cs mw-list-item"><a href="https://cs.wikipedia.org/wiki/Guillain%C5%AFv%E2%80%93Barr%C3%A9ho_syndrom" title="Guillainův–Barrého syndrom – Czech" lang="cs" hreflang="cs" class="interlanguage-link-target"><span>Čeština</span></a></li><li class="interlanguage-link interwiki-da mw-list-item"><a href="https://da.wikipedia.org/wiki/Guillain-Barr%C3%A9s_syndrom" title="Guillain-Barrés syndrom – Danish" lang="da" hreflang="da" class="interlanguage-link-target"><span>Dansk</span></a></li><li class="interlanguage-link interwiki-de mw-list-item"><a href="https://de.wikipedia.org/wiki/Guillain-Barr%C3%A9-Syndrom" title="Guillain-Barré-Syndrom – German" lang="de" hreflang="de" class="interlanguage-link-target"><span>Deutsch</span></a></li><li class="interlanguage-link interwiki-el mw-list-item"><a href="https://el.wikipedia.org/wiki/%CE%A3%CF%8D%CE%BD%CE%B4%CF%81%CE%BF%CE%BC%CE%BF_%CE%93%CE%BA%CE%B9%CE%BB%CE%B1%CE%AF%CE%BD-%CE%9C%CF%80%CE%B1%CF%81%CE%AD" title="Σύνδρομο Γκιλαίν-Μπαρέ – Greek" lang="el" hreflang="el" class="interlanguage-link-target"><span>Ελληνικά</span></a></li><li class="interlanguage-link interwiki-es mw-list-item"><a href="https://es.wikipedia.org/wiki/S%C3%ADndrome_de_Guillain-Barr%C3%A9" title="Síndrome de Guillain-Barré – Spanish" lang="es" hreflang="es" class="interlanguage-link-target"><span>Español</span></a></li><li class="interlanguage-link interwiki-eo mw-list-item"><a href="https://eo.wikipedia.org/wiki/Sindromo_de_Guillain-Barr%C3%A9" title="Sindromo de Guillain-Barré – Esperanto" lang="eo" hreflang="eo" class="interlanguage-link-target"><span>Esperanto</span></a></li><li class="interlanguage-link interwiki-eu mw-list-item"><a href="https://eu.wikipedia.org/wiki/Guillain-Barr%C3%A9ren_sindrome" title="Guillain-Barréren sindrome – Basque" lang="eu" hreflang="eu" class="interlanguage-link-target"><span>Euskara</span></a></li><li class="interlanguage-link interwiki-fa mw-list-item"><a href="https://fa.wikipedia.org/wiki/%D8%B3%D9%86%D8%AF%D8%B1%D9%88%D9%85_%DA%AF%DB%8C%D9%84%D9%86_%D8%A8%D8%A7%D8%B1%D9%87" title="سندروم گیلن باره – Persian" lang="fa" hreflang="fa" class="interlanguage-link-target"><span>فارسی</span></a></li><li class="interlanguage-link interwiki-fr mw-list-item"><a href="https://fr.wikipedia.org/wiki/Syndrome_de_Guillain-Barr%C3%A9" title="Syndrome de Guillain-Barré – French" lang="fr" hreflang="fr" class="interlanguage-link-target"><span>Français</span></a></li><li class="interlanguage-link interwiki-ga mw-list-item"><a href="https://ga.wikipedia.org/wiki/Siondr%C3%B3m_Guillain-Barr%C3%A9" title="Siondróm Guillain-Barré – Irish" lang="ga" hreflang="ga" class="interlanguage-link-target"><span>Gaeilge</span></a></li><li class="interlanguage-link interwiki-ko mw-list-item"><a href="https://ko.wikipedia.org/wiki/%EA%B8%B8%EB%9E%91-%EB%B0%94%EB%A0%88_%EC%A6%9D%ED%9B%84%EA%B5%B0" title="길랑-바레 증후군 – Korean" lang="ko" hreflang="ko" class="interlanguage-link-target"><span>한국어</span></a></li><li class="interlanguage-link interwiki-hy mw-list-item"><a href="https://hy.wikipedia.org/wiki/%D4%B3%D5%AB%D5%B5%D5%A5%D5%B6-%D4%B2%D5%A1%D6%80%D5%A5_%D5%B0%D5%A1%D5%B4%D5%A1%D5%AD%D5%BF%D5%A1%D5%B6%D5%AB%D5%B7" title="Գիյեն-Բարե համախտանիշ – Armenian" lang="hy" hreflang="hy" class="interlanguage-link-target"><span>Հայերեն</span></a></li><li class="interlanguage-link interwiki-hr mw-list-item"><a href="https://hr.wikipedia.org/wiki/Guillain-Barr%C3%A9ov_sindrom" title="Guillain-Barréov sindrom – Croatian" lang="hr" hreflang="hr" class="interlanguage-link-target"><span>Hrvatski</span></a></li><li class="interlanguage-link interwiki-id mw-list-item"><a href="https://id.wikipedia.org/wiki/Sindrom_Guillain%E2%80%93Barr%C3%A9" title="Sindrom Guillain–Barré – Indonesian" lang="id" hreflang="id" class="interlanguage-link-target"><span>Bahasa Indonesia</span></a></li><li class="interlanguage-link interwiki-ia mw-list-item"><a href="https://ia.wikipedia.org/wiki/Syndrome_de_Guillain-Barr%C3%A9" title="Syndrome de Guillain-Barré – Interlingua" lang="ia" hreflang="ia" class="interlanguage-link-target"><span>Interlingua</span></a></li><li class="interlanguage-link interwiki-it mw-list-item"><a href="https://it.wikipedia.org/wiki/Sindrome_di_Guillain-Barr%C3%A9" title="Sindrome di Guillain-Barré – Italian" lang="it" hreflang="it" class="interlanguage-link-target"><span>Italiano</span></a></li><li class="interlanguage-link interwiki-he mw-list-item"><a href="https://he.wikipedia.org/wiki/%D7%AA%D7%A1%D7%9E%D7%95%D7%A0%D7%AA_%D7%92%D7%99%D7%99%D7%90%D7%9F-%D7%91%D7%90%D7%A8%D7%94" title="תסמונת גייאן-בארה – Hebrew" lang="he" hreflang="he" class="interlanguage-link-target"><span>עברית</span></a></li><li class="interlanguage-link interwiki-lb mw-list-item"><a href="https://lb.wikipedia.org/wiki/Guillain-Barr%C3%A9-Syndrom" title="Guillain-Barré-Syndrom – Luxembourgish" lang="lb" hreflang="lb" class="interlanguage-link-target"><span>Lëtzebuergesch</span></a></li><li class="interlanguage-link interwiki-lfn mw-list-item"><a href="https://lfn.wikipedia.org/wiki/Sindrom_de_Guillain-Barr%C3%A9" title="Sindrom de Guillain-Barré – Lingua Franca Nova" lang="lfn" hreflang="lfn" class="interlanguage-link-target"><span>Lingua Franca Nova</span></a></li><li class="interlanguage-link interwiki-hu badge-Q17437796 badge-featuredarticle mw-list-item" title="featured article badge"><a href="https://hu.wikipedia.org/wiki/Guillain%E2%80%93Barr%C3%A9-szindr%C3%B3ma" title="Guillain–Barré-szindróma – Hungarian" lang="hu" hreflang="hu" class="interlanguage-link-target"><span>Magyar</span></a></li><li class="interlanguage-link interwiki-mk mw-list-item"><a href="https://mk.wikipedia.org/wiki/%D0%93%D0%B8%D1%98%D0%B5%D0%BD-%D0%91%D0%B0%D1%80%D0%B5%D0%BE%D0%B2_%D1%81%D0%B8%D0%BD%D0%B4%D1%80%D0%BE%D0%BC" title="Гијен-Бареов синдром – Macedonian" lang="mk" hreflang="mk" class="interlanguage-link-target"><span>Македонски</span></a></li><li class="interlanguage-link interwiki-ms mw-list-item"><a href="https://ms.wikipedia.org/wiki/Sindrom_Guillain-Barr%C3%A9" title="Sindrom Guillain-Barré – Malay" lang="ms" hreflang="ms" class="interlanguage-link-target"><span>Bahasa Melayu</span></a></li><li class="interlanguage-link interwiki-nl mw-list-item"><a href="https://nl.wikipedia.org/wiki/Syndroom_van_Guillain-Barr%C3%A9" title="Syndroom van Guillain-Barré – Dutch" lang="nl" hreflang="nl" class="interlanguage-link-target"><span>Nederlands</span></a></li><li class="interlanguage-link interwiki-ja mw-list-item"><a href="https://ja.wikipedia.org/wiki/%E3%82%AE%E3%83%A9%E3%83%B3%E3%83%BB%E3%83%90%E3%83%AC%E3%83%BC%E7%97%87%E5%80%99%E7%BE%A4" title="ギラン・バレー症候群 – Japanese" lang="ja" hreflang="ja" class="interlanguage-link-target"><span>日本語</span></a></li><li class="interlanguage-link interwiki-no mw-list-item"><a href="https://no.wikipedia.org/wiki/Guillain-Barr%C3%A9_syndrom" title="Guillain-Barré syndrom – Norwegian Bokmål" lang="nb" hreflang="nb" class="interlanguage-link-target"><span>Norsk bokmål</span></a></li><li class="interlanguage-link interwiki-nn mw-list-item"><a href="https://nn.wikipedia.org/wiki/Guillain-Barr%C3%A9-syndrom" title="Guillain-Barré-syndrom – Norwegian Nynorsk" lang="nn" hreflang="nn" class="interlanguage-link-target"><span>Norsk nynorsk</span></a></li><li class="interlanguage-link interwiki-or mw-list-item"><a href="https://or.wikipedia.org/wiki/%E0%AC%97%E0%AD%81%E0%AC%B2%E0%AD%87%E0%AC%A8-%E0%AC%AC%E0%AC%BE%E0%AC%B0%E0%AD%87_%E0%AC%B8%E0%AC%BF%E0%AC%A3%E0%AD%8D%E0%AC%A1%E0%AD%8D%E0%AC%B0%E0%AD%8B%E0%AC%AE" title="ଗୁଲେନ-ବାରେ ସିଣ୍ଡ୍ରୋମ – Odia" lang="or" hreflang="or" class="interlanguage-link-target"><span>ଓଡ଼ିଆ</span></a></li><li class="interlanguage-link interwiki-pms mw-list-item"><a href="https://pms.wikipedia.org/wiki/S%C3%ACndrom_%C3%ABd_Guillain-Barr%C3%A9" title="Sìndrom ëd Guillain-Barré – Piedmontese" lang="pms" hreflang="pms" class="interlanguage-link-target"><span>Piemontèis</span></a></li><li class="interlanguage-link interwiki-pl mw-list-item"><a href="https://pl.wikipedia.org/wiki/Zesp%C3%B3%C5%82_Guillaina-Barr%C3%A9go" title="Zespół Guillaina-Barrégo – Polish" lang="pl" hreflang="pl" class="interlanguage-link-target"><span>Polski</span></a></li><li class="interlanguage-link interwiki-pt mw-list-item"><a href="https://pt.wikipedia.org/wiki/S%C3%ADndrome_de_Guillain-Barr%C3%A9" title="Síndrome de Guillain-Barré – Portuguese" lang="pt" hreflang="pt" class="interlanguage-link-target"><span>Português</span></a></li><li class="interlanguage-link interwiki-ro mw-list-item"><a href="https://ro.wikipedia.org/wiki/Sindromul_Guillain-Barr%C3%A9" title="Sindromul Guillain-Barré – Romanian" lang="ro" hreflang="ro" class="interlanguage-link-target"><span>Română</span></a></li><li class="interlanguage-link interwiki-ru mw-list-item"><a href="https://ru.wikipedia.org/wiki/%D0%A1%D0%B8%D0%BD%D0%B4%D1%80%D0%BE%D0%BC_%D0%93%D0%B8%D0%B9%D0%B5%D0%BD%D0%B0_%E2%80%94_%D0%91%D0%B0%D1%80%D1%80%D0%B5" title="Синдром Гийена — Барре – Russian" lang="ru" hreflang="ru" class="interlanguage-link-target"><span>Русский</span></a></li><li class="interlanguage-link interwiki-si mw-list-item"><a href="https://si.wikipedia.org/wiki/%E0%B6%9C%E0%B7%92%E0%B6%BD%E0%B6%B1%E0%B7%8A_%E0%B6%B6%E0%B7%8F%E0%B6%BB%E0%B7%9A_%E0%B7%83%E0%B7%84%E0%B6%BD%E0%B6%9A%E0%B7%8A%E0%B7%82%E0%B6%AB%E0%B6%BA" title="ගිලන් බාරේ සහලක්ෂණය – Sinhala" lang="si" hreflang="si" class="interlanguage-link-target"><span>සිංහල</span></a></li><li class="interlanguage-link interwiki-simple mw-list-item"><a href="https://simple.wikipedia.org/wiki/Guillain%E2%80%93Barr%C3%A9_syndrome" title="Guillain–Barré syndrome – Simple English" lang="en-simple" hreflang="en-simple" class="interlanguage-link-target"><span>Simple English</span></a></li><li class="interlanguage-link interwiki-sk mw-list-item"><a href="https://sk.wikipedia.org/wiki/Guillainov-Barr%C3%A9ho_syndr%C3%B3m" title="Guillainov-Barrého syndróm – Slovak" lang="sk" hreflang="sk" class="interlanguage-link-target"><span>Slovenčina</span></a></li><li class="interlanguage-link interwiki-sl mw-list-item"><a href="https://sl.wikipedia.org/wiki/Guillain-Barr%C3%A9jev_sindrom" title="Guillain-Barréjev sindrom – Slovenian" lang="sl" hreflang="sl" class="interlanguage-link-target"><span>Slovenščina</span></a></li><li class="interlanguage-link interwiki-ckb mw-list-item"><a href="https://ckb.wikipedia.org/wiki/%D8%B3%DB%8C%D9%86%D8%AF%D8%B1%DB%86%D9%85%DB%8C_%DA%AF%DB%8C%D9%84%DB%95%D9%86_%D8%A8%D8%A7%D8%B1%DB%8E" title="سیندرۆمی گیلەن بارێ – Central Kurdish" lang="ckb" hreflang="ckb" class="interlanguage-link-target"><span>کوردی</span></a></li><li class="interlanguage-link interwiki-sr mw-list-item"><a href="https://sr.wikipedia.org/wiki/%D0%93%D0%B8%D0%BB%D0%B5%D0%BD-%D0%91%D0%B0%D1%80%D0%B5%D0%BE%D0%B2_%D1%81%D0%B8%D0%BD%D0%B4%D1%80%D0%BE%D0%BC" title="Гилен-Бареов синдром – Serbian" lang="sr" hreflang="sr" class="interlanguage-link-target"><span>Српски / srpski</span></a></li><li class="interlanguage-link interwiki-sh mw-list-item"><a href="https://sh.wikipedia.org/wiki/Guillain-Barr%C3%A9ov_sindrom" title="Guillain-Barréov sindrom – Serbo-Croatian" lang="sh" hreflang="sh" class="interlanguage-link-target"><span>Srpskohrvatski / српскохрватски</span></a></li><li class="interlanguage-link interwiki-fi mw-list-item"><a href="https://fi.wikipedia.org/wiki/Guillain%E2%80%93Barr%C3%A9n_oireyhtym%C3%A4" title="Guillain–Barrén oireyhtymä – Finnish" lang="fi" hreflang="fi" class="interlanguage-link-target"><span>Suomi</span></a></li><li class="interlanguage-link interwiki-sv mw-list-item"><a href="https://sv.wikipedia.org/wiki/Guillain-Barr%C3%A9s_syndrom" title="Guillain-Barrés syndrom – Swedish" lang="sv" hreflang="sv" class="interlanguage-link-target"><span>Svenska</span></a></li><li class="interlanguage-link interwiki-th mw-list-item"><a href="https://th.wikipedia.org/wiki/%E0%B8%81%E0%B8%A5%E0%B8%B8%E0%B9%88%E0%B8%A1%E0%B8%AD%E0%B8%B2%E0%B8%81%E0%B8%B2%E0%B8%A3%E0%B8%81%E0%B8%B4%E0%B8%A5%E0%B9%81%E0%B8%A5%E0%B8%87-%E0%B8%9A%E0%B8%B2%E0%B8%A3%E0%B9%8C%E0%B9%80%E0%B8%A3" title="กลุ่มอาการกิลแลง-บาร์เร – Thai" lang="th" hreflang="th" class="interlanguage-link-target"><span>ไทย</span></a></li><li class="interlanguage-link interwiki-tr mw-list-item"><a href="https://tr.wikipedia.org/wiki/Guillain-Barr%C3%A9_sendromu" title="Guillain-Barré sendromu – Turkish" lang="tr" hreflang="tr" class="interlanguage-link-target"><span>Türkçe</span></a></li><li class="interlanguage-link interwiki-uk mw-list-item"><a href="https://uk.wikipedia.org/wiki/%D0%A1%D0%B8%D0%BD%D0%B4%D1%80%D0%BE%D0%BC_%D0%93%D1%96%D1%94%D0%BD%D0%B0_%E2%80%94_%D0%91%D0%B0%D1%80%D1%80%D0%B5" title="Синдром Гієна — Барре – Ukrainian" lang="uk" hreflang="uk" class="interlanguage-link-target"><span>Українська</span></a></li><li class="interlanguage-link interwiki-vi mw-list-item"><a href="https://vi.wikipedia.org/wiki/H%E1%BB%99i_ch%E1%BB%A9ng_Guillain-Barr%C3%A9" title="Hội chứng Guillain-Barré – Vietnamese" lang="vi" hreflang="vi" class="interlanguage-link-target"><span>Tiếng Việt</span></a></li><li class="interlanguage-link interwiki-zh-yue mw-list-item"><a href="https://zh-yue.wikipedia.org/wiki/%E5%90%89%E5%B7%B4%E6%B0%8F%E7%B6%9C%E5%90%88%E7%97%87" title="吉巴氏綜合症 – Cantonese" lang="yue" hreflang="yue" class="interlanguage-link-target"><span>粵語</span></a></li><li class="interlanguage-link interwiki-zh mw-list-item"><a href="https://zh.wikipedia.org/wiki/%E6%A0%BC%E6%9E%97-%E5%B7%B4%E5%88%A9%E7%BB%BC%E5%90%88%E5%BE%81" title="格林-巴利综合征 – Chinese" lang="zh" hreflang="zh" class="interlanguage-link-target"><span>中文</span></a></li></ul>
			<div class="after-portlet after-portlet-lang"><span class="wb-langlinks-edit wb-langlinks-link"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q205214#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>
		</div>

	</div>
</div>
				</header>
				<div class="vector-page-toolbar">
					<div class="vector-page-toolbar-container">
						<div id="left-navigation">
							<nav aria-label="Namespaces">
								
<div id="p-associated-pages" class="vector-menu vector-menu-tabs mw-portlet mw-portlet-associated-pages"  >
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list">
			<li id="ca-nstab-main" class="selected vector-tab-noicon mw-list-item"><a data-mw="interface" href="/wiki/Guillain%E2%80%93Barr%C3%A9_syndrome" title="View the content page [c]" accesskey="c" class=""><span>Article</span></a>
</li>
<li id="ca-talk" class="vector-tab-noicon mw-list-item"><a data-mw="interface" href="/wiki/Talk:Guillain%E2%80%93Barr%C3%A9_syndrome" rel="discussion" title="Discuss improvements to the content page [t]" accesskey="t" class=""><span>Talk</span></a>
</li>

		</ul>
		
	</div>
</div>

								

<div id="p-variants" class="vector-menu vector-dropdown vector-menu-dropdown mw-portlet mw-portlet-variants emptyPortlet"  >
	<input type="checkbox"
		id="p-variants-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-p-variants"
		class="vector-menu-checkbox"
		aria-label="Change language variant"
		
		
	/>
	<label
		id="p-variants-label"
		for="p-variants-checkbox"
		class="vector-menu-heading "
		aria-hidden="true"
		
	>
		
		<span class="vector-menu-heading-label">English</span>
	</label>
	<div class="vector-menu-content vector-dropdown-content">

	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"></ul>
		
	</div>

	</div>
</div>
							</nav>
						</div>
						<div id="right-navigation" class="vector-collapsible">
							<nav aria-label="Views">
								
<div id="p-views" class="vector-menu vector-menu-tabs mw-portlet mw-portlet-views"  >
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list">
			<li id="ca-view" class="selected vector-tab-noicon mw-list-item"><a data-mw="interface" href="/wiki/Guillain%E2%80%93Barr%C3%A9_syndrome" class=""><span>Read</span></a>
</li>
<li id="ca-edit" class="vector-tab-noicon mw-list-item"><a data-mw="interface" href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=edit" title="Edit this page [e]" accesskey="e" class=""><span>Edit</span></a>
</li>
<li id="ca-history" class="vector-tab-noicon mw-list-item"><a data-mw="interface" href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=history" title="Past revisions of this page [h]" accesskey="h" class=""><span>View history</span></a>
</li>

		</ul>
		
	</div>
</div>

							</nav>
				
							<nav class="vector-page-tools-landmark" aria-label="More options">
								
<div id="vector-page-tools-dropdown" class="vector-menu vector-dropdown vector-menu-dropdown vector-page-tools-dropdown"  >
	<input type="checkbox"
		id="vector-page-tools-dropdown-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-vector-page-tools-dropdown"
		class="vector-menu-checkbox "
		
		aria-label="Tools"
		
	/>
	<label
		id="vector-page-tools-dropdown-label"
		for="vector-page-tools-dropdown-checkbox"
		class="vector-menu-heading cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet"
		aria-hidden="true"
		
	>
		
		<span class="vector-menu-heading-label">Tools</span>
	</label>
	<div class="vector-menu-content vector-dropdown-content">


									<div id="vector-page-tools-unpinned-container" class="vector-unpinned-container">
						
<div id="vector-page-tools" class="vector-page-tools vector-pinnable-element">
	<div
	class="vector-pinnable-header vector-page-tools-pinnable-header vector-pinnable-header-unpinned"
	data-feature-name="page-tools-pinned"
	data-pinnable-element-id="vector-page-tools"
	data-pinned-container-id="vector-page-tools-pinned-container"
	data-unpinned-container-id="vector-page-tools-unpinned-container"
>
	<div class="vector-pinnable-header-label">Tools</div>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-page-tools.pin">move to sidebar</button>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-page-tools.unpin">hide</button>
</div>

	
<div id="p-cactions" class="vector-menu mw-portlet mw-portlet-cactions emptyPortlet vector-has-collapsible-items"  title="More options" >
	<div class="vector-menu-heading">
		Actions
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="ca-more-view" class="selected vector-more-collapsible-item mw-list-item"><a href="/wiki/Guillain%E2%80%93Barr%C3%A9_syndrome"><span>Read</span></a></li><li id="ca-more-edit" class="vector-more-collapsible-item mw-list-item"><a href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=edit"><span>Edit</span></a></li><li id="ca-more-history" class="vector-more-collapsible-item mw-list-item"><a href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=history"><span>View history</span></a></li></ul>
		
	</div>
</div>

<div id="p-tb" class="vector-menu mw-portlet mw-portlet-tb"  >
	<div class="vector-menu-heading">
		General
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="t-whatlinkshere" class="mw-list-item"><a href="/wiki/Special:WhatLinksHere/Guillain%E2%80%93Barr%C3%A9_syndrome" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j"><span>What links here</span></a></li><li id="t-recentchangeslinked" class="mw-list-item"><a href="/wiki/Special:RecentChangesLinked/Guillain%E2%80%93Barr%C3%A9_syndrome" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k"><span>Related changes</span></a></li><li id="t-upload" class="mw-list-item"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u"><span>Upload file</span></a></li><li id="t-specialpages" class="mw-list-item"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q"><span>Special pages</span></a></li><li id="t-permalink" class="mw-list-item"><a href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;oldid=1160020717" title="Permanent link to this revision of this page"><span>Permanent link</span></a></li><li id="t-info" class="mw-list-item"><a href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=info" title="More information about this page"><span>Page information</span></a></li><li id="t-cite" class="mw-list-item"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;id=1160020717&amp;wpFormIdentifier=titleform" title="Information on how to cite this page"><span>Cite this page</span></a></li><li id="t-wikibase" class="mw-list-item"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q205214" title="Structured data on this page hosted by Wikidata [g]" accesskey="g"><span>Wikidata item</span></a></li></ul>
		
	</div>
</div>

<div id="p-coll-print_export" class="vector-menu mw-portlet mw-portlet-coll-print_export"  >
	<div class="vector-menu-heading">
		Print/export
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="coll-download-as-rl" class="mw-list-item"><a href="/w/index.php?title=Special:DownloadAsPdf&amp;page=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=show-download-screen" title="Download this page as a PDF file"><span>Download as PDF</span></a></li><li id="t-print" class="mw-list-item"><a href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;printable=yes" title="Printable version of this page [p]" accesskey="p"><span>Printable version</span></a></li></ul>
		
	</div>
</div>

<div id="p-wikibase-otherprojects" class="vector-menu mw-portlet mw-portlet-wikibase-otherprojects"  >
	<div class="vector-menu-heading">
		In other projects
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li class="wb-otherproject-link wb-otherproject-commons mw-list-item"><a href="https://commons.wikimedia.org/wiki/Category:Guillain%E2%80%93Barr%C3%A9_syndrome" hreflang="en"><span>Wikimedia Commons</span></a></li></ul>
		
	</div>
</div>

</div>

									</div>
				
	</div>
</div>
							</nav>
						</div>
					</div>
				</div>
				<div class="vector-column-end">
					<nav class="vector-page-tools-landmark vector-sticky-pinned-container" aria-label="More options">
						<div id="vector-page-tools-pinned-container" class="vector-pinned-container">
			
						</div>
	</nav>
				</div>
				<div id="bodyContent" class="vector-body" aria-labelledby="firstHeading" data-mw-ve-target-container>
					<div class="vector-body-before-content">
							<div class="mw-indicators">
		<div id="mw-indicator-good-star" class="mw-indicator"><div class="mw-parser-output"><a href="/wiki/Wikipedia:Good_articles" title="This is a good article. Click here for more information."><img alt="This is a good article. Click here for more information." src="//upload.wikimedia.org/wikipedia/en/thumb/9/94/Symbol_support_vote.svg/19px-Symbol_support_vote.svg.png" decoding="async" width="19" height="20" srcset="//upload.wikimedia.org/wikipedia/en/thumb/9/94/Symbol_support_vote.svg/29px-Symbol_support_vote.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/94/Symbol_support_vote.svg/39px-Symbol_support_vote.svg.png 2x" data-file-width="180" data-file-height="185" /></a></div></div>
		</div>

						<div id="siteSub" class="noprint">From Wikipedia, the free encyclopedia</div>
					</div>
					<div id="contentSub"><div id="mw-content-subtitle"></div></div>
					
					
					<div id="mw-content-text" class="mw-body-content mw-content-ltr" lang="en" dir="ltr"><div class="mw-parser-output"><div class="shortdescription nomobile noexcerpt noprint searchaux" style="display:none">Autoimmune disease affecting the peripheral nervous system</div>
<p class="mw-empty-elt">
</p>
<div class="shortdescription nomobile noexcerpt noprint searchaux" style="display:none">Medical condition</div><style data-mw-deduplicate="TemplateStyles:r1066479718">.mw-parser-output .infobox-subbox{padding:0;border:none;margin:-3px;width:auto;min-width:100%;font-size:100%;clear:none;float:none;background-color:transparent}.mw-parser-output .infobox-3cols-child{margin:auto}.mw-parser-output .infobox .navbar{font-size:100%}body.skin-minerva .mw-parser-output .infobox-header,body.skin-minerva .mw-parser-output .infobox-subheader,body.skin-minerva .mw-parser-output .infobox-above,body.skin-minerva .mw-parser-output .infobox-title,body.skin-minerva .mw-parser-output .infobox-image,body.skin-minerva .mw-parser-output .infobox-full-data,body.skin-minerva .mw-parser-output .infobox-below{text-align:center}</style><table class="infobox"><tbody><tr><th colspan="2" class="infobox-above" style="background:#ccc">Guillain–Barré syndrome</th></tr><tr><th scope="row" class="infobox-label">Other names</th><td class="infobox-data">Guillain–Barré–Strohl syndrome, Landry's paralysis, postinfectious polyneuritis<sup id="cite_ref-Fer2016_1-0" class="reference"><a href="#cite_note-Fer2016-1">&#91;1&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label">Pronunciation</th><td class="infobox-data"><style data-mw-deduplicate="TemplateStyles:r1126788409">.mw-parser-output .plainlist ol,.mw-parser-output .plainlist ul{line-height:inherit;list-style:none;margin:0;padding:0}.mw-parser-output .plainlist ol li,.mw-parser-output .plainlist ul li{margin-bottom:0}</style><div class="plainlist"><ul><li><span class="rt-commentedText nowrap"><small><a href="/wiki/British_English" title="British English">UK</a>: </small><span class="IPA nopopups noexcerpt" lang="en-fonipa"><a href="/wiki/Help:IPA/English" title="Help:IPA/English">/<span style="border-bottom:1px dotted"><span title="/ˈ/: primary stress follows">ˈ</span><span title="/ɡ/: &#39;g&#39; in &#39;guy&#39;">ɡ</span><span title="/iː/: &#39;ee&#39; in &#39;fleece&#39;">iː</span><span title="/j/: &#39;y&#39; in &#39;yes&#39;">j</span><span title="/æ̃/: nasal &#39;in&#39; in &#39;vin blanc&#39;">æ̃</span></span><span class="wrap"> </span><span style="border-bottom:1px dotted"><span title="/ˈ/: primary stress follows">ˈ</span><span title="&#39;b&#39; in &#39;buy&#39;">b</span><span title="/ær/: &#39;arr&#39; in &#39;marry&#39;">ær</span><span title="/eɪ/: &#39;a&#39; in &#39;face&#39;">eɪ</span></span>/</a></span></span><br /><span class="rt-commentedText nowrap"><small><a href="/wiki/American_English" title="American English">US</a>: </small><span class="IPA nopopups noexcerpt" lang="en-fonipa"><a href="/wiki/Help:IPA/English" title="Help:IPA/English">/<span style="border-bottom:1px dotted"><span title="/ˌ/: secondary stress follows">ˌ</span><span title="/ɡ/: &#39;g&#39; in &#39;guy&#39;">ɡ</span><span title="/i/: &#39;y&#39; in &#39;happy&#39;">i</span><span title="/ˈ/: primary stress follows">ˈ</span><span title="&#39;l&#39; in &#39;lie&#39;">l</span><span title="/æ/: &#39;a&#39; in &#39;bad&#39;">æ</span><span title="&#39;n&#39; in &#39;nigh&#39;">n</span></span><span class="wrap"> </span><span style="border-bottom:1px dotted"><span title="/ˌ/: secondary stress follows">ˌ</span><span title="&#39;b&#39; in &#39;buy&#39;">b</span><span title="/ɑː/: &#39;a&#39; in &#39;father&#39;">ɑː</span><span title="/ˈ/: primary stress follows">ˈ</span><span title="&#39;r&#39; in &#39;rye&#39;">r</span><span title="/eɪ/: &#39;a&#39; in &#39;face&#39;">eɪ</span></span>/</a></span></span><sup id="cite_ref-2" class="reference"><a href="#cite_note-2">&#91;2&#93;</a></sup><br /><small>French:&#160;</small><span title="Representation in the International Phonetic Alphabet (IPA)" class="IPA" lang="fr-Latn-fonipa"><a href="/wiki/Help:IPA/French" title="Help:IPA/French">[ɡilɛ̃ baʁe]</a></span>&#x20;</li></ul></div></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Medical_specialty" title="Medical specialty">Specialty</a></th><td class="infobox-data"><a href="/wiki/Neurology" title="Neurology">Neurology</a></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Signs_and_symptoms" title="Signs and symptoms">Symptoms</a></th><td class="infobox-data">Muscle weakness beginning in the feet and hands, usually ascending<sup id="cite_ref-NIH2016_3-0" class="reference"><a href="#cite_note-NIH2016-3">&#91;3&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Complication_(medicine)" title="Complication (medicine)">Complications</a></th><td class="infobox-data">Breathing difficulties, heart and blood pressure problems<sup id="cite_ref-Fer2016_1-1" class="reference"><a href="#cite_note-Fer2016-1">&#91;1&#93;</a></sup><sup id="cite_ref-NIH2016_3-1" class="reference"><a href="#cite_note-NIH2016-3">&#91;3&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label">Usual onset</th><td class="infobox-data">Rapid (hours to weeks)<sup id="cite_ref-NIH2016_3-2" class="reference"><a href="#cite_note-NIH2016-3">&#91;3&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label">Causes</th><td class="infobox-data">Typically triggered by an infection; occasionally by surgery and by vaccination</td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Medical_diagnosis" title="Medical diagnosis">Diagnostic method</a></th><td class="infobox-data">Based on symptoms, <a href="/wiki/Nerve_conduction_study" title="Nerve conduction study">nerve conduction studies</a>, <a href="/wiki/Lumbar_puncture" title="Lumbar puncture">lumbar puncture</a><sup id="cite_ref-NIH2016_3-3" class="reference"><a href="#cite_note-NIH2016-3">&#91;3&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label">Treatment</th><td class="infobox-data"><a href="/wiki/Supportive_care" class="mw-redirect" title="Supportive care">Supportive care</a>, <a href="/wiki/Intravenous_immunoglobulin" class="mw-redirect" title="Intravenous immunoglobulin">intravenous immunoglobulin</a>, <a href="/wiki/Plasmapheresis" title="Plasmapheresis">plasmapheresis</a></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Prognosis" title="Prognosis">Prognosis</a></th><td class="infobox-data">Weeks to years for recovery<sup id="cite_ref-NIH2016_3-4" class="reference"><a href="#cite_note-NIH2016-3">&#91;3&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label">Frequency</th><td class="infobox-data">2 per 100,000 people per year<sup id="cite_ref-NIH2016_3-5" class="reference"><a href="#cite_note-NIH2016-3">&#91;3&#93;</a></sup><sup id="cite_ref-Sejvar2011_4-0" class="reference"><a href="#cite_note-Sejvar2011-4">&#91;4&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label">Deaths</th><td class="infobox-data">7.5% of those affected<sup id="cite_ref-Fer2016_1-2" class="reference"><a href="#cite_note-Fer2016-1">&#91;1&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Eponym" title="Eponym">Named after</a></th><td class="infobox-data"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409"><div class="plainlist"><ul><li><a href="/wiki/Georges_Guillain" title="Georges Guillain">Georges Guillain</a></li><li><a href="/wiki/Jean_Alexandre_Barr%C3%A9" title="Jean Alexandre Barré">Jean Alexandre Barré</a></li></ul></div></td></tr></tbody></table>
<p><b>Guillain–Barré syndrome</b> (<b>GBS</b>) is a rapid-onset <a href="/wiki/Paralysis" title="Paralysis">muscle weakness</a> caused by the <a href="/wiki/Immune_system" title="Immune system">immune system</a> damaging the <a href="/wiki/Peripheral_nervous_system" title="Peripheral nervous system">peripheral nervous system</a>.<sup id="cite_ref-NIH2016_3-6" class="reference"><a href="#cite_note-NIH2016-3">&#91;3&#93;</a></sup> Typically, both sides of the body are involved, and the initial symptoms are changes in sensation or pain often in the back along with muscle weakness, beginning in the feet and hands, often spreading to the arms and upper body.<sup id="cite_ref-NIH2016_3-7" class="reference"><a href="#cite_note-NIH2016-3">&#91;3&#93;</a></sup> The symptoms may develop over hours to a few weeks.<sup id="cite_ref-NIH2016_3-8" class="reference"><a href="#cite_note-NIH2016-3">&#91;3&#93;</a></sup> During the acute phase, the disorder can be life-threatening, with about 15% of people developing weakness of the <a href="/wiki/Respiratory_system" title="Respiratory system">breathing muscles</a> and, therefore, requiring <a href="/wiki/Mechanical_ventilation" title="Mechanical ventilation">mechanical ventilation</a>.<sup id="cite_ref-Fer2016_1-3" class="reference"><a href="#cite_note-Fer2016-1">&#91;1&#93;</a></sup> Some are affected by <a href="/wiki/Dysautonomia" title="Dysautonomia">changes in the function</a> of the <a href="/wiki/Autonomic_nervous_system" title="Autonomic nervous system">autonomic nervous system</a>, which can lead to dangerous abnormalities in <a href="/wiki/Heart_rate" title="Heart rate">heart rate</a> and <a href="/wiki/Blood_pressure" title="Blood pressure">blood pressure</a>.<sup id="cite_ref-NIH2016_3-9" class="reference"><a href="#cite_note-NIH2016-3">&#91;3&#93;</a></sup>
</p><p>Although the cause is unknown, the underlying mechanism involves an <a href="/wiki/Autoimmune_disorder" class="mw-redirect" title="Autoimmune disorder">autoimmune disorder</a> in which the body's immune system mistakenly attacks the peripheral nerves and damages their <a href="/wiki/Myelin" title="Myelin">myelin</a> insulation.<sup id="cite_ref-NIH2016_3-10" class="reference"><a href="#cite_note-NIH2016-3">&#91;3&#93;</a></sup> Sometimes this immune dysfunction is triggered by an infection or, less commonly, by surgery, and rarely, by <a href="/wiki/Vaccination" title="Vaccination">vaccination</a>.<sup id="cite_ref-Fer2016_1-4" class="reference"><a href="#cite_note-Fer2016-1">&#91;1&#93;</a></sup><sup id="cite_ref-NIH2016_3-11" class="reference"><a href="#cite_note-NIH2016-3">&#91;3&#93;</a></sup> The diagnosis is usually based on the signs and symptoms through the exclusion of alternative causes and supported by tests such as <a href="/wiki/Nerve_conduction_study" title="Nerve conduction study">nerve conduction studies</a> and examination of the <a href="/wiki/Cerebrospinal_fluid" title="Cerebrospinal fluid">cerebrospinal fluid</a>.<sup id="cite_ref-NIH2016_3-12" class="reference"><a href="#cite_note-NIH2016-3">&#91;3&#93;</a></sup> There are a number of subtypes based on the areas of weakness, results of nerve conduction studies, and the presence of <a href="/wiki/Antiganglioside_antibodies" title="Antiganglioside antibodies">certain antibodies</a>.<sup id="cite_ref-NatRevNeurol2014_5-0" class="reference"><a href="#cite_note-NatRevNeurol2014-5">&#91;5&#93;</a></sup> It is classified as an acute <a href="/wiki/Polyneuropathy" title="Polyneuropathy">polyneuropathy</a>.<sup id="cite_ref-Fer2016_1-5" class="reference"><a href="#cite_note-Fer2016-1">&#91;1&#93;</a></sup>
</p><p>In those with severe weakness, prompt treatment with <a href="/wiki/Intravenous_immunoglobulin" class="mw-redirect" title="Intravenous immunoglobulin">intravenous immunoglobulins</a> or <a href="/wiki/Plasmapheresis" title="Plasmapheresis">plasmapheresis</a>, together with supportive care, will lead to good recovery in the majority of cases.<sup id="cite_ref-NIH2016_3-13" class="reference"><a href="#cite_note-NIH2016-3">&#91;3&#93;</a></sup> Recovery may take weeks to years, with about a third having some permanent weakness.<sup id="cite_ref-NIH2016_3-14" class="reference"><a href="#cite_note-NIH2016-3">&#91;3&#93;</a></sup> Globally, death occurs in approximately 7.5% of those affected.<sup id="cite_ref-Fer2016_1-6" class="reference"><a href="#cite_note-Fer2016-1">&#91;1&#93;</a></sup> Guillain–Barré syndrome is rare, at 1 or 2 cases per 100,000 people every year.<sup id="cite_ref-NIH2016_3-15" class="reference"><a href="#cite_note-NIH2016-3">&#91;3&#93;</a></sup><sup id="cite_ref-Sejvar2011_4-1" class="reference"><a href="#cite_note-Sejvar2011-4">&#91;4&#93;</a></sup> Both sexes and all parts of the world have similar rates of disease.<sup id="cite_ref-Fer2016_1-7" class="reference"><a href="#cite_note-Fer2016-1">&#91;1&#93;</a></sup><sup id="cite_ref-NIH2016_3-16" class="reference"><a href="#cite_note-NIH2016-3">&#91;3&#93;</a></sup> 
</p><p>The syndrome is named after the French <a href="/wiki/Neurologist" class="mw-redirect" title="Neurologist">neurologists</a> <a href="/wiki/Georges_Guillain" title="Georges Guillain">Georges Guillain</a> and <a href="/wiki/Jean_Alexandre_Barr%C3%A9" title="Jean Alexandre Barré">Jean Alexandre Barré</a>, who, together with French physician <a href="/wiki/Andr%C3%A9_Strohl" title="André Strohl">André Strohl</a>, described the condition in 1916.<sup id="cite_ref-vanDoorn2008_6-0" class="reference"><a href="#cite_note-vanDoorn2008-6">&#91;6&#93;</a></sup><sup id="cite_ref-Eldar2014_7-0" class="reference"><a href="#cite_note-Eldar2014-7">&#91;7&#93;</a></sup>
</p>
<meta property="mw:PageProp/toc" />
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=edit&amp;section=1" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The first symptoms of Guillain–Barré syndrome are numbness, tingling, and pain, alone or in combination. This is followed by weakness of the legs and arms that affects both sides equally and worsens over time.<sup id="cite_ref-Willison2016_8-0" class="reference"><a href="#cite_note-Willison2016-8">&#91;8&#93;</a></sup><sup id="cite_ref-NEJM2012_9-0" class="reference"><a href="#cite_note-NEJM2012-9">&#91;9&#93;</a></sup> The weakness can take half a day to over two weeks to reach maximum severity, and then becomes steady.<sup id="cite_ref-NEJM2012_9-1" class="reference"><a href="#cite_note-NEJM2012-9">&#91;9&#93;</a></sup> In one in five people, the weakness continues to progress for as long as four weeks.<sup id="cite_ref-NatRevNeurol2014_5-1" class="reference"><a href="#cite_note-NatRevNeurol2014-5">&#91;5&#93;</a></sup> The muscles of the neck may also be affected, and about half experience involvement of the <a href="/wiki/Cranial_nerves" title="Cranial nerves">cranial nerves</a> that supply the head and face; this may lead to <a href="/wiki/Facial_weakness" title="Facial weakness">weakness of the muscles of the face</a>, <a href="/wiki/Dysphagia" title="Dysphagia">swallowing difficulties</a> and sometimes <a href="/wiki/Ophthalmoparesis" title="Ophthalmoparesis">weakness of the eye muscles</a>.<sup id="cite_ref-NatRevNeurol2014_5-2" class="reference"><a href="#cite_note-NatRevNeurol2014-5">&#91;5&#93;</a></sup> In 8%, the weakness <a href="/wiki/Paraplegia" title="Paraplegia">affects only the legs</a> (paraplegia or paraparesis).<sup id="cite_ref-NatRevNeurol2014_5-3" class="reference"><a href="#cite_note-NatRevNeurol2014-5">&#91;5&#93;</a></sup> Involvement of the muscles that control the bladder and anus is unusual.<sup id="cite_ref-NEJM2012_9-2" class="reference"><a href="#cite_note-NEJM2012-9">&#91;9&#93;</a></sup> In total, about a third of people with Guillain–Barré syndrome continue to be able to walk.<sup id="cite_ref-NatRevNeurol2014_5-4" class="reference"><a href="#cite_note-NatRevNeurol2014-5">&#91;5&#93;</a></sup> Once the weakness has stopped progressing, it persists at a stable level ("plateau phase") before improvement occurs. The plateau phase can take between two days and six months, but the most common duration is a week.<sup id="cite_ref-NatRevNeurol2014_5-5" class="reference"><a href="#cite_note-NatRevNeurol2014-5">&#91;5&#93;</a></sup> Pain-related symptoms affect more than half, and include <a href="/wiki/Back_pain" title="Back pain">back pain</a>, painful tingling, <a href="/wiki/Myalgia" title="Myalgia">muscle pain</a>, and pain in the head and neck relating to irritation of the lining of the brain.<sup id="cite_ref-NatRevNeurol2014_5-6" class="reference"><a href="#cite_note-NatRevNeurol2014-5">&#91;5&#93;</a></sup>
</p><p>Many people with Guillain–Barré syndrome have experienced the signs and symptoms of an infection in the 3–6 weeks before the onset of the neurological symptoms. This may consist of <a href="/wiki/Upper_respiratory_tract_infection" title="Upper respiratory tract infection">upper respiratory tract infection</a> (rhinitis, sore throat), or <a href="/wiki/Diarrhea" title="Diarrhea">diarrhea</a>.<sup id="cite_ref-NEJM2012_9-3" class="reference"><a href="#cite_note-NEJM2012-9">&#91;9&#93;</a></sup>
</p>
<div class="thumb tright"><div class="thumbinner" style="width:402px;"><a href="/wiki/File:Guillain_Barre_Patterns.png" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/4/40/Guillain_Barre_Patterns.png/400px-Guillain_Barre_Patterns.png" decoding="async" width="400" height="145" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/4/40/Guillain_Barre_Patterns.png/600px-Guillain_Barre_Patterns.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/40/Guillain_Barre_Patterns.png/800px-Guillain_Barre_Patterns.png 2x" data-file-width="2128" data-file-height="773" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Guillain_Barre_Patterns.png" class="internal" title="Enlarge"></a></div>Various patterns of manifestation of Guillain–Barré syndrome</div></div></div>
<p>In children, particularly those younger than six years old, the diagnosis can be difficult and the condition is often initially mistaken (sometimes for up to two weeks) for other causes of pains and difficulty walking, such as viral infections,<sup id="cite_ref-NatRevNeurol2014_5-7" class="reference"><a href="#cite_note-NatRevNeurol2014-5">&#91;5&#93;</a></sup> or bone and joint problems.<sup id="cite_ref-Ryan2013_10-0" class="reference"><a href="#cite_note-Ryan2013-10">&#91;10&#93;</a></sup>
</p><p>On <a href="/wiki/Neurological_examination" title="Neurological examination">neurological examination</a>, characteristic features are the reduced strength of muscles and reduced or absent <a href="/wiki/Stretch_reflex" title="Stretch reflex">tendon reflexes</a> (<a href="/wiki/Hyporeflexia" title="Hyporeflexia">hypo- or areflexia</a>, respectively). However, a small proportion have normal reflexes in affected limbs before developing areflexia, and some may have exaggerated reflexes.<sup id="cite_ref-NatRevNeurol2014_5-8" class="reference"><a href="#cite_note-NatRevNeurol2014-5">&#91;5&#93;</a></sup> In the Miller Fisher variant of Guillain–Barré syndrome (see below), a triad of weakness of the eye muscles, <a href="/wiki/Ataxia" title="Ataxia">abnormalities in coordination</a>, as well as absent reflexes can be found.<sup id="cite_ref-NEJM2012_9-4" class="reference"><a href="#cite_note-NEJM2012-9">&#91;9&#93;</a></sup> The <a href="/wiki/Altered_level_of_consciousness" title="Altered level of consciousness">level of consciousness</a> is normally unaffected in Guillain–Barré syndrome, but the <a href="/wiki/Bickerstaff%27s_encephalitis" class="mw-redirect" title="Bickerstaff&#39;s encephalitis">Bickerstaff brainstem encephalitis</a> subtype may feature drowsiness, sleepiness, or coma.<sup id="cite_ref-vanDoorn2008_6-1" class="reference"><a href="#cite_note-vanDoorn2008-6">&#91;6&#93;</a></sup><sup id="cite_ref-Shahrizaila2013_11-0" class="reference"><a href="#cite_note-Shahrizaila2013-11">&#91;11&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Respiratory_failure">Respiratory failure</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=edit&amp;section=2" title="Edit section: Respiratory failure">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>A quarter of all people with Guillain–Barré syndrome develop weakness of the breathing muscles leading to <a href="/wiki/Respiratory_failure" title="Respiratory failure">respiratory failure</a>, the inability to breathe adequately to maintain healthy levels of <a href="/wiki/Oxygen" title="Oxygen">oxygen</a>, and/or <a href="/wiki/Carbon_dioxide" title="Carbon dioxide">carbon dioxide</a> in the blood.<sup id="cite_ref-NatRevNeurol2014_5-9" class="reference"><a href="#cite_note-NatRevNeurol2014-5">&#91;5&#93;</a></sup><sup id="cite_ref-NEJM2012_9-5" class="reference"><a href="#cite_note-NEJM2012-9">&#91;9&#93;</a></sup><sup id="cite_ref-vanDoorn2010_12-0" class="reference"><a href="#cite_note-vanDoorn2010-12">&#91;12&#93;</a></sup> This life-threatening scenario is complicated by other medical problems such as <a href="/wiki/Pneumonia" title="Pneumonia">pneumonia</a>, <a href="/wiki/Sepsis" title="Sepsis">severe infections</a>, <a href="/wiki/Pulmonary_embolism" title="Pulmonary embolism">blood clots in the lungs</a>, and <a href="/wiki/Gastrointestinal_hemorrhage" class="mw-redirect" title="Gastrointestinal hemorrhage">bleeding in the digestive tract</a> in 60% of those who require artificial ventilation.<sup id="cite_ref-NEJM2012_9-6" class="reference"><a href="#cite_note-NEJM2012-9">&#91;9&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Autonomic_dysfunction">Autonomic dysfunction</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=edit&amp;section=3" title="Edit section: Autonomic dysfunction">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The <a href="/wiki/Autonomic_nervous_system" title="Autonomic nervous system">autonomic or involuntary nervous system</a>, which is involved in the control of body functions such as <a href="/wiki/Heart_rate" title="Heart rate">heart rate</a> and <a href="/wiki/Blood_pressure" title="Blood pressure">blood pressure</a>, is affected in two-thirds of people with Guillain–Barré syndrome, but the impact is variable.<sup id="cite_ref-NatRevNeurol2014_5-10" class="reference"><a href="#cite_note-NatRevNeurol2014-5">&#91;5&#93;</a></sup> Twenty percent may experience severe blood-pressure fluctuations and <a href="/wiki/Cardiac_dysrhythmia" class="mw-redirect" title="Cardiac dysrhythmia">irregularities in the heart beat</a>, sometimes to the point that the <a href="/wiki/Asystole" title="Asystole">heart beat stops</a> and requires <a href="/wiki/Artificial_cardiac_pacemaker" title="Artificial cardiac pacemaker">pacemaker-based treatment</a>.<sup id="cite_ref-NEJM2012_9-7" class="reference"><a href="#cite_note-NEJM2012-9">&#91;9&#93;</a></sup> Other associated problems are abnormalities in <a href="/wiki/Perspiration" title="Perspiration">perspiration</a> and changes in the <a href="/wiki/Pupillary_response" title="Pupillary response">reactivity of the pupils</a>.<sup id="cite_ref-vanDoorn2008_6-2" class="reference"><a href="#cite_note-vanDoorn2008-6">&#91;6&#93;</a></sup> Autonomic nervous system involvement can affect even those who do not have severe muscle weakness.<sup id="cite_ref-vanDoorn2008_6-3" class="reference"><a href="#cite_note-vanDoorn2008-6">&#91;6&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Causes">Causes</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=edit&amp;section=4" title="Edit section: Causes">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Infection_onset">Infection onset</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=edit&amp;section=5" title="Edit section: Infection onset">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:ARS_Campylobacter_jejuni.jpg" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/d/df/ARS_Campylobacter_jejuni.jpg/220px-ARS_Campylobacter_jejuni.jpg" decoding="async" width="220" height="293" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/d/df/ARS_Campylobacter_jejuni.jpg/330px-ARS_Campylobacter_jejuni.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/df/ARS_Campylobacter_jejuni.jpg/440px-ARS_Campylobacter_jejuni.jpg 2x" data-file-width="2025" data-file-height="2700" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:ARS_Campylobacter_jejuni.jpg" class="internal" title="Enlarge"></a></div>A <a href="/wiki/Scanning_electron_microscope" title="Scanning electron microscope">scanning electron microscope</a>-derived image of <i><a href="/wiki/Campylobacter_jejuni" title="Campylobacter jejuni">Campylobacter jejuni</a></i>, which triggers about 30% of cases of Guillain–Barré syndrome</div></div></div>
<p>Two-thirds of people with Guillain–Barré syndrome have experienced an infection before the onset of the condition. Most commonly, these are episodes of <a href="/wiki/Gastroenteritis" title="Gastroenteritis">gastroenteritis</a> or a <a href="/wiki/Respiratory_tract_infection" title="Respiratory tract infection">respiratory tract infection</a>. In many cases, the exact nature of the infection can be confirmed.<sup id="cite_ref-NatRevNeurol2014_5-11" class="reference"><a href="#cite_note-NatRevNeurol2014-5">&#91;5&#93;</a></sup> Approximately 30% of cases are provoked by <i><a href="/wiki/Campylobacter_jejuni" title="Campylobacter jejuni">Campylobacter jejuni</a></i> bacteria, which cause diarrhea. A further 10% are attributable to <a href="/wiki/Human_cytomegalovirus" class="mw-redirect" title="Human cytomegalovirus">cytomegalovirus</a> (CMV, HHV-5). Despite this, only very few people with <i>Campylobacter</i> or CMV infections develop Guillain–Barré syndrome (0.25–0.65 per 1000 and 0.6–2.2 per 1000 episodes, respectively).<sup id="cite_ref-NEJM2012_9-8" class="reference"><a href="#cite_note-NEJM2012-9">&#91;9&#93;</a></sup> The strain of <i>Campylobacter</i> involved may determine the risk of GBS; different forms of the bacteria have different <a href="/wiki/Lipopolysaccharide" title="Lipopolysaccharide">lipopolysaccharides</a> on their surface, and some may induce illness (see below) while others will not.<sup id="cite_ref-NatRevNeurol2014_5-12" class="reference"><a href="#cite_note-NatRevNeurol2014-5">&#91;5&#93;</a></sup> 
</p><p>Links between other infections and GBS are less certain. Two other herpes viruses (<a href="/wiki/Epstein%E2%80%93Barr_virus" title="Epstein–Barr virus">Epstein–Barr virus</a>/HHV-4 and <a href="/wiki/Varicella_zoster_virus" title="Varicella zoster virus">varicella zoster virus</a>/HHV-3) and the bacterium <i><a href="/wiki/Mycoplasma_pneumoniae" title="Mycoplasma pneumoniae">Mycoplasma pneumoniae</a></i> have been associated with GBS.<sup id="cite_ref-NEJM2012_9-9" class="reference"><a href="#cite_note-NEJM2012-9">&#91;9&#93;</a></sup> GBS is known to occur after influenza, and influenza vaccination has been demonstrated to be associated with a reduced risk.<sup id="cite_ref-13" class="reference"><a href="#cite_note-13">&#91;13&#93;</a></sup> The tropical flaviviral infections <a href="/wiki/Dengue_fever" title="Dengue fever">dengue fever</a> and <a href="/wiki/Zika_virus" title="Zika virus">Zika virus</a> have also been associated with episodes of GBS.<sup id="cite_ref-Carod2013_14-0" class="reference"><a href="#cite_note-Carod2013-14">&#91;14&#93;</a></sup><sup id="cite_ref-15" class="reference"><a href="#cite_note-15">&#91;15&#93;</a></sup> Previous <a href="/wiki/Hepatitis_E_virus" class="mw-redirect" title="Hepatitis E virus">hepatitis E virus</a> infection has been found to be more common in people with GBS.<sup id="cite_ref-NatRevNeurol2014_5-13" class="reference"><a href="#cite_note-NatRevNeurol2014-5">&#91;5&#93;</a></sup><sup id="cite_ref-Eldar2014_7-1" class="reference"><a href="#cite_note-Eldar2014-7">&#91;7&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Vaccine_onset">Vaccine onset</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=edit&amp;section=6" title="Edit section: Vaccine onset">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<style data-mw-deduplicate="TemplateStyles:r1033289096">.mw-parser-output .hatnote{font-style:italic}.mw-parser-output div.hatnote{padding-left:1.6em;margin-bottom:0.5em}.mw-parser-output .hatnote i{font-style:normal}.mw-parser-output .hatnote+link+.hatnote{margin-top:-0.5em}</style><div role="note" class="hatnote navigation-not-searchable">See also: <a href="/wiki/1976_swine_flu_outbreak" title="1976 swine flu outbreak">1976 swine flu outbreak</a></div>
<p>An increased incidence of Guillain–Barré syndrome followed influenza immunization that followed the <a href="/wiki/1976_swine_flu_outbreak" title="1976 swine flu outbreak">1976 swine flu outbreak</a> (H1N1&#160;A/NJ/76); 8.8 cases per million (0.0088 per 1000) recipients developed it as a complication.<sup id="cite_ref-Lehmann2010_16-0" class="reference"><a href="#cite_note-Lehmann2010-16">&#91;16&#93;</a></sup> GBS cases occurred in 362 patients during the 6 weeks after influenza vaccination of 45 million persons, an 8.8-fold increase over normal rates.<sup id="cite_ref-nelson12_17-0" class="reference"><a href="#cite_note-nelson12-17">&#91;17&#93;</a></sup> The 1976 swine flu vaccination-induced GBS was an outlier; small increases in incidence have been observed in subsequent vaccination campaigns, but not to the same extent.<sup id="cite_ref-Lehmann2010_16-1" class="reference"><a href="#cite_note-Lehmann2010-16">&#91;16&#93;</a></sup> The <a href="/wiki/2009_flu_pandemic_vaccine" class="mw-redirect" title="2009 flu pandemic vaccine">2009 flu pandemic vaccine</a> against <a href="/wiki/Pandemic_H1N1/09_virus" title="Pandemic H1N1/09 virus">pandemic swine flu virus H1N1/PDM09</a> did not cause a significant increase in cases. In fact, "studies found a small increase of approximately 1 case per million vaccines above the baseline rate, which is similar to that observed after administration of seasonal influenza vaccines over the past several years."<sup id="cite_ref-NEJM2012_9-10" class="reference"><a href="#cite_note-NEJM2012-9">&#91;9&#93;</a></sup> Natural influenza infection is a stronger risk factor for the development of GBS than is influenza vaccination and the vaccination reduced the risk of GBS overall by lowering the risk of catching influenza.<sup id="cite_ref-DeStefano2019_18-0" class="reference"><a href="#cite_note-DeStefano2019-18">&#91;18&#93;</a></sup>
</p><p>In the United States, GBS after seasonal influenza vaccination is listed on the federal government's <a href="/wiki/Vaccine_adverse_event" title="Vaccine adverse event">vaccine injury table</a>.<sup id="cite_ref-19" class="reference"><a href="#cite_note-19">&#91;19&#93;</a></sup> On March 24, 2021, after reviewing several post-marketing observational studies, where an increased risk of Guillain–Barré syndrome was observed after 42 days following vaccination with the <a href="/wiki/Zoster_vaccine" title="Zoster vaccine">Zoster vaccine</a> Shingrix, the <a href="/wiki/FDA" class="mw-redirect" title="FDA">FDA</a> required safety label changes from the manufacturer <a href="/wiki/GlaxoSmithKline" class="mw-redirect" title="GlaxoSmithKline">GlaxoSmithKline</a> to include warnings for risk of Guillain–Barré syndrome.<sup id="cite_ref-U.S._Food_and_Drug_Administration_2021_20-0" class="reference"><a href="#cite_note-U.S._Food_and_Drug_Administration_2021-20">&#91;20&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="COVID-19_infection_or_vaccine_related">COVID-19 infection or vaccine related</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=edit&amp;section=7" title="Edit section: COVID-19 infection or vaccine related">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>GBS has been reported in association with <a href="/wiki/COVID-19" title="COVID-19">COVID-19</a>, and may be a potential neurological complication of the disease.<sup id="cite_ref-21" class="reference"><a href="#cite_note-21">&#91;21&#93;</a></sup><sup id="cite_ref-22" class="reference"><a href="#cite_note-22">&#91;22&#93;</a></sup><sup id="cite_ref-23" class="reference"><a href="#cite_note-23">&#91;23&#93;</a></sup><sup id="cite_ref-24" class="reference"><a href="#cite_note-24">&#91;24&#93;</a></sup>
GBS has been reported as a very rare side effect of the <a href="/wiki/Janssen_Pharmaceuticals" title="Janssen Pharmaceuticals">Janssen</a> and the <a href="/wiki/Oxford%E2%80%93AstraZeneca_COVID-19_vaccine" title="Oxford–AstraZeneca COVID-19 vaccine">Oxford–AstraZeneca COVID-19</a> vaccine for COVID-19<sup id="cite_ref-EMAEU_25-0" class="reference"><a href="#cite_note-EMAEU-25">&#91;25&#93;</a></sup> and European Medicines Agency (EMA) had issued warning to the patients and healthcare providers.<sup id="cite_ref-26" class="reference"><a href="#cite_note-26">&#91;26&#93;</a></sup> The incidence of GBS following the vaccination with the Oxford-AstraZeneca vaccine was originally reported as being lower than the incidence of GBS following a COVID-19 infection.<sup id="cite_ref-27" class="reference"><a href="#cite_note-27">&#91;27&#93;</a></sup> More recent studies, however, found no measurable link between COVID-19 infection and GBS, while correlations with a first dose of AstraZeneca or Janssen vaccines were still positive.<sup id="cite_ref-28" class="reference"><a href="#cite_note-28">&#91;28&#93;</a></sup>
</p><p>COVID-19 has been reported as causing peripheral neuropathy and more recently some evidence of aggravation of autoimmune disorders including GBS.<sup id="cite_ref-29" class="reference"><a href="#cite_note-29">&#91;29&#93;</a></sup> Some studies are now finding Parkinson's Disease is more common in infection survivors.<sup id="cite_ref-30" class="reference"><a href="#cite_note-30">&#91;30&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Drug_induced">Drug induced</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=edit&amp;section=8" title="Edit section: Drug induced">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Zimelidine" title="Zimelidine">Zimelidine</a>, an antidepressant, had a very favorable safety profile but as a result of rare case reports of Guillain–Barré syndrome was withdrawn from the market.<sup id="cite_ref-Fagius_31-0" class="reference"><a href="#cite_note-Fagius-31">&#91;31&#93;</a></sup><sup id="cite_ref-32" class="reference"><a href="#cite_note-32">&#91;32&#93;</a></sup><sup id="cite_ref-33" class="reference"><a href="#cite_note-33">&#91;33&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Pathophysiology">Pathophysiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=edit&amp;section=9" title="Edit section: Pathophysiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright" style=""><div class="thumbinner" style="width:-moz-fit-content; width:-webkit-fit-content; width:fit-content;"><div class="thumbimage noresize" style="width:auto;">
<div style="position: relative;"><a href="/wiki/File:Neuron_Hand-tuned.svg" class="image"><img alt="At one end of an elongated structure is a branching mass. At the centre of this mass is the nucleus and the branches are dendrites. A thick axon trails away from the mass, ending with further branching which are labeled as axon terminals. Along the axon are a number of protuberances labeled as myelin sheaths." src="//upload.wikimedia.org/wikipedia/commons/thumb/b/bc/Neuron_Hand-tuned.svg/400px-Neuron_Hand-tuned.svg.png" decoding="async" width="400" height="215" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/bc/Neuron_Hand-tuned.svg/600px-Neuron_Hand-tuned.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/bc/Neuron_Hand-tuned.svg/800px-Neuron_Hand-tuned.svg.png 2x" data-file-width="1179" data-file-height="634" /></a>
<div style="position:absolute; left:50px; top:2px"><a href="/wiki/Dendrite" title="Dendrite">Dendrite</a></div>
<div style="position:absolute; left:135px; top:60px"><a href="/wiki/Perikaryon" class="mw-redirect" title="Perikaryon">Soma</a></div>
<div style="position:absolute; left:189px; top:116px"><a href="/wiki/Axon" title="Axon">Axon</a></div>
<div style="position:absolute; left:13px; top:197px"><a href="/wiki/Cell_nucleus" title="Cell nucleus">Nucleus</a></div>
<div style="position:absolute; left:226px; top:38px"><a href="/wiki/Node_of_Ranvier" title="Node of Ranvier">Node of<br />Ranvier</a></div>
<div style="position:absolute; left:319px; top:0px"><a href="/wiki/Axon_terminal" title="Axon terminal">Axon terminal</a></div>
<div style="position:absolute; left:306px; top:161px"><a href="/wiki/Schwann_cell" title="Schwann cell">Schwann cell</a></div>
<div style="position:absolute; left:220px; top:187px"><a href="/wiki/Myelin" title="Myelin">Myelin sheath</a></div></div></div><div class="thumbcaption">Structure of a typical neuron</div></div></div>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Guillain-barr%C3%A9_syndrome_-_Nerve_Damage.gif" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/7/7f/Guillain-barr%C3%A9_syndrome_-_Nerve_Damage.gif/220px-Guillain-barr%C3%A9_syndrome_-_Nerve_Damage.gif" decoding="async" width="220" height="124" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/7f/Guillain-barr%C3%A9_syndrome_-_Nerve_Damage.gif/330px-Guillain-barr%C3%A9_syndrome_-_Nerve_Damage.gif 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/7f/Guillain-barr%C3%A9_syndrome_-_Nerve_Damage.gif/440px-Guillain-barr%C3%A9_syndrome_-_Nerve_Damage.gif 2x" data-file-width="500" data-file-height="282" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Guillain-barr%C3%A9_syndrome_-_Nerve_Damage.gif" class="internal" title="Enlarge"></a></div>Guillain–Barré syndrome – nerve damage</div></div></div>
<p>The nerve dysfunction in Guillain–Barré syndrome is caused by an immune attack on the nerve cells of the peripheral nervous system and their support structures. The nerve cells have their body (the soma) in the <a href="/wiki/Spinal_cord" title="Spinal cord">spinal cord</a> and a long projection (the <a href="/wiki/Axon" title="Axon">axon</a>) that carries <a href="/wiki/Action_potential" title="Action potential">electrical nerve impulses</a> to the <a href="/wiki/Neuromuscular_junction" title="Neuromuscular junction">neuromuscular junction</a>, where the impulse is transferred to the muscle. Axons are wrapped in a sheath of <a href="/wiki/Schwann_cell" title="Schwann cell">Schwann cells</a> that contain <a href="/wiki/Myelin" title="Myelin">myelin</a>. Between Schwann cells are gaps (<a href="/wiki/Node_of_Ranvier" title="Node of Ranvier">nodes of Ranvier</a>) where the axon is exposed.<sup id="cite_ref-NEJM2012_9-11" class="reference"><a href="#cite_note-NEJM2012-9">&#91;9&#93;</a></sup> Different types of Guillain–Barré syndrome feature different types of immune attacks. The demyelinating variant (AIDP, see below) features damage to the myelin sheath by <a href="/wiki/White_blood_cell" title="White blood cell">white blood cells</a> (<a href="/wiki/T_cell" title="T cell">T lymphocytes</a> and <a href="/wiki/Macrophage" title="Macrophage">macrophages</a>); this process is preceded by activation of a group of blood proteins known as <a href="/wiki/Complement_system" title="Complement system">complement</a>. In contrast, the axonal variant is mediated by <a href="/wiki/Immunoglobulin_G" title="Immunoglobulin G">IgG antibodies</a> and complement against the <a href="/wiki/Axolemma" title="Axolemma">cell membrane covering the axon</a> without direct lymphocyte involvement.<sup id="cite_ref-NEJM2012_9-12" class="reference"><a href="#cite_note-NEJM2012-9">&#91;9&#93;</a></sup>
</p><p>Various antibodies directed at nerve cells have been reported in Guillain–Barré syndrome. In the axonal subtype, these antibodies have been shown to bind to <a href="/wiki/Ganglioside" title="Ganglioside">gangliosides</a>, a group of substances found in peripheral nerves. A ganglioside is a molecule consisting of <a href="/wiki/Ceramide" title="Ceramide">ceramide</a> bound to a small group of <a href="/wiki/Hexose" title="Hexose">hexose</a>-type sugars and containing various numbers of <a href="/wiki/N-Acetylneuraminic_acid" title="N-Acetylneuraminic acid"><i>N</i>-acetylneuraminic acid</a> groups. The key four gangliosides <a href="/wiki/Antiganglioside_antibodies" title="Antiganglioside antibodies">against which antibodies have been described</a> are <a href="/wiki/GM1" title="GM1">GM1</a>, GD1a, GT1a, and GQ1b, with different antiganglioside antibodies being associated with particular features; for instance, GQ1b antibodies have been linked with Miller Fisher variant GBS and related forms including Bickerstaff encephalitis.<sup id="cite_ref-NEJM2012_9-13" class="reference"><a href="#cite_note-NEJM2012-9">&#91;9&#93;</a></sup> The production of these antibodies after an infection probably is the result of <a href="/wiki/Molecular_mimicry" title="Molecular mimicry">molecular mimicry</a>, where the immune system is reacting to microbial substances, but the resultant antibodies also react with substances occurring naturally in the body.<sup id="cite_ref-NEJM2012_9-14" class="reference"><a href="#cite_note-NEJM2012-9">&#91;9&#93;</a></sup><sup id="cite_ref-Kuwabara2013_34-0" class="reference"><a href="#cite_note-Kuwabara2013-34">&#91;34&#93;</a></sup> After a <i>Campylobacter</i> infection, the body produces antibodies of the <a href="/wiki/Immunoglobulin_A" title="Immunoglobulin A">IgA</a> class; only a small proportion of people also produce IgG antibodies against bacterial substance cell wall substances (e.g. lipooligosaccharides) that cross react with human nerve cell gangliosides. It is not currently known how this process escapes <a href="/wiki/Central_tolerance" title="Central tolerance">central tolerance</a> to gangliosides, which is meant to suppress the production of antibodies against the body's own substances.<sup id="cite_ref-WillisonGoodyear2013_35-0" class="reference"><a href="#cite_note-WillisonGoodyear2013-35">&#91;35&#93;</a></sup> Not all <a href="/wiki/Undecaprenyl_phosphate_N,N%27-diacetylbacillosamine_1-phosphate_transferase" title="Undecaprenyl phosphate N,N&#39;-diacetylbacillosamine 1-phosphate transferase">antiganglioside antibodies</a> cause disease, and it has recently been suggested that some antibodies bind to more than one type of <a href="/wiki/Epitope" title="Epitope">epitope</a> simultaneously (heterodimeric binding) and that this determines the response. Furthermore, the development of pathogenic antibodies may depend on the presence of other strains of bacteria in the bowel.<sup id="cite_ref-WillisonGoodyear2013_35-1" class="reference"><a href="#cite_note-WillisonGoodyear2013-35">&#91;35&#93;</a></sup>
</p><p>It has been suggested that a poor injection technique may also cause a direct injury to the axillary nerves adjacent to the injection site in deltoid muscle that may lead to peripheral neuropathy. The consequent vaccine transfection and translation in the nerves may spur an immune response against nerve cells potentially causing an autoimmune nerve damage, leading to conditions like Guillain–Barré syndrome.<sup id="cite_ref-36" class="reference"><a href="#cite_note-36">&#91;36&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=edit&amp;section=10" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The diagnosis of Guillain–Barré syndrome depends on findings such as rapid development of muscle paralysis, absent reflexes, absence of fever, and absence of a likely cause. Cerebrospinal fluid analysis (through a <a href="/wiki/Lumbar_puncture" title="Lumbar puncture">lumbar spinal puncture</a>) and <a href="/wiki/Nerve_conduction_study" title="Nerve conduction study">nerve conduction studies</a> are supportive investigations commonly performed in the diagnosis of GBS.<sup id="cite_ref-NatRevNeurol2014_5-14" class="reference"><a href="#cite_note-NatRevNeurol2014-5">&#91;5&#93;</a></sup><sup id="cite_ref-Eldar2014_7-2" class="reference"><a href="#cite_note-Eldar2014-7">&#91;7&#93;</a></sup><sup id="cite_ref-NEJM2012_9-15" class="reference"><a href="#cite_note-NEJM2012-9">&#91;9&#93;</a></sup> Testing for antiganglioside antibodies is often performed, but their contribution to diagnosis is usually limited.<sup id="cite_ref-NatRevNeurol2014_5-15" class="reference"><a href="#cite_note-NatRevNeurol2014-5">&#91;5&#93;</a></sup> Blood tests are generally performed to exclude the possibility of another cause for weakness, such as a <a href="/wiki/Hypokalemia" title="Hypokalemia">low level of potassium in the blood</a>.<sup id="cite_ref-NEJM2012_9-16" class="reference"><a href="#cite_note-NEJM2012-9">&#91;9&#93;</a></sup> An <a href="/wiki/Hyponatremia" title="Hyponatremia">abnormally low level of sodium in the blood</a> is often encountered in Guillain–Barré syndrome. This has been attributed to the <a href="/wiki/Syndrome_of_inappropriate_antidiuretic_hormone_secretion" title="Syndrome of inappropriate antidiuretic hormone secretion">inappropriate secretion of antidiuretic hormone</a>, leading to relative retention of water.<sup id="cite_ref-37" class="reference"><a href="#cite_note-37">&#91;37&#93;</a></sup>
</p><p>In many cases, <a href="/wiki/Magnetic_resonance_imaging" title="Magnetic resonance imaging">magnetic resonance imaging</a> of the spinal cord is performed to distinguish between Guillain–Barré syndrome and other conditions causing limb weakness, such as <a href="/wiki/Spinal_cord_compression" title="Spinal cord compression">spinal cord compression</a>.<sup id="cite_ref-NatRevNeurol2014_5-16" class="reference"><a href="#cite_note-NatRevNeurol2014-5">&#91;5&#93;</a></sup><sup id="cite_ref-NEJM2012_9-17" class="reference"><a href="#cite_note-NEJM2012-9">&#91;9&#93;</a></sup> If an MRI scan shows enhancement of the <a href="/wiki/Nerve_root" title="Nerve root">nerve roots</a>, this may be indicative of GBS.<sup id="cite_ref-NatRevNeurol2014_5-17" class="reference"><a href="#cite_note-NatRevNeurol2014-5">&#91;5&#93;</a></sup> In children, this feature is present in 95% of scans, but it is not specific to Guillain–Barré syndrome, so other confirmation is also needed.<sup id="cite_ref-Ryan2013_10-1" class="reference"><a href="#cite_note-Ryan2013-10">&#91;10&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Spinal_fluid">Spinal fluid</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=edit&amp;section=11" title="Edit section: Spinal fluid">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Cerebrospinal_fluid" title="Cerebrospinal fluid">Cerebrospinal fluid</a> envelops the brain and the spine, and lumbar puncture or spinal tap is the removal of a small amount of fluid using a needle inserted between the <a href="/wiki/Lumbar_vertebrae" title="Lumbar vertebrae">lumbar vertebrae</a>. Characteristic findings in Guillain–Barré syndrome are an elevated protein level, usually greater than 0.55&#160;g/L, and fewer than 10 white blood cells per cubic millimeter of fluid ("albuminocytological dissociation").<sup id="cite_ref-38" class="reference"><a href="#cite_note-38">&#91;38&#93;</a></sup> This pattern distinguishes Guillain–Barré syndrome from other conditions (such as <a href="/wiki/Lymphoma" title="Lymphoma">lymphoma</a> and <a href="/wiki/Poliomyelitis" class="mw-redirect" title="Poliomyelitis">poliomyelitis</a>) in which both the protein and the <a href="/wiki/Pleocytosis" title="Pleocytosis">cell count are elevated</a>. Elevated CSF protein levels are found in approximately 50% of patients in the first 3 days after onset of weakness, which increases to 80% after the first week.<sup id="cite_ref-NatRevNeurol2014_5-18" class="reference"><a href="#cite_note-NatRevNeurol2014-5">&#91;5&#93;</a></sup>
</p><p>Repeating the lumbar puncture during the disease course is not recommended. The protein levels may rise after treatment has been administered.<sup id="cite_ref-NatRevNeurol2014_5-19" class="reference"><a href="#cite_note-NatRevNeurol2014-5">&#91;5&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Neurophysiology">Neurophysiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=edit&amp;section=12" title="Edit section: Neurophysiology">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Directly assessing <a href="/wiki/Electrodiagnostic_medicine" title="Electrodiagnostic medicine">nerve conduction of electrical impulses</a> can exclude other causes of acute muscle weakness, as well as distinguish the different types of Guillain–Barré syndrome. Needle <a href="/wiki/Electromyography" title="Electromyography">electromyography</a> (EMG) and nerve conduction studies may be performed. In the first two weeks, these investigations may not show any abnormality.<sup id="cite_ref-NatRevNeurol2014_5-20" class="reference"><a href="#cite_note-NatRevNeurol2014-5">&#91;5&#93;</a></sup><sup id="cite_ref-Rinaldi2013_39-0" class="reference"><a href="#cite_note-Rinaldi2013-39">&#91;39&#93;</a></sup> Neurophysiology studies are not required for the diagnosis.<sup id="cite_ref-NEJM2012_9-18" class="reference"><a href="#cite_note-NEJM2012-9">&#91;9&#93;</a></sup>
</p><p>Formal criteria exist for each of the main subtypes of Guillain–Barré syndrome (AIDP and AMAN/AMSAN, see below), but these may misclassify some cases (particularly where there is reversible conduction failure) and therefore changes to these criteria have been proposed.<sup id="cite_ref-Uncini2012_40-0" class="reference"><a href="#cite_note-Uncini2012-40">&#91;40&#93;</a></sup> Sometimes, repeated testing may be helpful.<sup id="cite_ref-Uncini2012_40-1" class="reference"><a href="#cite_note-Uncini2012-40">&#91;40&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Clinical_subtypes">Clinical subtypes</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=edit&amp;section=13" title="Edit section: Clinical subtypes">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>A number of subtypes of Guillain–Barré syndrome are recognized.<sup id="cite_ref-NatRevNeurol2014_5-21" class="reference"><a href="#cite_note-NatRevNeurol2014-5">&#91;5&#93;</a></sup><sup id="cite_ref-Uncini2012_40-2" class="reference"><a href="#cite_note-Uncini2012-40">&#91;40&#93;</a></sup> Despite this, many people have overlapping symptoms that can make the classification difficult in individual cases.<sup id="cite_ref-vanDoorn2008_6-4" class="reference"><a href="#cite_note-vanDoorn2008-6">&#91;6&#93;</a></sup><sup id="cite_ref-Wakerley2014_41-0" class="reference"><a href="#cite_note-Wakerley2014-41">&#91;41&#93;</a></sup> All types have partial forms. For instance, some people experience only isolated eye-movement or coordination problems; these are thought to be a subtype of <b>Miller Fisher syndrome</b> and have similar antiganglioside antibody patterns.<sup id="cite_ref-Shahrizaila2013_11-1" class="reference"><a href="#cite_note-Shahrizaila2013-11">&#91;11&#93;</a></sup><sup id="cite_ref-Wakerley2014_41-1" class="reference"><a href="#cite_note-Wakerley2014-41">&#91;41&#93;</a></sup>
</p>
<table class="wikitable" style="margin-left:15px; text-align:center">
<tbody><tr>
<th>Type<sup id="cite_ref-NatRevNeurol2014_5-22" class="reference"><a href="#cite_note-NatRevNeurol2014-5">&#91;5&#93;</a></sup>
</th>
<th>Symptoms
</th>
<th>Population affected
</th>
<th>Nerve conduction studies
</th>
<th>Antiganglioside antibodies
</th></tr>
<tr>
<td>Acute inflammatory demyelinating polyradiculoneuropathy (AIDP)
</td>
<td>Sensory symptoms and muscle weakness, often with cranial nerve weakness and autonomic involvement
</td>
<td>Most common in Europe and North America
</td>
<td>Demyelinating polyneuropathy
</td>
<td>No clear association
</td></tr>
<tr>
<td><a href="/wiki/Acute_motor_axonal_neuropathy" title="Acute motor axonal neuropathy">Acute motor axonal neuropathy</a> (AMAN)
</td>
<td>Isolated muscle weakness without sensory symptoms in less than 10%; cranial nerve involvement uncommon
</td>
<td>Rare in Europe and North America, a substantial proportion (30–65%) in Asia and Central and South America; sometimes called "Chinese paralytic syndrome"
</td>
<td>Axonal polyneuropathy, normal sensory action potential
</td>
<td>GM1a/b, GD1a &amp; GalNac-GD1a
</td></tr>
<tr>
<td>Acute motor and sensory axonal neuropathy (AMSAN)
</td>
<td>Severe muscle weakness similar to AMAN but with sensory loss
</td>
<td>—
</td>
<td>Axonal polyneuropathy, reduced or absent sensory action potential
</td>
<td>GM1, GD1a
</td></tr>
<tr>
<td>Pharyngeal-cervical-brachial variant
</td>
<td>Weakness particularly of the throat muscles, and face, neck, and shoulder muscles
</td>
<td>—
</td>
<td>Generally normal, sometimes axonal neuropathy in arms
</td>
<td>Mostly GT1a, occasionally GQ1b, rarely GD1a
</td></tr>
<tr>
<td>Miller Fisher syndrome
</td>
<td><a href="/wiki/Ataxia" title="Ataxia">Ataxia</a>, eye muscle weakness, areflexia but usually no limb weakness
</td>
<td>This variant occurs more commonly in men than in women (2:1 ratio). Cases typically occur in the spring and the average age of occurrence is 43 years old.<sup id="cite_ref-Mori2012_42-0" class="reference"><a href="#cite_note-Mori2012-42">&#91;42&#93;</a></sup>
</td>
<td>Generally normal, sometimes discrete changes in sensory conduction or <a href="/wiki/H-reflex" title="H-reflex">H-reflex</a> detected
</td>
<td>GQ1b, GT1a
</td></tr></tbody></table>
<p>Other diagnostic entities are often included in the spectrum of Guillain–Barré syndrome. <a href="/wiki/Bickerstaff%27s_brainstem_encephalitis" class="mw-redirect" title="Bickerstaff&#39;s brainstem encephalitis">Bickerstaff's brainstem encephalitis</a> (BBE), for instance, is part of the group of conditions now regarded as forms of Miller Fisher syndrome (anti-GQ1b antibody syndrome),<sup id="cite_ref-Shahrizaila2013_11-2" class="reference"><a href="#cite_note-Shahrizaila2013-11">&#91;11&#93;</a></sup> as well as a related condition labelled "acute ataxic hypersomnolence"<sup id="cite_ref-43" class="reference"><a href="#cite_note-43">&#91;43&#93;</a></sup> where coordination problems and drowsiness are present but no muscle weakness can be detected.<sup id="cite_ref-Wakerley2014_41-2" class="reference"><a href="#cite_note-Wakerley2014-41">&#91;41&#93;</a></sup> BBE is characterized by the rapid onset of ophthalmoplegia, ataxia, and disturbance of consciousness, and may be associated with absent or decreased tendon reflexes and as well as <a href="/wiki/Plantar_reflex" title="Plantar reflex">Babinski's sign</a>.<sup id="cite_ref-Wakerley2014_41-3" class="reference"><a href="#cite_note-Wakerley2014-41">&#91;41&#93;</a></sup> The course of the disease is usually monophasic, but recurrent episodes have been reported. MRI abnormalities in the brainstem have been reported in 11%.<sup id="cite_ref-Shahrizaila2013_11-3" class="reference"><a href="#cite_note-Shahrizaila2013-11">&#91;11&#93;</a></sup>
</p><p>Whether isolated acute sensory loss can be regarded as a form of Guillain–Barré syndrome is a matter of dispute; this is a rare occurrence compared to GBS with muscle weakness but no sensory symptoms.<sup id="cite_ref-Rinaldi2013_39-1" class="reference"><a href="#cite_note-Rinaldi2013-39">&#91;39&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Treatment">Treatment</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=edit&amp;section=14" title="Edit section: Treatment">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Immunotherapy">Immunotherapy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=edit&amp;section=15" title="Edit section: Immunotherapy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Plasmapheresis" title="Plasmapheresis">Plasmapheresis</a> and <a href="/wiki/Intravenous_immunoglobulins" class="mw-redirect" title="Intravenous immunoglobulins">intravenous immunoglobulins</a> (IVIG) are the two main immunotherapy treatments for GBS. Plasmapheresis attempts to reduce the body's attack on the nervous system by filtering antibodies out of the bloodstream.<sup id="cite_ref-Liu_Dong_Ubogu_2021_p._44-0" class="reference"><a href="#cite_note-Liu_Dong_Ubogu_2021_p.-44">&#91;44&#93;</a></sup> Similarly, administration of IVIG neutralizes harmful antibodies and inflammation. These two treatments are equally effective, but a combination of the two is not significantly better than either alone.<sup id="cite_ref-45" class="reference"><a href="#cite_note-45">&#91;45&#93;</a></sup> Plasmapheresis speeds recovery when used within four weeks of the onset of symptoms.<sup id="cite_ref-Hughes_46-0" class="reference"><a href="#cite_note-Hughes-46">&#91;46&#93;</a></sup> IVIG works as well as plasmapheresis when started within two weeks of the onset of symptoms, and has fewer complications.<sup id="cite_ref-Hughes_46-1" class="reference"><a href="#cite_note-Hughes-46">&#91;46&#93;</a></sup> IVIG is usually used first because of its ease of administration and safety; the risks include occasionally causing <a href="/wiki/Hepatitis" title="Hepatitis">liver inflammation</a>, or in rare cases, kidney failure.<sup id="cite_ref-Dantal2013_47-0" class="reference"><a href="#cite_note-Dantal2013-47">&#91;47&#93;</a></sup> <a href="/wiki/Glucocorticoids" class="mw-redirect" title="Glucocorticoids">Glucocorticoids</a> alone have not been found to be effective in speeding recovery and could potentially delay recovery.<sup id="cite_ref-48" class="reference"><a href="#cite_note-48">&#91;48&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Respiratory_failure_2">Respiratory failure</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=edit&amp;section=16" title="Edit section: Respiratory failure">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Respiratory failure may require <a href="/wiki/Tracheal_intubation" title="Tracheal intubation">intubation of the trachea</a> and breathing support through <a href="/wiki/Mechanical_ventilation" title="Mechanical ventilation">mechanical ventilation</a>, generally on an <a href="/wiki/Intensive_care_unit" title="Intensive care unit">intensive care unit</a>. The need for ventilatory support can be anticipated by measurement of two <a href="/wiki/Spirometry" title="Spirometry">spirometry</a>-based breathing tests: the <a href="/wiki/Forced_vital_capacity" class="mw-redirect" title="Forced vital capacity">forced vital capacity</a> (FVC) and the <a href="/wiki/Negative_inspiratory_force" class="mw-redirect" title="Negative inspiratory force">negative inspiratory force</a> (NIF). An FVC of less than 15&#160;mL per kilogram body weight or an NIF of less than 60&#160;<a href="/wiki/Centimetre_of_water" class="mw-redirect" title="Centimetre of water">cmH<sub>2</sub>O</a> are considered markers of severe respiratory failure.<sup id="cite_ref-Dimachkie2013_49-0" class="reference"><a href="#cite_note-Dimachkie2013-49">&#91;49&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Pain">Pain</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=edit&amp;section=17" title="Edit section: Pain">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>While pain is common in people with Guillain–Barré syndrome, studies comparing different types of <a href="/wiki/Analgesic" title="Analgesic">pain medication</a> are insufficient to make a recommendation as to which should be used.<sup id="cite_ref-50" class="reference"><a href="#cite_note-50">&#91;50&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Rehabilitation">Rehabilitation</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=edit&amp;section=18" title="Edit section: Rehabilitation">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Following the acute phase, around 40% of people require intensive rehabilitation with the help of a multidisciplinary team to focus on improving <a href="/wiki/Activities_of_daily_living" title="Activities of daily living">activities of daily living</a> (ADLs).<sup id="cite_ref-Khan2012_51-0" class="reference"><a href="#cite_note-Khan2012-51">&#91;51&#93;</a></sup> Studies into the subject have been limited, but it is likely that intensive rehabilitation improves long-term symptoms.<sup id="cite_ref-52" class="reference"><a href="#cite_note-52">&#91;52&#93;</a></sup> Teams may include <a href="/wiki/Physical_therapy" title="Physical therapy">physical therapists</a>, <a href="/wiki/Occupational_therapy" title="Occupational therapy">occupational therapists</a>, speech language pathologists, social workers, <a href="/wiki/Psychologist" title="Psychologist">psychologists</a>, other <a href="/wiki/Allied_health_professions" title="Allied health professions">allied health professionals</a> and <a href="/wiki/Nursing" title="Nursing">nurses</a>. The team usually works under the supervision of a neurologist or <a href="/wiki/Physical_medicine_and_rehabilitation" title="Physical medicine and rehabilitation">rehabilitation physician</a> directing treatment goals.<sup id="cite_ref-Khan2012_51-1" class="reference"><a href="#cite_note-Khan2012-51">&#91;51&#93;</a></sup>
</p><p>Physiotherapy interventions include strength, endurance, and gait training with graduated increases in mobility, maintenance of posture and alignment as well as joint function. Occupational therapy aims to improve everyday function with domestic and community tasks as well as driving and work. Home modifications, gait aids, <a href="/wiki/Orthotics" title="Orthotics">orthotics</a>, and splints may be provided.<sup id="cite_ref-Khan2012_51-2" class="reference"><a href="#cite_note-Khan2012-51">&#91;51&#93;</a></sup> <a href="/wiki/Speech-language_pathology" class="mw-redirect" title="Speech-language pathology">Speech-language pathology</a> input may be required in those with speech and swallowing problems, as well as to support communication in those who require ongoing breathing support (often through a <a href="/wiki/Tracheostomy" class="mw-redirect" title="Tracheostomy">tracheostomy</a>). Nutritional support may be provided by the team and by <a href="/wiki/Dietitian" title="Dietitian">dietitians</a>. Psychologists may provide counseling and support. Psychological interventions may also be required for anxiety, fear, and depression.<sup id="cite_ref-Khan2012_51-3" class="reference"><a href="#cite_note-Khan2012-51">&#91;51&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Prognosis">Prognosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=edit&amp;section=19" title="Edit section: Prognosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Guillain–Barré syndrome can lead to death as a result of many complications: severe infections, blood clots, and cardiac arrest likely due to autonomic neuropathy. Despite optimum care, this occurs in about 5% of cases.<sup id="cite_ref-NEJM2012_9-19" class="reference"><a href="#cite_note-NEJM2012-9">&#91;9&#93;</a></sup>
</p><p>There is a variation in the rate and extent of recovery.<sup id="cite_ref-NEJM2012_9-20" class="reference"><a href="#cite_note-NEJM2012-9">&#91;9&#93;</a></sup> The prognosis of Guillain–Barré syndrome is determined mainly by age (those over 40 may have a poorer outcome), and by the severity of symptoms after two weeks. Furthermore, those who experienced diarrhea before the onset of the disease have a worse prognosis.<sup id="cite_ref-vanDoorn2010_12-1" class="reference"><a href="#cite_note-vanDoorn2010-12">&#91;12&#93;</a></sup> On the nerve conduction study, the presence of conduction block predicts poorer outcome at 6 months.<sup id="cite_ref-vanDoorn2010_12-2" class="reference"><a href="#cite_note-vanDoorn2010-12">&#91;12&#93;</a></sup> In those who have received intravenous immunoglobulins, a smaller increase in IgG in the blood two weeks after administration is associated with poorer mobility outcomes at six months than those whose IgG level increased substantially.<sup id="cite_ref-vanDoorn2010_12-3" class="reference"><a href="#cite_note-vanDoorn2010-12">&#91;12&#93;</a></sup> If the disease continues to progress beyond four weeks, or there are multiple fluctuations in the severity (more than two in eight weeks), the diagnosis may be <a href="/wiki/Chronic_inflammatory_demyelinating_polyneuropathy" title="Chronic inflammatory demyelinating polyneuropathy">chronic inflammatory demyelinating polyneuropathy</a>, which is treated differently.<sup id="cite_ref-NatRevNeurol2014_5-23" class="reference"><a href="#cite_note-NatRevNeurol2014-5">&#91;5&#93;</a></sup>
</p><p>In research studies, the outcome from an episode of Guillain–Barré syndrome is recorded on a scale from 0 to 6, where 0 denotes completely healthy; 1 very minor symptoms but able to run; 2 able to walk but not to run; 3 requiring a stick or other support; 4 confined to bed or chair; 5 requiring long-term respiratory support; 6 death.<sup id="cite_ref-53" class="reference"><a href="#cite_note-53">&#91;53&#93;</a></sup>
</p><p>The <a href="/wiki/Quality_of_life_(healthcare)" title="Quality of life (healthcare)">health-related quality of life</a> (HRQL) after an attack of Guillain–Barré syndrome can be significantly impaired. About a fifth are unable to walk unaided after six months, and many experience <a href="/wiki/Chronic_pain" title="Chronic pain">chronic pain</a>, <a href="/wiki/Fatigue_(medical)" class="mw-redirect" title="Fatigue (medical)">fatigue</a> and difficulty with work, education, hobbies and social activities.<sup id="cite_ref-Darweesh2014_54-0" class="reference"><a href="#cite_note-Darweesh2014-54">&#91;54&#93;</a></sup> HRQL improves significantly in the first year.<sup id="cite_ref-Darweesh2014_54-1" class="reference"><a href="#cite_note-Darweesh2014-54">&#91;54&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=edit&amp;section=20" title="Edit section: Epidemiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1033289096"><div role="note" class="hatnote navigation-not-searchable">See also: <a href="/wiki/List_of_people_with_Guillain%E2%80%93Barr%C3%A9_syndrome" title="List of people with Guillain–Barré syndrome">List of people with Guillain–Barré syndrome</a></div>
<p>In Western countries, the number of new episodes per year has been estimated to be between 0.89 and 1.89 cases per 100,000 people. Children and young adults are less likely to be affected than the elderly: the relative risk increases by 20% for every decade of life.<sup id="cite_ref-Sejvar2011_4-2" class="reference"><a href="#cite_note-Sejvar2011-4">&#91;4&#93;</a></sup> Men are more likely to develop Guillain–Barré syndrome than women; the <a href="/wiki/Relative_risk" title="Relative risk">relative risk</a> for men is 1.78 compared to women.<sup id="cite_ref-Sejvar2011_4-3" class="reference"><a href="#cite_note-Sejvar2011-4">&#91;4&#93;</a></sup><sup id="cite_ref-NEJM2012_9-21" class="reference"><a href="#cite_note-NEJM2012-9">&#91;9&#93;</a></sup>
</p><p>The distribution of subtypes varies between countries. In Europe and the United States, 60–80% of people with Guillain–Barré syndrome have the demyelinating subtype (AIDP), and AMAN affects only a small number (6–7%). In Asia and Central and South America, that proportion is significantly higher (30–65%). This may be related to the exposure to different kinds of infection, but also the genetic characteristics of that population.<sup id="cite_ref-NatRevNeurol2014_5-24" class="reference"><a href="#cite_note-NatRevNeurol2014-5">&#91;5&#93;</a></sup> Miller Fisher variant is thought to be more common in Southeast Asia.<sup id="cite_ref-NEJM2012_9-22" class="reference"><a href="#cite_note-NEJM2012-9">&#91;9&#93;</a></sup><sup id="cite_ref-Shahrizaila2013_11-4" class="reference"><a href="#cite_note-Shahrizaila2013-11">&#91;11&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=edit&amp;section=21" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright"><div class="thumbinner" style="width:172px;"><a href="/wiki/File:Georges_Guillain.jpg" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/5/5f/Georges_Guillain.jpg/170px-Georges_Guillain.jpg" decoding="async" width="170" height="256" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/5/5f/Georges_Guillain.jpg/255px-Georges_Guillain.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/5f/Georges_Guillain.jpg/340px-Georges_Guillain.jpg 2x" data-file-width="524" data-file-height="788" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Georges_Guillain.jpg" class="internal" title="Enlarge"></a></div><a href="/wiki/Georges_Guillain" title="Georges Guillain">Georges Guillain</a>, together with Barré and Strohl, described two cases of self-limiting acute paralysis with peculiar changes in the cerebrospinal fluid. He succeeded his teacher <a href="/wiki/Pierre_Marie" title="Pierre Marie">Pierre Marie</a> as professor of neurology at the <a href="/wiki/Piti%C3%A9-Salp%C3%AAtri%C3%A8re_Hospital" title="Pitié-Salpêtrière Hospital">Salpêtrière</a> hospital in Paris in 1925.<sup id="cite_ref-55" class="reference"><a href="#cite_note-55">&#91;55&#93;</a></sup></div></div></div>
<p><a href="/wiki/Jean_Landry_(physician)" title="Jean Landry (physician)">Jean-Baptiste Octave Landry</a> first described the disorder in 1859.<sup id="cite_ref-56" class="reference"><a href="#cite_note-56">&#91;56&#93;</a></sup> In 1916, <a href="/wiki/Georges_Guillain" title="Georges Guillain">Georges Guillain</a>, <a href="/wiki/Jean_Alexandre_Barr%C3%A9" title="Jean Alexandre Barré">Jean Alexandre Barré</a>, and <a href="/wiki/Andr%C3%A9_Strohl" title="André Strohl">André Strohl</a> diagnosed two soldiers with the illness and described the key diagnostic abnormality—albuminocytological dissociation—of increased spinal fluid protein concentration but a normal cell count.<sup id="cite_ref-vanDoorn2008_6-5" class="reference"><a href="#cite_note-vanDoorn2008-6">&#91;6&#93;</a></sup><sup id="cite_ref-Eldar2014_7-3" class="reference"><a href="#cite_note-Eldar2014-7">&#91;7&#93;</a></sup><sup id="cite_ref-Guillain1916_57-0" class="reference"><a href="#cite_note-Guillain1916-57">&#91;57&#93;</a></sup>
</p><p><a href="/wiki/Miller_Fisher" class="mw-redirect" title="Miller Fisher">C. Miller Fisher</a> described the variant that bears his name in 1956.<sup id="cite_ref-Shahrizaila2013_11-5" class="reference"><a href="#cite_note-Shahrizaila2013-11">&#91;11&#93;</a></sup><sup id="cite_ref-58" class="reference"><a href="#cite_note-58">&#91;58&#93;</a></sup> British neurologist <a href="/wiki/Edwin_Bickerstaff" title="Edwin Bickerstaff">Edwin Bickerstaff</a> described the <a href="/wiki/Bickerstaff_brainstem_encephalitis" title="Bickerstaff brainstem encephalitis">encephalitis</a> type in 1951 and made further contributions with another paper in 1957.<sup id="cite_ref-Shahrizaila2013_11-6" class="reference"><a href="#cite_note-Shahrizaila2013-11">&#91;11&#93;</a></sup><sup id="cite_ref-59" class="reference"><a href="#cite_note-59">&#91;59&#93;</a></sup><sup id="cite_ref-60" class="reference"><a href="#cite_note-60">&#91;60&#93;</a></sup> Guillain had reported on some of these features before their full description in 1938.<sup id="cite_ref-Shahrizaila2013_11-7" class="reference"><a href="#cite_note-Shahrizaila2013-11">&#91;11&#93;</a></sup> Further subtypes have been described since then, such as the form featuring pure ataxia and the type causing pharyngeal-cervical-brachial weakness.<sup id="cite_ref-Shahrizaila2013_11-8" class="reference"><a href="#cite_note-Shahrizaila2013-11">&#91;11&#93;</a></sup> The axonal subtype was first described in 1986.<sup id="cite_ref-61" class="reference"><a href="#cite_note-61">&#91;61&#93;</a></sup>
</p><p>Diagnostic criteria were developed in the late 1970s after the series of cases associated with <a href="/wiki/Swine_influenza" title="Swine influenza">swine flu</a> vaccination. These were refined in 1990.<sup id="cite_ref-NatRevNeurol2014_5-25" class="reference"><a href="#cite_note-NatRevNeurol2014-5">&#91;5&#93;</a></sup><sup id="cite_ref-62" class="reference"><a href="#cite_note-62">&#91;62&#93;</a></sup> The case definition was revised by the <a href="/wiki/Brighton_Collaboration" title="Brighton Collaboration">Brighton Collaboration</a> for vaccine safety in 2009,<sup id="cite_ref-63" class="reference"><a href="#cite_note-63">&#91;63&#93;</a></sup> but is mainly intended for research.<sup id="cite_ref-NatRevNeurol2014_5-26" class="reference"><a href="#cite_note-NatRevNeurol2014-5">&#91;5&#93;</a></sup> Plasma exchange was first used in 1978, and its benefit was confirmed in larger studies in 1985.<sup id="cite_ref-Walgaard2011_64-0" class="reference"><a href="#cite_note-Walgaard2011-64">&#91;64&#93;</a></sup> Intravenous immunoglobulins were introduced in 1988, and studies in the early 1990s demonstrated that they were no less effective than plasma exchange.<sup id="cite_ref-Walgaard2011_64-1" class="reference"><a href="#cite_note-Walgaard2011-64">&#91;64&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Research_directions">Research directions</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=edit&amp;section=22" title="Edit section: Research directions">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The understanding of the disease mechanism of Guillain–Barré syndrome has evolved in recent years.<sup id="cite_ref-Rinaldi2013_39-2" class="reference"><a href="#cite_note-Rinaldi2013-39">&#91;39&#93;</a></sup> Development of new treatments has been limited since immunotherapy was introduced in the 1980s and 1990s.<sup id="cite_ref-Rinaldi2013_39-3" class="reference"><a href="#cite_note-Rinaldi2013-39">&#91;39&#93;</a></sup><sup id="cite_ref-Walgaard2011_64-2" class="reference"><a href="#cite_note-Walgaard2011-64">&#91;64&#93;</a></sup> Current research is aimed at demonstrating whether some people who have received IVIg might benefit from a second course if the antibody levels measured in blood after treatment have shown only a small increase.<sup id="cite_ref-vanDoorn2010_12-4" class="reference"><a href="#cite_note-vanDoorn2010-12">&#91;12&#93;</a></sup><sup id="cite_ref-Walgaard2011_64-3" class="reference"><a href="#cite_note-Walgaard2011-64">&#91;64&#93;</a></sup> Studies of the immunosuppressive drugs <a href="/wiki/Mycophenolic_acid" title="Mycophenolic acid">mycophenolate mofetil</a>, <a href="/wiki/Brain-derived_neurotrophic_factor" title="Brain-derived neurotrophic factor">brain-derived neurotrophic factor</a> and <a href="/wiki/Interferon_type_I" title="Interferon type I">interferon beta</a> (IFN-β) have not demonstrated benefit to support their widespread use.<sup id="cite_ref-Walgaard2011_64-4" class="reference"><a href="#cite_note-Walgaard2011-64">&#91;64&#93;</a></sup>
</p><p>An animal model (experimental autoimmune neuritis in rats) is often used for studies, and some agents have shown promise: <a href="/wiki/Glatiramer_acetate" title="Glatiramer acetate">glatiramer acetate</a>, <a href="/w/index.php?title=Quinpramine&amp;action=edit&amp;redlink=1" class="new" title="Quinpramine (page does not exist)">quinpramine</a>, <a href="/wiki/Fasudil" title="Fasudil">fasudil</a> (an inhibitor of the <a href="/wiki/Rho-associated_protein_kinase" title="Rho-associated protein kinase">Rho-kinase</a> enzyme),<sup id="cite_ref-Rinaldi2013_39-4" class="reference"><a href="#cite_note-Rinaldi2013-39">&#91;39&#93;</a></sup> and the heart drug <a href="/wiki/Flecainide" title="Flecainide">flecainide</a>.<sup id="cite_ref-Walgaard2011_64-5" class="reference"><a href="#cite_note-Walgaard2011-64">&#91;64&#93;</a></sup> An antibody targeted against the anti-GD3 antiganglioside antibody has shown benefit in laboratory research.<sup id="cite_ref-Rinaldi2013_39-5" class="reference"><a href="#cite_note-Rinaldi2013-39">&#91;39&#93;</a></sup> Given the role of the complement system in GBS, it has been suggested that complement inhibitors (such as the drug <a href="/wiki/Eculizumab" title="Eculizumab">eculizumab</a>) may be effective.<sup id="cite_ref-Walgaard2011_64-6" class="reference"><a href="#cite_note-Walgaard2011-64">&#91;64&#93;</a></sup>
</p>
<div style="clear:both;"></div>
<p>In animals it is called acute polyradiculoneuritis or "coonhound paralysis", and may onset in the <a href="/wiki/Coonhound" title="Coonhound">coonhound</a> 7 to 10 days after transmission from <a href="/wiki/Raccoons" class="mw-redirect" title="Raccoons">raccoons</a>. If the coonhound has not been around raccoons, the disease is called acute idiopathic polyradiculoneuritis.<sup id="cite_ref-65" class="reference"><a href="#cite_note-65">&#91;65&#93;</a></sup><sup id="cite_ref-66" class="reference"><a href="#cite_note-66">&#91;66&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=edit&amp;section=23" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<style data-mw-deduplicate="TemplateStyles:r1011085734">.mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}</style><div class="reflist">
<div class="mw-references-wrap mw-references-columns"><ol class="references">
<li id="cite_note-Fer2016-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-Fer2016_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Fer2016_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Fer2016_1-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Fer2016_1-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Fer2016_1-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Fer2016_1-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Fer2016_1-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Fer2016_1-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><style data-mw-deduplicate="TemplateStyles:r1133582631">.mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:#d33}.mw-parser-output .cs1-visible-error{color:#d33}.mw-parser-output .cs1-maint{display:none;color:#3a3;margin-left:0.3em}.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style><cite id="CITEREFFerri2016" class="citation book cs1">Ferri FF (2016). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=rRhCDAAAQBAJ&amp;pg=PA529"><i>Ferri's Clinical Advisor 2017: 5 Books in 1</i></a>. Elsevier Health Sciences. p.&#160;529. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/9780323448383" title="Special:BookSources/9780323448383"><bdi>9780323448383</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20160821222609/https://books.google.ca/books?id=rRhCDAAAQBAJ&amp;pg=PA529">Archived</a> from the original on 2016-08-21.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Ferri%27s+Clinical+Advisor+2017%3A+5+Books+in+1&amp;rft.pages=529&amp;rft.pub=Elsevier+Health+Sciences&amp;rft.date=2016&amp;rft.isbn=9780323448383&amp;rft.aulast=Ferri&amp;rft.aufirst=Fred+F.&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DrRhCDAAAQBAJ%26pg%3DPA529&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-2"><span class="mw-cite-backlink"><b><a href="#cite_ref-2">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.merriam-webster.com/dictionary/Guillain-Barr%C3%A9+syndrome">"Definition of GUILLAIN-BARRÉ SYNDROME"</a>. <i>www.merriam-webster.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2023-01-27</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.merriam-webster.com&amp;rft.atitle=Definition+of+GUILLAIN-BARR%C3%89+SYNDROME&amp;rft_id=https%3A%2F%2Fwww.merriam-webster.com%2Fdictionary%2FGuillain-Barr%25C3%25A9%2Bsyndrome&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-NIH2016-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-NIH2016_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NIH2016_3-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-NIH2016_3-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-NIH2016_3-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-NIH2016_3-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-NIH2016_3-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-NIH2016_3-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-NIH2016_3-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-NIH2016_3-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-NIH2016_3-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-NIH2016_3-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-NIH2016_3-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-NIH2016_3-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-NIH2016_3-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-NIH2016_3-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-NIH2016_3-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-NIH2016_3-16"><sup><i><b>q</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Guillain-Barré-Syndrome-Fact-Sheet">"Guillain–Barré Syndrome Fact Sheet"</a>. <i>NIAMS</i>. June 1, 2016. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20160805044252/http://www.ninds.nih.gov/disorders/gbs/detail_gbs.htm">Archived</a> from the original on 5 August 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">29 August</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=NIAMS&amp;rft.atitle=Guillain%E2%80%93Barr%C3%A9+Syndrome+Fact+Sheet&amp;rft.date=2016-06-01&amp;rft_id=https%3A%2F%2Fwww.ninds.nih.gov%2FDisorders%2FPatient-Caregiver-Education%2FFact-Sheets%2FGuillain-Barr%C3%A9-Syndrome-Fact-Sheet&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-Sejvar2011-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-Sejvar2011_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Sejvar2011_4-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Sejvar2011_4-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Sejvar2011_4-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSejvarBaughmanWiseMorgan2011" class="citation journal cs1">Sejvar JJ, Baughman AL, Wise M, Morgan OW (2011). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703046">"Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis"</a>. <i>Neuroepidemiology</i>. <b>36</b> (2): 123–33. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1159%2F000324710">10.1159/000324710</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703046">5703046</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21422765">21422765</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuroepidemiology&amp;rft.atitle=Population+incidence+of+Guillain-Barr%C3%A9+syndrome%3A+a+systematic+review+and+meta-analysis&amp;rft.volume=36&amp;rft.issue=2&amp;rft.pages=123-33&amp;rft.date=2011&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5703046%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F21422765&amp;rft_id=info%3Adoi%2F10.1159%2F000324710&amp;rft.aulast=Sejvar&amp;rft.aufirst=JJ&amp;rft.au=Baughman%2C+AL&amp;rft.au=Wise%2C+M&amp;rft.au=Morgan%2C+OW&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5703046&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-NatRevNeurol2014-5"><span class="mw-cite-backlink">^ <a href="#cite_ref-NatRevNeurol2014_5-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NatRevNeurol2014_5-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-NatRevNeurol2014_5-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-NatRevNeurol2014_5-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-NatRevNeurol2014_5-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-NatRevNeurol2014_5-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-NatRevNeurol2014_5-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-NatRevNeurol2014_5-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-NatRevNeurol2014_5-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-NatRevNeurol2014_5-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-NatRevNeurol2014_5-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-NatRevNeurol2014_5-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-NatRevNeurol2014_5-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-NatRevNeurol2014_5-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-NatRevNeurol2014_5-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-NatRevNeurol2014_5-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-NatRevNeurol2014_5-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-NatRevNeurol2014_5-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-NatRevNeurol2014_5-18"><sup><i><b>s</b></i></sup></a> <a href="#cite_ref-NatRevNeurol2014_5-19"><sup><i><b>t</b></i></sup></a> <a href="#cite_ref-NatRevNeurol2014_5-20"><sup><i><b>u</b></i></sup></a> <a href="#cite_ref-NatRevNeurol2014_5-21"><sup><i><b>v</b></i></sup></a> <a href="#cite_ref-NatRevNeurol2014_5-22"><sup><i><b>w</b></i></sup></a> <a href="#cite_ref-NatRevNeurol2014_5-23"><sup><i><b>x</b></i></sup></a> <a href="#cite_ref-NatRevNeurol2014_5-24"><sup><i><b>y</b></i></sup></a> <a href="#cite_ref-NatRevNeurol2014_5-25"><sup><i><b>z</b></i></sup></a> <a href="#cite_ref-NatRevNeurol2014_5-26"><sup><i><b>aa</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFvan_den_BergWalgaardDrenthenFokke2014" class="citation journal cs1">van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA (August 2014). <a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrneurol.2014.121">"Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis"</a>. <i>Nature Reviews. Neurology</i>. <b>10</b> (8): 469–82. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrneurol.2014.121">10.1038/nrneurol.2014.121</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25023340">25023340</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:25154778">25154778</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Neurology&amp;rft.atitle=Guillain-Barr%C3%A9+syndrome%3A+pathogenesis%2C+diagnosis%2C+treatment+and+prognosis&amp;rft.volume=10&amp;rft.issue=8&amp;rft.pages=469-82&amp;rft.date=2014-08&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A25154778%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F25023340&amp;rft_id=info%3Adoi%2F10.1038%2Fnrneurol.2014.121&amp;rft.aulast=van+den+Berg&amp;rft.aufirst=B&amp;rft.au=Walgaard%2C+C&amp;rft.au=Drenthen%2C+J&amp;rft.au=Fokke%2C+C&amp;rft.au=Jacobs%2C+BC&amp;rft.au=van+Doorn%2C+PA&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fnrneurol.2014.121&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-vanDoorn2008-6"><span class="mw-cite-backlink">^ <a href="#cite_ref-vanDoorn2008_6-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-vanDoorn2008_6-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-vanDoorn2008_6-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-vanDoorn2008_6-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-vanDoorn2008_6-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-vanDoorn2008_6-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFvan_DoornRutsJacobs2008" class="citation journal cs1">van Doorn PA, Ruts L, Jacobs BC (October 2008). "Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome". <i>The Lancet. Neurology</i>. <b>7</b> (10): 939–50. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2808%2970215-1">10.1016/S1474-4422(08)70215-1</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18848313">18848313</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:9307245">9307245</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=Clinical+features%2C+pathogenesis%2C+and+treatment+of+Guillain-Barr%C3%A9+syndrome&amp;rft.volume=7&amp;rft.issue=10&amp;rft.pages=939-50&amp;rft.date=2008-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A9307245%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F18848313&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2808%2970215-1&amp;rft.aulast=van+Doorn&amp;rft.aufirst=PA&amp;rft.au=Ruts%2C+L&amp;rft.au=Jacobs%2C+BC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-Eldar2014-7"><span class="mw-cite-backlink">^ <a href="#cite_ref-Eldar2014_7-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Eldar2014_7-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Eldar2014_7-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Eldar2014_7-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFEldarChapman2014" class="citation journal cs1">Eldar AH, Chapman J (April 2014). "Guillain Barré syndrome and other immune mediated neuropathies: diagnosis and classification". <i>Autoimmunity Reviews</i>. <b>13</b> (4–5): 525–30. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.autrev.2014.01.033">10.1016/j.autrev.2014.01.033</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24434363">24434363</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Autoimmunity+Reviews&amp;rft.atitle=Guillain+Barr%C3%A9+syndrome+and+other+immune+mediated+neuropathies%3A+diagnosis+and+classification&amp;rft.volume=13&amp;rft.issue=4%E2%80%935&amp;rft.pages=525-30&amp;rft.date=2014-04&amp;rft_id=info%3Adoi%2F10.1016%2Fj.autrev.2014.01.033&amp;rft_id=info%3Apmid%2F24434363&amp;rft.aulast=Eldar&amp;rft.aufirst=AH&amp;rft.au=Chapman%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-Willison2016-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-Willison2016_8-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFWillisonJacobsvan_Doorn2016" class="citation journal cs1">Willison HJ, Jacobs BC, van Doorn PA (August 2016). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0140-6736%2816%2900339-1">"Guillain-Barré syndrome"</a>. <i>Lancet</i>. <b>388</b> (10045): 717–27. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0140-6736%2816%2900339-1">10.1016/S0140-6736(16)00339-1</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26948435">26948435</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Guillain-Barr%C3%A9+syndrome&amp;rft.volume=388&amp;rft.issue=10045&amp;rft.pages=717-27&amp;rft.date=2016-08&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2816%2900339-1&amp;rft_id=info%3Apmid%2F26948435&amp;rft.aulast=Willison&amp;rft.aufirst=HJ&amp;rft.au=Jacobs%2C+BC&amp;rft.au=van+Doorn%2C+PA&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252FS0140-6736%252816%252900339-1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-NEJM2012-9"><span class="mw-cite-backlink">^ <a href="#cite_ref-NEJM2012_9-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NEJM2012_9-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-NEJM2012_9-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-NEJM2012_9-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-NEJM2012_9-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-NEJM2012_9-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-NEJM2012_9-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-NEJM2012_9-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-NEJM2012_9-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-NEJM2012_9-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-NEJM2012_9-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-NEJM2012_9-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-NEJM2012_9-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-NEJM2012_9-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-NEJM2012_9-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-NEJM2012_9-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-NEJM2012_9-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-NEJM2012_9-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-NEJM2012_9-18"><sup><i><b>s</b></i></sup></a> <a href="#cite_ref-NEJM2012_9-19"><sup><i><b>t</b></i></sup></a> <a href="#cite_ref-NEJM2012_9-20"><sup><i><b>u</b></i></sup></a> <a href="#cite_ref-NEJM2012_9-21"><sup><i><b>v</b></i></sup></a> <a href="#cite_ref-NEJM2012_9-22"><sup><i><b>w</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFYukiHartung2012" class="citation journal cs1">Yuki N, Hartung HP (June 2012). "Guillain-Barré syndrome". <i>The New England Journal of Medicine</i>. <b>366</b> (24): 2294–304. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1056%2FNEJMra1114525">10.1056/NEJMra1114525</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22694000">22694000</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=Guillain-Barr%C3%A9+syndrome&amp;rft.volume=366&amp;rft.issue=24&amp;rft.pages=2294-304&amp;rft.date=2012-06&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMra1114525&amp;rft_id=info%3Apmid%2F22694000&amp;rft.aulast=Yuki&amp;rft.aufirst=N&amp;rft.au=Hartung%2C+HP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-Ryan2013-10"><span class="mw-cite-backlink">^ <a href="#cite_ref-Ryan2013_10-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Ryan2013_10-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRyan2013" class="citation journal cs1">Ryan MM (December 2013). "Pediatric Guillain-Barré syndrome". <i>Current Opinion in Pediatrics</i>. <b>25</b> (6): 689–93. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FMOP.0b013e328365ad3f">10.1097/MOP.0b013e328365ad3f</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24240288">24240288</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:34011924">34011924</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Opinion+in+Pediatrics&amp;rft.atitle=Pediatric+Guillain-Barr%C3%A9+syndrome&amp;rft.volume=25&amp;rft.issue=6&amp;rft.pages=689-93&amp;rft.date=2013-12&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A34011924%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F24240288&amp;rft_id=info%3Adoi%2F10.1097%2FMOP.0b013e328365ad3f&amp;rft.aulast=Ryan&amp;rft.aufirst=MM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-Shahrizaila2013-11"><span class="mw-cite-backlink">^ <a href="#cite_ref-Shahrizaila2013_11-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Shahrizaila2013_11-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Shahrizaila2013_11-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Shahrizaila2013_11-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Shahrizaila2013_11-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Shahrizaila2013_11-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Shahrizaila2013_11-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Shahrizaila2013_11-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Shahrizaila2013_11-8"><sup><i><b>i</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFShahrizailaYuki2013" class="citation journal cs1">Shahrizaila N, Yuki N (May 2013). <a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjnnp-2012-302824">"Bickerstaff brainstem encephalitis and Fisher syndrome: anti-GQ1b antibody syndrome"</a>. <i>Journal of Neurology, Neurosurgery, and Psychiatry</i>. <b>84</b> (5): 576–83. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjnnp-2012-302824">10.1136/jnnp-2012-302824</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22984203">22984203</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurology%2C+Neurosurgery%2C+and+Psychiatry&amp;rft.atitle=Bickerstaff+brainstem+encephalitis+and+Fisher+syndrome%3A+anti-GQ1b+antibody+syndrome&amp;rft.volume=84&amp;rft.issue=5&amp;rft.pages=576-83&amp;rft.date=2013-05&amp;rft_id=info%3Adoi%2F10.1136%2Fjnnp-2012-302824&amp;rft_id=info%3Apmid%2F22984203&amp;rft.aulast=Shahrizaila&amp;rft.aufirst=N&amp;rft.au=Yuki%2C+N&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1136%252Fjnnp-2012-302824&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-vanDoorn2010-12"><span class="mw-cite-backlink">^ <a href="#cite_ref-vanDoorn2010_12-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-vanDoorn2010_12-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-vanDoorn2010_12-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-vanDoorn2010_12-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-vanDoorn2010_12-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFvan_DoornKuitwaardWalgaardvan_Koningsveld2010" class="citation journal cs1 cs1-prop-long-vol">van Doorn PA, Kuitwaard K, Walgaard C, van Koningsveld R, Ruts L, Jacobs BC (May 2010). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883091">"IVIG treatment and prognosis in Guillain-Barré syndrome"</a>. <i>Journal of Clinical Immunology</i>. 30 Suppl 1 (Suppl 1): S74-8. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs10875-010-9407-4">10.1007/s10875-010-9407-4</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883091">2883091</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/20396937">20396937</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Clinical+Immunology&amp;rft.atitle=IVIG+treatment+and+prognosis+in+Guillain-Barr%C3%A9+syndrome&amp;rft.volume=30+Suppl+1&amp;rft.issue=Suppl+1&amp;rft.pages=S74-8&amp;rft.date=2010-05&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2883091%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F20396937&amp;rft_id=info%3Adoi%2F10.1007%2Fs10875-010-9407-4&amp;rft.aulast=van+Doorn&amp;rft.aufirst=PA&amp;rft.au=Kuitwaard%2C+K&amp;rft.au=Walgaard%2C+C&amp;rft.au=van+Koningsveld%2C+R&amp;rft.au=Ruts%2C+L&amp;rft.au=Jacobs%2C+BC&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2883091&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFVellozziIqbalBroder2014" class="citation journal cs1">Vellozzi, C.; Iqbal, S.; Broder, K. (15 April 2014). <a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fcid%2Fciu005">"Guillain-Barre Syndrome, Influenza, and Influenza Vaccination: The Epidemiologic Evidence"</a>. <i>Clinical Infectious Diseases</i>. <b>58</b> (8): 1149–1155. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fcid%2Fciu005">10.1093/cid/ciu005</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24415636">24415636</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Infectious+Diseases&amp;rft.atitle=Guillain-Barre+Syndrome%2C+Influenza%2C+and+Influenza+Vaccination%3A+The+Epidemiologic+Evidence&amp;rft.volume=58&amp;rft.issue=8&amp;rft.pages=1149-1155&amp;rft.date=2014-04-15&amp;rft_id=info%3Adoi%2F10.1093%2Fcid%2Fciu005&amp;rft_id=info%3Apmid%2F24415636&amp;rft.aulast=Vellozzi&amp;rft.aufirst=C.&amp;rft.au=Iqbal%2C+S.&amp;rft.au=Broder%2C+K.&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1093%252Fcid%252Fciu005&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-Carod2013-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-Carod2013_14-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFCarod-ArtalWichmannFarrarGascón2013" class="citation journal cs1">Carod-Artal FJ, Wichmann O, Farrar J, Gascón J (September 2013). "Neurological complications of dengue virus infection". <i>The Lancet. Neurology</i>. <b>12</b> (9): 906–919. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2813%2970150-9">10.1016/S1474-4422(13)70150-9</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23948177">23948177</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:13948773">13948773</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=Neurological+complications+of+dengue+virus+infection&amp;rft.volume=12&amp;rft.issue=9&amp;rft.pages=906-919&amp;rft.date=2013-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A13948773%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F23948177&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2813%2970150-9&amp;rft.aulast=Carod-Artal&amp;rft.aufirst=FJ&amp;rft.au=Wichmann%2C+O&amp;rft.au=Farrar%2C+J&amp;rft.au=Gasc%C3%B3n%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFGathererKohl2016" class="citation journal cs1">Gatherer D, Kohl A (February 2016). <a rel="nofollow" class="external text" href="http://eprints.gla.ac.uk/113711/1/113711.pdf">"Zika virus: a previously slow pandemic spreads rapidly through the Americas"</a> <span class="cs1-format">(PDF)</span>. <i>The Journal of General Virology</i>. <b>97</b> (2): 269–273. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1099%2Fjgv.0.000381">10.1099/jgv.0.000381</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26684466">26684466</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+General+Virology&amp;rft.atitle=Zika+virus%3A+a+previously+slow+pandemic+spreads+rapidly+through+the+Americas&amp;rft.volume=97&amp;rft.issue=2&amp;rft.pages=269-273&amp;rft.date=2016-02&amp;rft_id=info%3Adoi%2F10.1099%2Fjgv.0.000381&amp;rft_id=info%3Apmid%2F26684466&amp;rft.aulast=Gatherer&amp;rft.aufirst=D&amp;rft.au=Kohl%2C+A&amp;rft_id=http%3A%2F%2Feprints.gla.ac.uk%2F113711%2F1%2F113711.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-Lehmann2010-16"><span class="mw-cite-backlink">^ <a href="#cite_ref-Lehmann2010_16-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Lehmann2010_16-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLehmannHartungKieseierHughes2010" class="citation journal cs1">Lehmann HC, Hartung HP, Kieseier BC, Hughes RA (September 2010). "Guillain-Barré syndrome after exposure to influenza virus". <i>The Lancet. Infectious Diseases</i>. <b>10</b> (9): 643–51. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1473-3099%2810%2970140-7">10.1016/S1473-3099(10)70140-7</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/20797646">20797646</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Infectious+Diseases&amp;rft.atitle=Guillain-Barr%C3%A9+syndrome+after+exposure+to+influenza+virus&amp;rft.volume=10&amp;rft.issue=9&amp;rft.pages=643-51&amp;rft.date=2010-09&amp;rft_id=info%3Adoi%2F10.1016%2FS1473-3099%2810%2970140-7&amp;rft_id=info%3Apmid%2F20797646&amp;rft.aulast=Lehmann&amp;rft.aufirst=HC&amp;rft.au=Hartung%2C+HP&amp;rft.au=Kieseier%2C+BC&amp;rft.au=Hughes%2C+RA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-nelson12-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-nelson12_17-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFNelson2012" class="citation journal cs1">Nelson, K. E. (2012). <a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Faje%2Fkws194">"Invited Commentary: Influenza Vaccine and Guillain-Barre Syndrome--Is There a Risk?"</a>. <i>American Journal of Epidemiology</i>. <b>175</b> (11): 1129–1132. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Faje%2Fkws194">10.1093/aje/kws194</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22582208">22582208</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Epidemiology&amp;rft.atitle=Invited+Commentary%3A+Influenza+Vaccine+and+Guillain-Barre+Syndrome--Is+There+a+Risk%3F&amp;rft.volume=175&amp;rft.issue=11&amp;rft.pages=1129-1132&amp;rft.date=2012&amp;rft_id=info%3Adoi%2F10.1093%2Faje%2Fkws194&amp;rft_id=info%3Apmid%2F22582208&amp;rft.aulast=Nelson&amp;rft.aufirst=K.+E.&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1093%252Faje%252Fkws194&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-DeStefano2019-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-DeStefano2019_18-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFDeStefanoBodenstabOffit2019" class="citation journal cs1">DeStefano F, Bodenstab HM, Offit PA (August 2019). <a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fcid%2Fciz135">"Principal controversies in vaccine safety in the United States"</a>. <i>Clinical Infectious Diseases</i>. <b>69</b> (4): 726–731. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fcid%2Fciz135">10.1093/cid/ciz135</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30753348">30753348</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Infectious+Diseases&amp;rft.atitle=Principal+controversies+in+vaccine+safety+in+the+United+States&amp;rft.volume=69&amp;rft.issue=4&amp;rft.pages=726-731&amp;rft.date=2019-08&amp;rft_id=info%3Adoi%2F10.1093%2Fcid%2Fciz135&amp;rft_id=info%3Apmid%2F30753348&amp;rft.aulast=DeStefano&amp;rft.aufirst=F&amp;rft.au=Bodenstab%2C+HM&amp;rft.au=Offit%2C+PA&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1093%252Fcid%252Fciz135&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-19">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.hrsa.gov/sites/default/files/vaccinecompensation/vaccineinjurytable.pdf">"Vaccine Injury Table - HRSA"</a> <span class="cs1-format">(PDF)</span>. <i>HRSA</i>. March 22, 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">October 23,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=HRSA&amp;rft.atitle=Vaccine+Injury+Table+-+HRSA&amp;rft.date=2017-03-22&amp;rft_id=https%3A%2F%2Fwww.hrsa.gov%2Fsites%2Fdefault%2Ffiles%2Fvaccinecompensation%2Fvaccineinjurytable.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-U.S._Food_and_Drug_Administration_2021-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-U.S._Food_and_Drug_Administration_2021_20-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/fda-requires-warning-about-guillain-barre-syndrome-gbs-be-included-prescribing-information-shingrix">"New safety communication regarding Shingrix vaccine"</a>. <i>U.S. Food and Drug Administration</i>. 2021-03-25<span class="reference-accessdate">. Retrieved <span class="nowrap">2021-10-18</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=U.S.+Food+and+Drug+Administration&amp;rft.atitle=New+safety+communication+regarding+Shingrix+vaccine&amp;rft.date=2021-03-25&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fvaccines-blood-biologics%2Fsafety-availability-biologics%2Ffda-requires-warning-about-guillain-barre-syndrome-gbs-be-included-prescribing-information-shingrix&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-21">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFEllulBenjaminSinghLant2020" class="citation journal cs1">Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A,  et&#160;al. (September 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332267">"Neurological associations of COVID-19"</a>. <i>The Lancet. Neurology</i>. <b>19</b> (9): 767–783. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2820%2930221-0">10.1016/S1474-4422(20)30221-0</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332267">7332267</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32622375">32622375</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=Neurological+associations+of+COVID-19&amp;rft.volume=19&amp;rft.issue=9&amp;rft.pages=767-783&amp;rft.date=2020-09&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7332267%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F32622375&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2820%2930221-0&amp;rft.aulast=Ellul&amp;rft.aufirst=MA&amp;rft.au=Benjamin%2C+L&amp;rft.au=Singh%2C+B&amp;rft.au=Lant%2C+S&amp;rft.au=Michael%2C+BD&amp;rft.au=Easton%2C+A&amp;rft.au=Kneen%2C+R&amp;rft.au=Defres%2C+S&amp;rft.au=Sejvar%2C+J&amp;rft.au=Solomon%2C+T&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7332267&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-22">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFToscanoPalmeriniRavagliaRuiz2020" class="citation journal cs1">Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG,  et&#160;al. (June 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182017">"Guillain-Barré Syndrome Associated with SARS-CoV-2"</a>. <i>The New England Journal of Medicine</i>. <b>382</b> (26): 2574–2576. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1056%2FNEJMc2009191">10.1056/NEJMc2009191</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182017">7182017</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32302082">32302082</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=Guillain-Barr%C3%A9+Syndrome+Associated+with+SARS-CoV-2&amp;rft.volume=382&amp;rft.issue=26&amp;rft.pages=2574-2576&amp;rft.date=2020-06&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7182017%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F32302082&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMc2009191&amp;rft.aulast=Toscano&amp;rft.aufirst=G&amp;rft.au=Palmerini%2C+F&amp;rft.au=Ravaglia%2C+S&amp;rft.au=Ruiz%2C+L&amp;rft.au=Invernizzi%2C+P&amp;rft.au=Cuzzoni%2C+MG&amp;rft.au=Franciotta%2C+D&amp;rft.au=Baldanti%2C+F&amp;rft.au=Daturi%2C+R&amp;rft.au=Postorino%2C+P&amp;rft.au=Cavallini%2C+A&amp;rft.au=Micieli%2C+G&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7182017&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-23">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFPatersonBrownBenjaminNortley2020" class="citation journal cs1">Paterson RW, Brown RL, Benjamin L, Nortley R, Wiethoff S, Bharucha T,  et&#160;al. (July 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454352">"The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings"</a>. <i>Brain</i>. <b>143</b> (10): 3104–3120. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fbrain%2Fawaa240">10.1093/brain/awaa240</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454352">7454352</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32637987">32637987</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Brain&amp;rft.atitle=The+emerging+spectrum+of+COVID-19+neurology%3A+clinical%2C+radiological+and+laboratory+findings&amp;rft.volume=143&amp;rft.issue=10&amp;rft.pages=3104-3120&amp;rft.date=2020-07&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7454352%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F32637987&amp;rft_id=info%3Adoi%2F10.1093%2Fbrain%2Fawaa240&amp;rft.aulast=Paterson&amp;rft.aufirst=RW&amp;rft.au=Brown%2C+RL&amp;rft.au=Benjamin%2C+L&amp;rft.au=Nortley%2C+R&amp;rft.au=Wiethoff%2C+S&amp;rft.au=Bharucha%2C+T&amp;rft.au=Jayaseelan%2C+DL&amp;rft.au=Kumar%2C+G&amp;rft.au=Raftopoulos%2C+RE&amp;rft.au=Zambreanu%2C+L&amp;rft.au=Vivekanandam%2C+V&amp;rft.au=Khoo%2C+A&amp;rft.au=Geraldes%2C+R&amp;rft.au=Chinthapalli%2C+K&amp;rft.au=Boyd%2C+E&amp;rft.au=Tuzlali%2C+H&amp;rft.au=Price%2C+G&amp;rft.au=Christofi%2C+G&amp;rft.au=Morrow%2C+J&amp;rft.au=McNamara%2C+P&amp;rft.au=McLoughlin%2C+B&amp;rft.au=Lim%2C+ST&amp;rft.au=Mehta%2C+PR&amp;rft.au=Levee%2C+V&amp;rft.au=Keddie%2C+S&amp;rft.au=Yong%2C+W&amp;rft.au=Trip%2C+SA&amp;rft.au=Foulkes%2C+AJ&amp;rft.au=Hotton%2C+G&amp;rft.au=Miller%2C+TD&amp;rft.au=Everitt%2C+AD&amp;rft.au=Carswell%2C+C&amp;rft.au=Davies%2C+NW&amp;rft.au=Yoong%2C+M&amp;rft.au=Attwell%2C+D&amp;rft.au=Sreedharan%2C+J&amp;rft.au=Silber%2C+E&amp;rft.au=Schott%2C+JM&amp;rft.au=Chandratheva%2C+A&amp;rft.au=Perry%2C+RJ&amp;rft.au=Simister%2C+R&amp;rft.au=Checkley%2C+A&amp;rft.au=Longley%2C+N&amp;rft.au=Farmer%2C+SF&amp;rft.au=Carletti%2C+F&amp;rft.au=Houlihan%2C+C&amp;rft.au=Thom%2C+M&amp;rft.au=Lunn%2C+MP&amp;rft.au=Spillane%2C+J&amp;rft.au=Howard%2C+R&amp;rft.au=Vincent%2C+A&amp;rft.au=Werring%2C+DJ&amp;rft.au=Hoskote%2C+C&amp;rft.au=J%C3%A4ger%2C+HR&amp;rft.au=Manji%2C+H&amp;rft.au=Zandi%2C+MS&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7454352&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFAbu-RumeilehAbdelhakFoschiTumani2021" class="citation journal cs1">Abu-Rumeileh, Samir; Abdelhak, Ahmed; Foschi, Matteo; Tumani, Hayrettin; Otto, Markus (2021). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445716">"Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases"</a>. <i>Journal of Neurology</i>. <b>268</b> (4): 1133–1170. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs00415-020-10124-x">10.1007/s00415-020-10124-x</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="https://www.worldcat.org/issn/1432-1459">1432-1459</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445716">7445716</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32840686">32840686</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurology&amp;rft.atitle=Guillain-Barr%C3%A9+syndrome+spectrum+associated+with+COVID-19%3A+an+up-to-date+systematic+review+of+73+cases&amp;rft.volume=268&amp;rft.issue=4&amp;rft.pages=1133-1170&amp;rft.date=2021&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7445716%23id-name%3DPMC&amp;rft.issn=1432-1459&amp;rft_id=info%3Apmid%2F32840686&amp;rft_id=info%3Adoi%2F10.1007%2Fs00415-020-10124-x&amp;rft.aulast=Abu-Rumeileh&amp;rft.aufirst=Samir&amp;rft.au=Abdelhak%2C+Ahmed&amp;rft.au=Foschi%2C+Matteo&amp;rft.au=Tumani%2C+Hayrettin&amp;rft.au=Otto%2C+Markus&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7445716&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-EMAEU-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-EMAEU_25-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.ema.europa.eu/en/news/covid-19-vaccine-janssen-guillain-barre-syndrome-listed-very-rare-side-effect">"COVID-19 Vaccine Janssen: Guillain-Barré syndrome listed as a very rare side effect"</a>. <i>European Medicines Agency</i><span class="reference-accessdate">. Retrieved <span class="nowrap">13 September</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=European+Medicines+Agency&amp;rft.atitle=COVID-19+Vaccine+Janssen%3A+Guillain-Barr%C3%A9+syndrome+listed+as+a+very+rare+side+effect&amp;rft_id=https%3A%2F%2Fwww.ema.europa.eu%2Fen%2Fnews%2Fcovid-19-vaccine-janssen-guillain-barre-syndrome-listed-very-rare-side-effect&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-26">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation journal cs1"><a rel="nofollow" class="external text" href="https://www.bmj.com/content/374/bmj.n1786/rr-0">"Autoimmune damage to the nerves following Covid vaccines: EMA issued warning to patients and healthcare professionals"</a>. 2022-06-21.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Autoimmune+damage+to+the+nerves+following+Covid+vaccines%3A+EMA+issued+warning+to+patients+and+healthcare+professionals&amp;rft.date=2022-06-21&amp;rft_id=https%3A%2F%2Fwww.bmj.com%2Fcontent%2F374%2Fbmj.n1786%2Frr-0&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span> <span class="cs1-hidden-error citation-comment"><code class="cs1-code">{{<a href="/wiki/Template:Cite_journal" title="Template:Cite journal">cite journal</a>}}</code>: </span><span class="cs1-hidden-error citation-comment">Cite journal requires <code class="cs1-code">&#124;journal=</code> (<a href="/wiki/Help:CS1_errors#missing_periodical" title="Help:CS1 errors">help</a>)</span></span>
</li>
<li id="cite_note-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-27">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFPatone2021" class="citation journal cs1">Patone, Martina (2021). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629105">"Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection"</a>. <i><a href="/wiki/Nature_Medicine" title="Nature Medicine">Nature Medicine</a></i>. <b>27</b> (12): 2144–2153. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fs41591-021-01556-7">10.1038/s41591-021-01556-7</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629105">8629105</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/34697502">34697502</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Medicine&amp;rft.atitle=Neurological+complications+after+first+dose+of+COVID-19+vaccines+and+SARS-CoV-2+infection&amp;rft.volume=27&amp;rft.issue=12&amp;rft.pages=2144-2153&amp;rft.date=2021&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8629105%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F34697502&amp;rft_id=info%3Adoi%2F10.1038%2Fs41591-021-01556-7&amp;rft.aulast=Patone&amp;rft.aufirst=Martina&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8629105&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-28">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFUCL2022" class="citation web cs1">UCL (2022-05-30). <a rel="nofollow" class="external text" href="https://www.ucl.ac.uk/news/2022/may/rise-guillain-barre-syndrome-following-astrazeneca-vaccine">"Rise in Guillain-Barré syndrome following AstraZeneca vaccine"</a>. <i>UCL News</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2022-06-22</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=UCL+News&amp;rft.atitle=Rise+in+Guillain-Barr%C3%A9+syndrome+following+AstraZeneca+vaccine&amp;rft.date=2022-05-30&amp;rft.au=UCL&amp;rft_id=https%3A%2F%2Fwww.ucl.ac.uk%2Fnews%2F2022%2Fmay%2Frise-guillain-barre-syndrome-following-astrazeneca-vaccine&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFFinstererScorzaScorzaFiorini2021" class="citation journal cs1">Finsterer, Josef; Scorza, Fulvio Alexandre; Scorza, Carla Alessandra; Fiorini, Ana Claudia (19 July 2021). <a rel="nofollow" class="external text" href="https://doi.org/10.1590%2F0004-282X-ANP-2021-0030">"Peripheral neuropathy in COVID-19 is due to immune-mechanisms, pre-existing risk factors, anti-viral drugs, or bedding in the Intensive Care Unit"</a>. <i>Arquivos de Neuro-Psiquiatria</i>. <b>79</b> (10): 924–928. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1590%2F0004-282X-ANP-2021-0030">10.1590/0004-282X-ANP-2021-0030</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/34287509">34287509</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:236157120">236157120</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Arquivos+de+Neuro-Psiquiatria&amp;rft.atitle=Peripheral+neuropathy+in+COVID-19+is+due+to+immune-mechanisms%2C+pre-existing+risk+factors%2C+anti-viral+drugs%2C+or+bedding+in+the+Intensive+Care+Unit&amp;rft.volume=79&amp;rft.issue=10&amp;rft.pages=924-928&amp;rft.date=2021-07-19&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A236157120%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F34287509&amp;rft_id=info%3Adoi%2F10.1590%2F0004-282X-ANP-2021-0030&amp;rft.aulast=Finsterer&amp;rft.aufirst=Josef&amp;rft.au=Scorza%2C+Fulvio+Alexandre&amp;rft.au=Scorza%2C+Carla+Alessandra&amp;rft.au=Fiorini%2C+Ana+Claudia&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1590%252F0004-282X-ANP-2021-0030&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSmeyneNoyceByrneSavica2021" class="citation journal cs1"><a href="/wiki/Richard_Smeyne" title="Richard Smeyne">Smeyne, Richard J.</a>; Noyce, Alastair J.; Byrne, Matthew; Savica, Rodolfo; Marras, Connie (2021). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990414">"Infection and Risk of Parkinson's Disease"</a>. <i>Journal of Parkinson's Disease</i>. <b>11</b> (1): 31–43. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3233%2FJPD-202279">10.3233/JPD-202279</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990414">7990414</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/33361610">33361610</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Parkinson%27s+Disease&amp;rft.atitle=Infection+and+Risk+of+Parkinson%27s+Disease&amp;rft.volume=11&amp;rft.issue=1&amp;rft.pages=31-43&amp;rft.date=2021&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7990414%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F33361610&amp;rft_id=info%3Adoi%2F10.3233%2FJPD-202279&amp;rft.aulast=Smeyne&amp;rft.aufirst=Richard+J.&amp;rft.au=Noyce%2C+Alastair+J.&amp;rft.au=Byrne%2C+Matthew&amp;rft.au=Savica%2C+Rodolfo&amp;rft.au=Marras%2C+Connie&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7990414&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-Fagius-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-Fagius_31-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFFagiusOstermanSidénWiholm1985" class="citation journal cs1">Fagius J, Osterman PO, Sidén A, Wiholm BE (January 1985). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1028185">"Guillain-Barré syndrome following zimeldine treatment"</a>. <i>Journal of Neurology, Neurosurgery, and Psychiatry</i>. <b>48</b> (1): 65–9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjnnp.48.1.65">10.1136/jnnp.48.1.65</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1028185">1028185</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/3156214">3156214</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurology%2C+Neurosurgery%2C+and+Psychiatry&amp;rft.atitle=Guillain-Barr%C3%A9+syndrome+following+zimeldine+treatment&amp;rft.volume=48&amp;rft.issue=1&amp;rft.pages=65-9&amp;rft.date=1985-01&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1028185%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F3156214&amp;rft_id=info%3Adoi%2F10.1136%2Fjnnp.48.1.65&amp;rft.aulast=Fagius&amp;rft.aufirst=J&amp;rft.au=Osterman%2C+PO&amp;rft.au=Sid%C3%A9n%2C+A&amp;rft.au=Wiholm%2C+BE&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1028185&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-32">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFCarlsson2001" class="citation journal cs1">Carlsson A (November 2001). "A paradigm shift in brain research". <i>Science</i>. <b>294</b> (5544): 1021–4. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2001Sci...294.1021C">2001Sci...294.1021C</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1126%2Fscience.1066969">10.1126/science.1066969</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11691978">11691978</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:24365669">24365669</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=A+paradigm+shift+in+brain+research&amp;rft.volume=294&amp;rft.issue=5544&amp;rft.pages=1021-4&amp;rft.date=2001-11&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.1066969&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A24365669%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11691978&amp;rft_id=info%3Abibcode%2F2001Sci...294.1021C&amp;rft.aulast=Carlsson&amp;rft.aufirst=A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.thecarlatreport.com/blog/the-rise-and-sudden-fall-of-zimelidine-the-first-ssri/">"The Rise and Sudden Fall of Zimelidine: The First SSRI"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+Rise+and+Sudden+Fall+of+Zimelidine%3A+The+First+SSRI&amp;rft_id=https%3A%2F%2Fwww.thecarlatreport.com%2Fblog%2Fthe-rise-and-sudden-fall-of-zimelidine-the-first-ssri%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-Kuwabara2013-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-Kuwabara2013_34-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFKuwabaraYuki2013" class="citation journal cs1">Kuwabara S, Yuki N (December 2013). "Axonal Guillain-Barré syndrome: concepts and controversies". <i>The Lancet. Neurology</i>. <b>12</b> (12): 1180–8. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2813%2970215-1">10.1016/S1474-4422(13)70215-1</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24229616">24229616</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:35101547">35101547</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=Axonal+Guillain-Barr%C3%A9+syndrome%3A+concepts+and+controversies&amp;rft.volume=12&amp;rft.issue=12&amp;rft.pages=1180-8&amp;rft.date=2013-12&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A35101547%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F24229616&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2813%2970215-1&amp;rft.aulast=Kuwabara&amp;rft.aufirst=S&amp;rft.au=Yuki%2C+N&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-WillisonGoodyear2013-35"><span class="mw-cite-backlink">^ <a href="#cite_ref-WillisonGoodyear2013_35-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-WillisonGoodyear2013_35-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFWillisonGoodyear2013" class="citation journal cs1">Willison HJ, Goodyear CS (September 2013). "Glycolipid antigens and autoantibodies in autoimmune neuropathies". <i>Trends in Immunology</i>. <b>34</b> (9): 453–9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.it.2013.05.001">10.1016/j.it.2013.05.001</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23770405">23770405</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Trends+in+Immunology&amp;rft.atitle=Glycolipid+antigens+and+autoantibodies+in+autoimmune+neuropathies&amp;rft.volume=34&amp;rft.issue=9&amp;rft.pages=453-9&amp;rft.date=2013-09&amp;rft_id=info%3Adoi%2F10.1016%2Fj.it.2013.05.001&amp;rft_id=info%3Apmid%2F23770405&amp;rft.aulast=Willison&amp;rft.aufirst=HJ&amp;rft.au=Goodyear%2C+CS&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-36">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMerchant2022" class="citation journal cs1">Merchant, Hamid (2022-07-01). <a rel="nofollow" class="external text" href="https://pmj.bmj.com/content/98/1161/e5">"Inadvertent injection of COVID-19 vaccine into deltoid muscle vasculature may result in vaccine distribution to distance tissues and consequent adverse reactions"</a>. <i>Postgraduate Medical Journal</i>. <b>98</b> (1161): e5. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fpostgradmedj-2021-141119">10.1136/postgradmedj-2021-141119</a></span>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="https://www.worldcat.org/issn/0032-5473">0032-5473</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/34588294">34588294</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:238229239">238229239</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Postgraduate+Medical+Journal&amp;rft.atitle=Inadvertent+injection+of+COVID-19+vaccine+into+deltoid+muscle+vasculature+may+result+in+vaccine+distribution+to+distance+tissues+and+consequent+adverse+reactions&amp;rft.volume=98&amp;rft.issue=1161&amp;rft.pages=e5&amp;rft.date=2022-07-01&amp;rft.issn=0032-5473&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A238229239%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F34588294&amp;rft_id=info%3Adoi%2F10.1136%2Fpostgradmedj-2021-141119&amp;rft.aulast=Merchant&amp;rft.aufirst=Hamid&amp;rft_id=https%3A%2F%2Fpmj.bmj.com%2Fcontent%2F98%2F1161%2Fe5&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-37">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSpasovskiVanholderAllolioAnnane2014" class="citation journal cs1">Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D,  et&#160;al. (March 2014). <a rel="nofollow" class="external text" href="https://doi.org/10.1530%2FEJE-13-1020">"Clinical practice guideline on diagnosis and treatment of hyponatraemia"</a>. <i>European Journal of Endocrinology</i>. <b>170</b> (3): G1-47. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1530%2FEJE-13-1020">10.1530/EJE-13-1020</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24569125">24569125</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Endocrinology&amp;rft.atitle=Clinical+practice+guideline+on+diagnosis+and+treatment+of+hyponatraemia&amp;rft.volume=170&amp;rft.issue=3&amp;rft.pages=G1-47&amp;rft.date=2014-03&amp;rft_id=info%3Adoi%2F10.1530%2FEJE-13-1020&amp;rft_id=info%3Apmid%2F24569125&amp;rft.aulast=Spasovski&amp;rft.aufirst=G&amp;rft.au=Vanholder%2C+R&amp;rft.au=Allolio%2C+B&amp;rft.au=Annane%2C+D&amp;rft.au=Ball%2C+S&amp;rft.au=Bichet%2C+D&amp;rft.au=Decaux%2C+G&amp;rft.au=Fenske%2C+W&amp;rft.au=Hoorn%2C+EJ&amp;rft.au=Ichai%2C+C&amp;rft.au=Joannidis%2C+M&amp;rft.au=Soupart%2C+A&amp;rft.au=Zietse%2C+R&amp;rft.au=Haller%2C+M&amp;rft.au=van+der+Veer%2C+S&amp;rft.au=Van+Biesen%2C+W&amp;rft.au=Nagler%2C+E&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1530%252FEJE-13-1020&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-38">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRopper1992" class="citation journal cs1">Ropper AH (April 1992). "The Guillain-Barré syndrome". <i>The New England Journal of Medicine</i>. <b>326</b> (17): 1130–6. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1056%2FNEJM199204233261706">10.1056/NEJM199204233261706</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/1552914">1552914</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=The+Guillain-Barr%C3%A9+syndrome&amp;rft.volume=326&amp;rft.issue=17&amp;rft.pages=1130-6&amp;rft.date=1992-04&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM199204233261706&amp;rft_id=info%3Apmid%2F1552914&amp;rft.aulast=Ropper&amp;rft.aufirst=AH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-Rinaldi2013-39"><span class="mw-cite-backlink">^ <a href="#cite_ref-Rinaldi2013_39-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Rinaldi2013_39-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Rinaldi2013_39-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Rinaldi2013_39-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Rinaldi2013_39-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Rinaldi2013_39-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRinaldi2013" class="citation journal cs1">Rinaldi S (June 2013). "Update on Guillain-Barré syndrome". <i>Journal of the Peripheral Nervous System</i>. <b>18</b> (2): 99–112. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fjns5.12020">10.1111/jns5.12020</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23781958">23781958</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:23577086">23577086</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+Peripheral+Nervous+System&amp;rft.atitle=Update+on+Guillain-Barr%C3%A9+syndrome&amp;rft.volume=18&amp;rft.issue=2&amp;rft.pages=99-112&amp;rft.date=2013-06&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A23577086%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F23781958&amp;rft_id=info%3Adoi%2F10.1111%2Fjns5.12020&amp;rft.aulast=Rinaldi&amp;rft.aufirst=S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-Uncini2012-40"><span class="mw-cite-backlink">^ <a href="#cite_ref-Uncini2012_40-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Uncini2012_40-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Uncini2012_40-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFUnciniKuwabara2012" class="citation journal cs1">Uncini A, Kuwabara S (August 2012). "Electrodiagnostic criteria for Guillain-Barrè syndrome: a critical revision and the need for an update". <i>Clinical Neurophysiology</i>. <b>123</b> (8): 1487–95. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.clinph.2012.01.025">10.1016/j.clinph.2012.01.025</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22480600">22480600</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:33276521">33276521</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Neurophysiology&amp;rft.atitle=Electrodiagnostic+criteria+for+Guillain-Barr%C3%A8+syndrome%3A+a+critical+revision+and+the+need+for+an+update&amp;rft.volume=123&amp;rft.issue=8&amp;rft.pages=1487-95&amp;rft.date=2012-08&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A33276521%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F22480600&amp;rft_id=info%3Adoi%2F10.1016%2Fj.clinph.2012.01.025&amp;rft.aulast=Uncini&amp;rft.aufirst=A&amp;rft.au=Kuwabara%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-Wakerley2014-41"><span class="mw-cite-backlink">^ <a href="#cite_ref-Wakerley2014_41-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Wakerley2014_41-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Wakerley2014_41-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Wakerley2014_41-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFWakerleyUnciniYuki2014" class="citation journal cs1">Wakerley BR, Uncini A, Yuki N (September 2014). "Guillain-Barré and Miller Fisher syndromes--new diagnostic classification". <i>Nature Reviews. Neurology</i>. <b>10</b> (9): 537–44. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrneurol.2014.138">10.1038/nrneurol.2014.138</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25072194">25072194</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:205515884">205515884</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Neurology&amp;rft.atitle=Guillain-Barr%C3%A9+and+Miller+Fisher+syndromes--new+diagnostic+classification&amp;rft.volume=10&amp;rft.issue=9&amp;rft.pages=537-44&amp;rft.date=2014-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A205515884%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F25072194&amp;rft_id=info%3Adoi%2F10.1038%2Fnrneurol.2014.138&amp;rft.aulast=Wakerley&amp;rft.aufirst=BR&amp;rft.au=Uncini%2C+A&amp;rft.au=Yuki%2C+N&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-Mori2012-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-Mori2012_42-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMoriKuwabaraYuki2012" class="citation journal cs1">Mori M, Kuwabara S, Yuki N (January 2012). "Fisher syndrome: clinical features, immunopathogenesis and management". <i>Expert Review of Neurotherapeutics</i>. <b>12</b> (1): 39–51. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1586%2Fern.11.182">10.1586/ern.11.182</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22149656">22149656</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:5597853">5597853</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Expert+Review+of+Neurotherapeutics&amp;rft.atitle=Fisher+syndrome%3A+clinical+features%2C+immunopathogenesis+and+management&amp;rft.volume=12&amp;rft.issue=1&amp;rft.pages=39-51&amp;rft.date=2012-01&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A5597853%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F22149656&amp;rft_id=info%3Adoi%2F10.1586%2Fern.11.182&amp;rft.aulast=Mori&amp;rft.aufirst=M&amp;rft.au=Kuwabara%2C+S&amp;rft.au=Yuki%2C+N&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-43">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFWakerleySoonYuki2013" class="citation journal cs1">Wakerley, BR; Soon, D; Yuki, N (2013). "Atypical Bickerstaff brainstem encephalitis: ataxic hypersomnolence without ophthalmoplegia". <i>J Neurol Neurosurg Psychiatry</i>. <b>84</b> (11): 1206–7. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjnnp-2013-304993">10.1136/jnnp-2013-304993</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23564757">23564757</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:22756453">22756453</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Neurol+Neurosurg+Psychiatry&amp;rft.atitle=Atypical+Bickerstaff+brainstem+encephalitis%3A+ataxic+hypersomnolence+without+ophthalmoplegia&amp;rft.volume=84&amp;rft.issue=11&amp;rft.pages=1206-7&amp;rft.date=2013&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A22756453%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F23564757&amp;rft_id=info%3Adoi%2F10.1136%2Fjnnp-2013-304993&amp;rft.aulast=Wakerley&amp;rft.aufirst=BR&amp;rft.au=Soon%2C+D&amp;rft.au=Yuki%2C+N&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-Liu_Dong_Ubogu_2021_p.-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-Liu_Dong_Ubogu_2021_p._44-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLiuDongUbogu2021" class="citation journal cs1">Liu, Shuang; Dong, Chaoling; Ubogu, Eroboghene Ekamereno (2021-06-02). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314401">"Immunotherapy of Guillain-Barré syndrome"</a>. <i>Human Vaccines &amp; Immunotherapeutics</i>. <b>14</b> (11): 2568–2579. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F21645515.2018.1493415">10.1080/21645515.2018.1493415</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314401">6314401</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29953326">29953326</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Human+Vaccines+%26+Immunotherapeutics&amp;rft.atitle=Immunotherapy+of+Guillain-Barr%C3%A9+syndrome&amp;rft.volume=14&amp;rft.issue=11&amp;rft.pages=2568-2579&amp;rft.date=2021-06-02&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6314401%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F29953326&amp;rft_id=info%3Adoi%2F10.1080%2F21645515.2018.1493415&amp;rft.aulast=Liu&amp;rft.aufirst=Shuang&amp;rft.au=Dong%2C+Chaoling&amp;rft.au=Ubogu%2C+Eroboghene+Ekamereno&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6314401&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-45">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHughesSwanvan_Doorn2014" class="citation journal cs1">Hughes RA, Swan AV, van Doorn PA (September 2014). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781841">"Intravenous immunoglobulin for Guillain-Barré syndrome"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>2019</b> (10): CD002063. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD002063.pub6">10.1002/14651858.CD002063.pub6</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781841">6781841</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25238327">25238327</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Intravenous+immunoglobulin+for+Guillain-Barr%C3%A9+syndrome&amp;rft.volume=2019&amp;rft.issue=10&amp;rft.pages=CD002063&amp;rft.date=2014-09&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6781841%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F25238327&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD002063.pub6&amp;rft.aulast=Hughes&amp;rft.aufirst=RA&amp;rft.au=Swan%2C+AV&amp;rft.au=van+Doorn%2C+PA&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6781841&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-Hughes-46"><span class="mw-cite-backlink">^ <a href="#cite_ref-Hughes_46-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Hughes_46-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHughesWijdicksBarohnBenson2003" class="citation journal cs1">Hughes RA, Wijdicks EF, Barohn R, Benson E, Cornblath DR, Hahn AF,  et&#160;al. (September 2003). <a rel="nofollow" class="external text" href="https://doi.org/10.1212%2FWNL.61.6.736">"Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology"</a>. <i>Neurology</i>. <b>61</b> (6): 736–40. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1212%2FWNL.61.6.736">10.1212/WNL.61.6.736</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/14504313">14504313</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=Practice+parameter%3A+immunotherapy+for+Guillain-Barr%C3%A9+syndrome%3A+report+of+the+Quality+Standards+Subcommittee+of+the+American+Academy+of+Neurology&amp;rft.volume=61&amp;rft.issue=6&amp;rft.pages=736-40&amp;rft.date=2003-09&amp;rft_id=info%3Adoi%2F10.1212%2FWNL.61.6.736&amp;rft_id=info%3Apmid%2F14504313&amp;rft.aulast=Hughes&amp;rft.aufirst=RA&amp;rft.au=Wijdicks%2C+EF&amp;rft.au=Barohn%2C+R&amp;rft.au=Benson%2C+E&amp;rft.au=Cornblath%2C+DR&amp;rft.au=Hahn%2C+AF&amp;rft.au=Meythaler%2C+JM&amp;rft.au=Miller%2C+RG&amp;rft.au=Sladky%2C+JT&amp;rft.au=Stevens%2C+JC&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1212%252FWNL.61.6.736&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-Dantal2013-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-Dantal2013_47-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFDantal2013" class="citation journal cs1">Dantal J (October 2013). <a rel="nofollow" class="external text" href="https://doi.org/10.1159%2F000354893">"Intravenous immunoglobulins: in-depth review of excipients and acute kidney injury risk"</a>. <i>American Journal of Nephrology</i>. <b>38</b> (4): 275–84. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1159%2F000354893">10.1159/000354893</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24051350">24051350</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Nephrology&amp;rft.atitle=Intravenous+immunoglobulins%3A+in-depth+review+of+excipients+and+acute+kidney+injury+risk&amp;rft.volume=38&amp;rft.issue=4&amp;rft.pages=275-84&amp;rft.date=2013-10&amp;rft_id=info%3Adoi%2F10.1159%2F000354893&amp;rft_id=info%3Apmid%2F24051350&amp;rft.aulast=Dantal&amp;rft.aufirst=J&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1159%252F000354893&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-48">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHughesBrassingtonGunnvan_Doorn2016" class="citation journal cs1">Hughes, Richard Ac; Brassington, Ruth; Gunn, Angela A.; van Doorn, Pieter A. (2016-10-24). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464149">"Corticosteroids for Guillain-Barré syndrome"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>2016</b> (10): CD001446. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD001446.pub5">10.1002/14651858.CD001446.pub5</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="https://www.worldcat.org/issn/1469-493X">1469-493X</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464149">6464149</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27775812">27775812</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Corticosteroids+for+Guillain-Barr%C3%A9+syndrome&amp;rft.volume=2016&amp;rft.issue=10&amp;rft.pages=CD001446&amp;rft.date=2016-10-24&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6464149%23id-name%3DPMC&amp;rft.issn=1469-493X&amp;rft_id=info%3Apmid%2F27775812&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD001446.pub5&amp;rft.aulast=Hughes&amp;rft.aufirst=Richard+Ac&amp;rft.au=Brassington%2C+Ruth&amp;rft.au=Gunn%2C+Angela+A.&amp;rft.au=van+Doorn%2C+Pieter+A.&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6464149&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-Dimachkie2013-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-Dimachkie2013_49-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFDimachkieBarohn2013" class="citation journal cs1">Dimachkie MM, Barohn RJ (May 2013). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939842">"Guillain-Barré syndrome and variants"</a>. <i>Neurologic Clinics</i>. <b>31</b> (2): 491–510. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.ncl.2013.01.005">10.1016/j.ncl.2013.01.005</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939842">3939842</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23642721">23642721</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurologic+Clinics&amp;rft.atitle=Guillain-Barr%C3%A9+syndrome+and+variants&amp;rft.volume=31&amp;rft.issue=2&amp;rft.pages=491-510&amp;rft.date=2013-05&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3939842%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F23642721&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ncl.2013.01.005&amp;rft.aulast=Dimachkie&amp;rft.aufirst=MM&amp;rft.au=Barohn%2C+RJ&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3939842&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-50">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLiuWangMcNicol2015" class="citation journal cs1">Liu, Jia; Wang, Lu-Ning; McNicol, Ewan D. (2015-04-09). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361619">"Pharmacological treatment for pain in Guillain-Barré syndrome"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>2015</b> (4): CD009950. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD009950.pub3">10.1002/14651858.CD009950.pub3</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="https://www.worldcat.org/issn/1469-493X">1469-493X</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361619">6361619</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25855461">25855461</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Pharmacological+treatment+for+pain+in+Guillain-Barr%C3%A9+syndrome&amp;rft.volume=2015&amp;rft.issue=4&amp;rft.pages=CD009950&amp;rft.date=2015-04-09&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6361619%23id-name%3DPMC&amp;rft.issn=1469-493X&amp;rft_id=info%3Apmid%2F25855461&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD009950.pub3&amp;rft.aulast=Liu&amp;rft.aufirst=Jia&amp;rft.au=Wang%2C+Lu-Ning&amp;rft.au=McNicol%2C+Ewan+D.&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6361619&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-Khan2012-51"><span class="mw-cite-backlink">^ <a href="#cite_ref-Khan2012_51-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Khan2012_51-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Khan2012_51-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Khan2012_51-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFKhanAmatya2012" class="citation journal cs1">Khan F, Amatya B (September 2012). <a rel="nofollow" class="external text" href="http://www.minervamedica.it/en/journals/europa-medicophysica/article.php?cod=R33Y2012N03A0507">"Rehabilitation interventions in patients with acute demyelinating inflammatory polyneuropathy: a systematic review"</a>. <i>European Journal of Physical and Rehabilitation Medicine</i>. <b>48</b> (3): 507–22. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22820829">22820829</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20150826223515/http://www.minervamedica.it/en/journals/europa-medicophysica/article.php?cod=R33Y2012N03A0507">Archived</a> from the original on 2015-08-26.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Physical+and+Rehabilitation+Medicine&amp;rft.atitle=Rehabilitation+interventions+in+patients+with+acute+demyelinating+inflammatory+polyneuropathy%3A+a+systematic+review&amp;rft.volume=48&amp;rft.issue=3&amp;rft.pages=507-22&amp;rft.date=2012-09&amp;rft_id=info%3Apmid%2F22820829&amp;rft.aulast=Khan&amp;rft.aufirst=F&amp;rft.au=Amatya%2C+B&amp;rft_id=http%3A%2F%2Fwww.minervamedica.it%2Fen%2Fjournals%2Feuropa-medicophysica%2Farticle.php%3Fcod%3DR33Y2012N03A0507&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-52">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFKhanNgAmatyaBrand2010" class="citation journal cs1">Khan F, Ng L, Amatya B, Brand C, Turner-Stokes L (October 2010). "Multidisciplinary care for Guillain-Barré syndrome". <i>The Cochrane Database of Systematic Reviews</i> (10): CD008505. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD008505.pub2">10.1002/14651858.CD008505.pub2</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/20927774">20927774</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Multidisciplinary+care+for+Guillain-Barr%C3%A9+syndrome&amp;rft.issue=10&amp;rft.pages=CD008505&amp;rft.date=2010-10&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD008505.pub2&amp;rft_id=info%3Apmid%2F20927774&amp;rft.aulast=Khan&amp;rft.aufirst=F&amp;rft.au=Ng%2C+L&amp;rft.au=Amatya%2C+B&amp;rft.au=Brand%2C+C&amp;rft.au=Turner-Stokes%2C+L&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-53">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHughesSwanRaphaëlAnnane2007" class="citation journal cs1">Hughes RA, Swan AV, Raphaël JC, Annane D, van Koningsveld R, van Doorn PA (September 2007). <a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fbrain%2Fawm004">"Immunotherapy for Guillain-Barré syndrome: a systematic review"</a>. <i>Brain</i>. <b>130</b> (Pt 9): 2245–57. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fbrain%2Fawm004">10.1093/brain/awm004</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17337484">17337484</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Brain&amp;rft.atitle=Immunotherapy+for+Guillain-Barr%C3%A9+syndrome%3A+a+systematic+review&amp;rft.volume=130&amp;rft.issue=Pt+9&amp;rft.pages=2245-57&amp;rft.date=2007-09&amp;rft_id=info%3Adoi%2F10.1093%2Fbrain%2Fawm004&amp;rft_id=info%3Apmid%2F17337484&amp;rft.aulast=Hughes&amp;rft.aufirst=RA&amp;rft.au=Swan%2C+AV&amp;rft.au=Rapha%C3%ABl%2C+JC&amp;rft.au=Annane%2C+D&amp;rft.au=van+Koningsveld%2C+R&amp;rft.au=van+Doorn%2C+PA&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1093%252Fbrain%252Fawm004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-Darweesh2014-54"><span class="mw-cite-backlink">^ <a href="#cite_ref-Darweesh2014_54-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Darweesh2014_54-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFDarweeshPolinderMulderBaena2014" class="citation journal cs1">Darweesh SK, Polinder S, Mulder MJ, Baena CP, van Leeuwen N, Franco OH,  et&#160;al. (March 2014). "Health-related quality of life in Guillain-Barré syndrome patients: a systematic review". <i>Journal of the Peripheral Nervous System</i>. <b>19</b> (1): 24–35. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fjns5.12051">10.1111/jns5.12051</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24456426">24456426</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:6822">6822</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+Peripheral+Nervous+System&amp;rft.atitle=Health-related+quality+of+life+in+Guillain-Barr%C3%A9+syndrome+patients%3A+a+systematic+review&amp;rft.volume=19&amp;rft.issue=1&amp;rft.pages=24-35&amp;rft.date=2014-03&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A6822%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F24456426&amp;rft_id=info%3Adoi%2F10.1111%2Fjns5.12051&amp;rft.aulast=Darweesh&amp;rft.aufirst=SK&amp;rft.au=Polinder%2C+S&amp;rft.au=Mulder%2C+MJ&amp;rft.au=Baena%2C+CP&amp;rft.au=van+Leeuwen%2C+N&amp;rft.au=Franco%2C+OH&amp;rft.au=Jacobs%2C+BC&amp;rft.au=van+Doorn%2C+PA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-55">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFGoetz1998" class="citation journal cs1">Goetz CG (May 1998). "Georges Guillain's neurologic exploration of America". <i>Neurology</i>. <b>50</b> (5): 1451–5. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1212%2FWNL.50.5.1451">10.1212/WNL.50.5.1451</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/9596004">9596004</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:823333">823333</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=Georges+Guillain%27s+neurologic+exploration+of+America&amp;rft.volume=50&amp;rft.issue=5&amp;rft.pages=1451-5&amp;rft.date=1998-05&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A823333%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F9596004&amp;rft_id=info%3Adoi%2F10.1212%2FWNL.50.5.1451&amp;rft.aulast=Goetz&amp;rft.aufirst=CG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-56">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLandry1859" class="citation journal cs1">Landry J (1859). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=rwxAAAAAcAAJ&amp;pg=PA486">"Note sur la paralysie ascendante aiguë"</a>. <i>Gazette Hebdomadaire de Médecine et de Chirurgie</i>. <b>6</b>: 472–474, 486–488. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170227205021/https://books.google.com/books?id=rwxAAAAAcAAJ&amp;pg=PA486">Archived</a> from the original on 2017-02-27.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Gazette+Hebdomadaire+de+M%C3%A9decine+et+de+Chirurgie&amp;rft.atitle=Note+sur+la+paralysie+ascendante+aigu%C3%AB&amp;rft.volume=6&amp;rft.pages=472-474%2C+486-488&amp;rft.date=1859&amp;rft.aulast=Landry&amp;rft.aufirst=Jean-Baptiste&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DrwxAAAAAcAAJ%26pg%3DPA486&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-Guillain1916-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-Guillain1916_57-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFGuillainBarréStrohl1916" class="citation journal cs1 cs1-prop-foreign-lang-source">Guillain G, Barré J, Strohl A (1916). <a rel="nofollow" class="external text" href="https://babel.hathitrust.org/cgi/pt?id=iau.31858012030783&amp;view=1up&amp;seq=286&amp;skin=2021">"Sur un syndrome de radiculonévrite avec hyperalbuminose du liquide céphalo-rachidien sans réaction cellulaire. Remarques sur les caractères cliniques et graphiques des réflexes tendineux"</a> &#91;On a syndrome of radiculoneuritis with hypoalbuminemia of the cerebrospinal fluid without cellular reaction. Remarks on the clinical and graphical characters of the tendon reflexes&#93;. <i>Bulletins et Mémoires de la Société des Médecins des Hôpitaux de Paris</i> (in French). <b>40</b>: 1462–70. <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><a href="/wiki/NAID_(identifier)" class="mw-redirect" title="NAID (identifier)">NAID</a>&#160;<a rel="nofollow" class="external text" href="https://ci.nii.ac.jp/naid/10024485853/en/">10024485853</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bulletins+et+M%C3%A9moires+de+la+Soci%C3%A9t%C3%A9+des+M%C3%A9decins+des+H%C3%B4pitaux+de+Paris&amp;rft.atitle=Sur+un+syndrome+de+radiculon%C3%A9vrite+avec+hyperalbuminose+du+liquide+c%C3%A9phalo-rachidien+sans+r%C3%A9action+cellulaire.+Remarques+sur+les+caract%C3%A8res+cliniques+et+graphiques+des+r%C3%A9flexes+tendineux&amp;rft.volume=40&amp;rft.pages=1462-70&amp;rft.date=1916&amp;rft.aulast=Guillain&amp;rft.aufirst=G&amp;rft.au=Barr%C3%A9%2C+J&amp;rft.au=Strohl%2C+A&amp;rft_id=https%3A%2F%2Fbabel.hathitrust.org%2Fcgi%2Fpt%3Fid%3Diau.31858012030783%26view%3D1up%26seq%3D286%26skin%3D2021&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-58"><span class="mw-cite-backlink"><b><a href="#cite_ref-58">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFFisher1956" class="citation journal cs1">Fisher M (July 1956). "An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia)". <i>The New England Journal of Medicine</i>. <b>255</b> (2): 57–65. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1056%2FNEJM195607122550201">10.1056/NEJM195607122550201</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/13334797">13334797</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=An+unusual+variant+of+acute+idiopathic+polyneuritis+%28syndrome+of+ophthalmoplegia%2C+ataxia+and+areflexia%29&amp;rft.volume=255&amp;rft.issue=2&amp;rft.pages=57-65&amp;rft.date=1956-07&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM195607122550201&amp;rft_id=info%3Apmid%2F13334797&amp;rft.aulast=Fisher&amp;rft.aufirst=M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-59">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBickerstaffCloake1951" class="citation journal cs1">Bickerstaff ER, Cloake PC (July 1951). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2069534">"Mesencephalitis and rhombencephalitis"</a>. <i>British Medical Journal</i>. <b>2</b> (4723): 77–81. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fbmj.2.4723.77">10.1136/bmj.2.4723.77</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2069534">2069534</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/14848512">14848512</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Medical+Journal&amp;rft.atitle=Mesencephalitis+and+rhombencephalitis&amp;rft.volume=2&amp;rft.issue=4723&amp;rft.pages=77-81&amp;rft.date=1951-07&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2069534%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F14848512&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.2.4723.77&amp;rft.aulast=Bickerstaff&amp;rft.aufirst=ER&amp;rft.au=Cloake%2C+PC&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2069534&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-60"><span class="mw-cite-backlink"><b><a href="#cite_ref-60">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBickerstaff1957" class="citation journal cs1">Bickerstaff ER (June 1957). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1973653">"Brain-stem encephalitis; further observations on a grave syndrome with benign prognosis"</a>. <i>British Medical Journal</i>. <b>1</b> (5032): 1384–7. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fbmj.1.5032.1384">10.1136/bmj.1.5032.1384</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1973653">1973653</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/13436795">13436795</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Medical+Journal&amp;rft.atitle=Brain-stem+encephalitis%3B+further+observations+on+a+grave+syndrome+with+benign+prognosis&amp;rft.volume=1&amp;rft.issue=5032&amp;rft.pages=1384-7&amp;rft.date=1957-06&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1973653%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F13436795&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.1.5032.1384&amp;rft.aulast=Bickerstaff&amp;rft.aufirst=ER&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1973653&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-61">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFCompston2016" class="citation journal cs1">Compston, Alastair (July 2016). <a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fbrain%2Faww127">"Recurrent and chronic relapsing Guillain-Barré polyneuritis by P.K. Thomas, R.G. Lascelles, J.F. Hallpike and R.L. Hewer. From the Institute of Neurology and National Hospital, Queen Square, the Royal National Orthopaedic Hospital, and Guy's Hospital, London. Brain 1969; 92: 589–606; with An acute axonal form of Guillain-Barré polyneuropathy by T.E. Feasby, J.J. Gilbert, W.F. Brown, C.F. Bolton, A.F. Hahn, W.F. Koopman and D.W. Zochodne. Brain 1986; 109: 1115–1126"</a>. <i>Brain</i>. <b>139</b> (7): 2096–2100. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fbrain%2Faww127">10.1093/brain/aww127</a></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Brain&amp;rft.atitle=Recurrent+and+chronic+relapsing+Guillain-Barr%C3%A9+polyneuritis+by+P.K.+Thomas%2C+R.G.+Lascelles%2C+J.F.+Hallpike+and+R.L.+Hewer.+From+the+Institute+of+Neurology+and+National+Hospital%2C+Queen+Square%2C+the+Royal+National+Orthopaedic+Hospital%2C+and+Guy%27s+Hospital%2C+London.+Brain+1969%3B+92%3A+589%E2%80%93606%3B+with+An+acute+axonal+form+of+Guillain-Barr%C3%A9+polyneuropathy+by+T.E.+Feasby%2C+J.J.+Gilbert%2C+W.F.+Brown%2C+C.F.+Bolton%2C+A.F.+Hahn%2C+W.F.+Koopman+and+D.W.+Zochodne.+Brain+1986%3B+109%3A+1115%E2%80%931126&amp;rft.volume=139&amp;rft.issue=7&amp;rft.pages=2096-2100&amp;rft.date=2016-07&amp;rft_id=info%3Adoi%2F10.1093%2Fbrain%2Faww127&amp;rft.aulast=Compston&amp;rft.aufirst=Alastair&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1093%252Fbrain%252Faww127&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-62"><span class="mw-cite-backlink"><b><a href="#cite_ref-62">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFAsburyCornblath1990" class="citation journal cs1 cs1-prop-long-vol">Asbury AK, Cornblath DR (1990). "Assessment of current diagnostic criteria for Guillain-Barré syndrome". <i>Annals of Neurology</i>. 27 Suppl: S21-4. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fana.410270707">10.1002/ana.410270707</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/2194422">2194422</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:39483795">39483795</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Neurology&amp;rft.atitle=Assessment+of+current+diagnostic+criteria+for+Guillain-Barr%C3%A9+syndrome&amp;rft.volume=27+Suppl&amp;rft.pages=S21-4&amp;rft.date=1990&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A39483795%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F2194422&amp;rft_id=info%3Adoi%2F10.1002%2Fana.410270707&amp;rft.aulast=Asbury&amp;rft.aufirst=AK&amp;rft.au=Cornblath%2C+DR&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-63"><span class="mw-cite-backlink"><b><a href="#cite_ref-63">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSejvarKohlGiduduAmato2011" class="citation journal cs1">Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R,  et&#160;al. (January 2011). <a rel="nofollow" class="external text" href="https://zenodo.org/record/1259431">"Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data"</a>. <i>Vaccine</i>. <b>29</b> (3): 599–612. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.vaccine.2010.06.003">10.1016/j.vaccine.2010.06.003</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/20600491">20600491</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Vaccine&amp;rft.atitle=Guillain-Barr%C3%A9+syndrome+and+Fisher+syndrome%3A+case+definitions+and+guidelines+for+collection%2C+analysis%2C+and+presentation+of+immunization+safety+data&amp;rft.volume=29&amp;rft.issue=3&amp;rft.pages=599-612&amp;rft.date=2011-01&amp;rft_id=info%3Adoi%2F10.1016%2Fj.vaccine.2010.06.003&amp;rft_id=info%3Apmid%2F20600491&amp;rft.aulast=Sejvar&amp;rft.aufirst=JJ&amp;rft.au=Kohl%2C+KS&amp;rft.au=Gidudu%2C+J&amp;rft.au=Amato%2C+A&amp;rft.au=Bakshi%2C+N&amp;rft.au=Baxter%2C+R&amp;rft.au=Burwen%2C+DR&amp;rft.au=Cornblath%2C+DR&amp;rft.au=Cleerbout%2C+J&amp;rft.au=Edwards%2C+KM&amp;rft.au=Heininger%2C+U&amp;rft.au=Hughes%2C+R&amp;rft.au=Khuri-Bulos%2C+N&amp;rft.au=Korinthenberg%2C+R&amp;rft.au=Law%2C+BJ&amp;rft.au=Munro%2C+U&amp;rft.au=Maltezou%2C+HC&amp;rft.au=Nell%2C+P&amp;rft.au=Oleske%2C+J&amp;rft.au=Sparks%2C+R&amp;rft.au=Velentgas%2C+P&amp;rft.au=Vermeer%2C+P&amp;rft.au=Wiznitzer%2C+M&amp;rft_id=https%3A%2F%2Fzenodo.org%2Frecord%2F1259431&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-Walgaard2011-64"><span class="mw-cite-backlink">^ <a href="#cite_ref-Walgaard2011_64-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Walgaard2011_64-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Walgaard2011_64-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Walgaard2011_64-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Walgaard2011_64-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Walgaard2011_64-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Walgaard2011_64-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFWalgaardJacobsvan_Doorn2011" class="citation journal cs1">Walgaard C, Jacobs BC, van Doorn PA (March 2011). "Emerging drugs for Guillain-Barré syndrome". <i>Expert Opinion on Emerging Drugs</i>. <b>16</b> (1): 105–20. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1517%2F14728214.2011.531699">10.1517/14728214.2011.531699</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21352072">21352072</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:3162151">3162151</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Expert+Opinion+on+Emerging+Drugs&amp;rft.atitle=Emerging+drugs+for+Guillain-Barr%C3%A9+syndrome&amp;rft.volume=16&amp;rft.issue=1&amp;rft.pages=105-20&amp;rft.date=2011-03&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A3162151%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F21352072&amp;rft_id=info%3Adoi%2F10.1517%2F14728214.2011.531699&amp;rft.aulast=Walgaard&amp;rft.aufirst=C&amp;rft.au=Jacobs%2C+BC&amp;rft.au=van+Doorn%2C+PA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-65"><span class="mw-cite-backlink"><b><a href="#cite_ref-65">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFKimChoiSongSeo2021" class="citation journal cs1">Kim, Se-Hoon; Choi, Seo-In; Song, Kun-Ho; Seo, Kyoung-Won (2021). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025411">"Two cases of acute polyradiculoneuritis in dogs consuming a raw poultry diet"</a>. <i>Journal of Veterinary Medical Science</i>. <b>83</b> (3): 465–468. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1292%2Fjvms.20-0522">10.1292/jvms.20-0522</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025411">8025411</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/33518606">33518606</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Veterinary+Medical+Science&amp;rft.atitle=Two+cases+of+acute+polyradiculoneuritis+in+dogs+consuming+a+raw+poultry+diet&amp;rft.volume=83&amp;rft.issue=3&amp;rft.pages=465-468&amp;rft.date=2021&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8025411%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F33518606&amp;rft_id=info%3Adoi%2F10.1292%2Fjvms.20-0522&amp;rft.aulast=Kim&amp;rft.aufirst=Se-Hoon&amp;rft.au=Choi%2C+Seo-In&amp;rft.au=Song%2C+Kun-Ho&amp;rft.au=Seo%2C+Kyoung-Won&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8025411&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
<li id="cite_note-66"><span class="mw-cite-backlink"><b><a href="#cite_ref-66">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://vcahospitals.com/know-your-pet/coonhound-paralysis">"Coonhound Paralysis"</a>. <i>VCA Animal Hospital</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=VCA+Animal+Hospital&amp;rft.atitle=Coonhound+Paralysis&amp;rft_id=https%3A%2F%2Fvcahospitals.com%2Fknow-your-pet%2Fcoonhound-paralysis&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></span>
</li>
</ol></div></div>
<h2><span class="mw-headline" id="Further_reading">Further reading</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=edit&amp;section=24" title="Edit section: Further reading">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul><li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSteinbergParry2006" class="citation book cs1">Steinberg GJ, Parry JS (2006). <i>Guillain–Barré syndrome: from diagnosis to recovery</i>. New York: Demos; ANN Press (American Academy of Neurology). <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/9781932603569" title="Special:BookSources/9781932603569"><bdi>9781932603569</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Guillain%E2%80%93Barr%C3%A9+syndrome%3A+from+diagnosis+to+recovery&amp;rft.place=New+York&amp;rft.pub=Demos%3B+ANN+Press+%28American+Academy+of+Neurology%29&amp;rft.date=2006&amp;rft.isbn=9781932603569&amp;rft.aulast=Steinberg&amp;rft.aufirst=Gareth+J.&amp;rft.au=Parry%2C+Joel+S.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGuillain%E2%80%93Barr%C3%A9+syndrome" class="Z3988"></span></li></ul>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;action=edit&amp;section=25" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="navbox-styles"><style data-mw-deduplicate="TemplateStyles:r1061467846">.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}</style><style data-mw-deduplicate="TemplateStyles:r1129693374">.mw-parser-output .hlist dl,.mw-parser-output .hlist ol,.mw-parser-output .hlist ul{margin:0;padding:0}.mw-parser-output .hlist dd,.mw-parser-output .hlist dt,.mw-parser-output .hlist li{margin:0;display:inline}.mw-parser-output .hlist.inline,.mw-parser-output .hlist.inline dl,.mw-parser-output .hlist.inline ol,.mw-parser-output .hlist.inline ul,.mw-parser-output .hlist dl dl,.mw-parser-output .hlist dl ol,.mw-parser-output .hlist dl ul,.mw-parser-output .hlist ol dl,.mw-parser-output .hlist ol ol,.mw-parser-output .hlist ol ul,.mw-parser-output .hlist ul dl,.mw-parser-output .hlist ul ol,.mw-parser-output .hlist ul ul{display:inline}.mw-parser-output .hlist .mw-empty-li{display:none}.mw-parser-output .hlist dt::after{content:": "}.mw-parser-output .hlist dd::after,.mw-parser-output .hlist li::after{content:" · ";font-weight:bold}.mw-parser-output .hlist dd:last-child::after,.mw-parser-output .hlist dt:last-child::after,.mw-parser-output .hlist li:last-child::after{content:none}.mw-parser-output .hlist dd dd:first-child::before,.mw-parser-output .hlist dd dt:first-child::before,.mw-parser-output .hlist dd li:first-child::before,.mw-parser-output .hlist dt dd:first-child::before,.mw-parser-output .hlist dt dt:first-child::before,.mw-parser-output .hlist dt li:first-child::before,.mw-parser-output .hlist li dd:first-child::before,.mw-parser-output .hlist li dt:first-child::before,.mw-parser-output .hlist li li:first-child::before{content:" (";font-weight:normal}.mw-parser-output .hlist dd dd:last-child::after,.mw-parser-output .hlist dd dt:last-child::after,.mw-parser-output .hlist dd li:last-child::after,.mw-parser-output .hlist dt dd:last-child::after,.mw-parser-output .hlist dt dt:last-child::after,.mw-parser-output .hlist dt li:last-child::after,.mw-parser-output .hlist li dd:last-child::after,.mw-parser-output .hlist li dt:last-child::after,.mw-parser-output .hlist li li:last-child::after{content:")";font-weight:normal}.mw-parser-output .hlist ol{counter-reset:listitem}.mw-parser-output .hlist ol>li{counter-increment:listitem}.mw-parser-output .hlist ol>li::before{content:" "counter(listitem)"\a0 "}.mw-parser-output .hlist dd ol>li:first-child::before,.mw-parser-output .hlist dt ol>li:first-child::before,.mw-parser-output .hlist li ol>li:first-child::before{content:" ("counter(listitem)"\a0 "}</style><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"></div><div role="navigation" class="navbox" aria-label="Navbox" style="width:100%; margin:0.5em 0 0.5em 0;;padding:3px"><table class="nowraplinks navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;background: #EAECF0">Classification</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"><div style="position:relative; float:right; font-size:0.8em;"><a href="https://www.wikidata.org/wiki/Q205214" class="extiw" title="d:Q205214">D</a></div><div class="hlist" style="text-align:left;"><ul><li><b><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" class="mw-redirect" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></b>: <a rel="nofollow" class="external text" href="https://icd.who.int/browse10/2019/en#/G61.0">G61.0</a></li><li><b><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" class="mw-redirect" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></b>: <a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=357.0">357.0</a></li><li><b><a href="/wiki/Online_Mendelian_Inheritance_in_Man" title="Online Mendelian Inheritance in Man">OMIM</a></b>: <a rel="nofollow" class="external text" href="https://omim.org/entry/139393">139393</a></li><li><b><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></b>: <a rel="nofollow" class="external text" href="https://meshb.nlm.nih.gov/record/ui?ui=D020275">D020275</a></li><li><b><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></b>: <a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb5465.htm">5465</a></li></ul></div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;background: #EAECF0">External resources</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"><div class="hlist" style="text-align:left;"><ul><li><b><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></b>: <a rel="nofollow" class="external text" href="https://www.nlm.nih.gov/medlineplus/ency/article/000684.htm">000684</a></li><li><b><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></b>: <a rel="nofollow" class="external text" href="https://emedicine.medscape.com/emerg/222-overview">emerg/222</a> <a rel="nofollow" class="external text" href="http://www.emedicine.com/neuro/topic7.htm#">neuro/7</a> <a rel="nofollow" class="external text" href="http://www.emedicine.com/pmr/topic48.htm#">pmr/48</a> <a rel="nofollow" class="external text" href="http://www.emedicine.com/neuro/topic598.htm#">neuro/598</a></li><li><b><a href="/wiki/Patient_UK" title="Patient UK">Patient UK</a></b>: <a rel="nofollow" class="external text" href="https://patient.info/doctor/guillain-barre-syndrome-pro">Guillain–Barré syndrome</a></li><li><b>Scholia</b>: <a class="external text" href="https://tools.wmflabs.org/scholia/topic/Q205214">Q205214</a></li></ul></div></div></td></tr></tbody></table></div>
<div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1061467846"></div><div role="navigation" class="navbox" aria-labelledby="Diseases_relating_to_the_peripheral_nervous_system" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><style data-mw-deduplicate="TemplateStyles:r1063604349">.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:"[ "}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:" ]"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}</style><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Peripheral_nervous_system_disease" title="Template:Peripheral nervous system disease"><abbr title="View this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Peripheral_nervous_system_disease" title="Template talk:Peripheral nervous system disease"><abbr title="Discuss this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">t</abbr></a></li><li class="nv-edit"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Template:Peripheral_nervous_system_disease&amp;action=edit"><abbr title="Edit this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">e</abbr></a></li></ul></div><div id="Diseases_relating_to_the_peripheral_nervous_system" style="font-size:114%;margin:0 4em">Diseases relating to the <a href="/wiki/Peripheral_nervous_system" title="Peripheral nervous system">peripheral nervous system</a></div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks mw-collapsible uncollapsed navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="col" class="navbox-title" colspan="2" style="padding-left: 0.5em; padding-right: 0.75em;"><div id="Mononeuropathy" style="font-size:114%;margin:0 4em"><a href="/wiki/Mononeuropathy" class="mw-redirect" title="Mononeuropathy">Mononeuropathy</a></div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Arm</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Median_nerve" title="Median nerve">median nerve</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Carpal_tunnel_syndrome" title="Carpal tunnel syndrome">Carpal tunnel syndrome</a></li>
<li><a href="/wiki/Ape_hand_deformity" title="Ape hand deformity">Ape hand deformity</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Ulnar_nerve" title="Ulnar nerve">ulnar nerve</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Ulnar_nerve_entrapment" title="Ulnar nerve entrapment">Ulnar nerve entrapment</a></li>
<li><a href="/wiki/Froment%27s_sign" title="Froment&#39;s sign">Froment's sign</a></li>
<li><a href="/wiki/Ulnar_tunnel_syndrome" title="Ulnar tunnel syndrome">Ulnar tunnel syndrome</a></li>
<li><a href="/wiki/Ulnar_claw" title="Ulnar claw">Ulnar claw</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Radial_nerve" title="Radial nerve">radial nerve</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Radial_neuropathy" title="Radial neuropathy">Radial neuropathy</a></li>
<li><a href="/wiki/Wrist_drop" title="Wrist drop">Wrist drop</a></li>
<li><a href="/wiki/Cheiralgia_paresthetica" title="Cheiralgia paresthetica">Cheiralgia paresthetica</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Long_thoracic_nerve" title="Long thoracic nerve">long thoracic nerve</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Winged_scapula" title="Winged scapula">Winged scapula</a></li>
<li><a href="/wiki/Brachial_plexus_injury" title="Brachial plexus injury">Backpack palsy</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Leg</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Lateral_cutaneous_nerve_of_thigh" title="Lateral cutaneous nerve of thigh">lateral cutaneous nerve of thigh</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Meralgia_paraesthetica" title="Meralgia paraesthetica">Meralgia paraesthetica</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Tibial_nerve" title="Tibial nerve">tibial nerve</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Tarsal_tunnel_syndrome" title="Tarsal tunnel syndrome">Tarsal tunnel syndrome</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Plantar_nerve" title="Plantar nerve">plantar nerve</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Morton%27s_neuroma" title="Morton&#39;s neuroma">Morton's neuroma</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Superior_gluteal_nerve" title="Superior gluteal nerve">superior gluteal nerve</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Trendelenburg%27s_sign" title="Trendelenburg&#39;s sign">Trendelenburg's sign</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Sciatic_nerve" title="Sciatic nerve">sciatic nerve</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Piriformis_syndrome" title="Piriformis syndrome">Piriformis syndrome</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Cranial_nerve_disease" title="Cranial nerve disease">Cranial nerves</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li>See <a href="/wiki/Template:Cranial_nerve_disease" title="Template:Cranial nerve disease">Template:Cranial nerve disease</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks mw-collapsible uncollapsed navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="col" class="navbox-title" colspan="2" style="padding-left: 0.5em; padding-right: 0.75em;"><div id="Polyneuropathy_and_Polyradiculoneuropathy" style="font-size:114%;margin:0 4em"><a href="/wiki/Polyneuropathy" title="Polyneuropathy">Polyneuropathy</a> and <a href="/wiki/Polyradiculoneuropathy" title="Polyradiculoneuropathy">Polyradiculoneuropathy</a></div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Hereditary_motor_and_sensory_neuropathy" title="Hereditary motor and sensory neuropathy">HMSN</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Charcot%E2%80%93Marie%E2%80%93Tooth_disease" title="Charcot–Marie–Tooth disease">Charcot–Marie–Tooth disease</a></li>
<li><a href="/wiki/Dejerine%E2%80%93Sottas_disease" title="Dejerine–Sottas disease">Dejerine–Sottas disease</a></li>
<li><a href="/wiki/Refsum_disease" title="Refsum disease">Refsum's disease</a></li>
<li><a href="/wiki/Hereditary_spastic_paraplegia" title="Hereditary spastic paraplegia">Hereditary spastic paraplegia</a></li>
<li><a href="/wiki/Hereditary_neuropathy_with_liability_to_pressure_palsy" title="Hereditary neuropathy with liability to pressure palsy">Hereditary neuropathy with liability to pressure palsy</a></li>
<li><a href="/wiki/Familial_amyloid_neuropathy" title="Familial amyloid neuropathy">Familial amyloid neuropathy</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Autoimmunity" title="Autoimmunity">Autoimmune</a> and <a href="/wiki/Demyelinating_disease" title="Demyelinating disease">demyelinating disease</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a class="mw-selflink selflink">Guillain–Barré syndrome</a></li>
<li><a href="/wiki/Chronic_inflammatory_demyelinating_polyneuropathy" title="Chronic inflammatory demyelinating polyneuropathy">Chronic inflammatory demyelinating polyneuropathy</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Radiculopathy" title="Radiculopathy">Radiculopathy</a> and <a href="/wiki/Plexopathy" title="Plexopathy">plexopathy</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Brachial_plexus_injury" title="Brachial plexus injury">Brachial plexus injury</a></li>
<li><a href="/wiki/Pectoralis_minor_syndrome" title="Pectoralis minor syndrome">Pectoralis minor syndrome</a></li>
<li><a href="/wiki/Thoracic_outlet_syndrome" title="Thoracic outlet syndrome">Thoracic outlet syndrome</a></li>
<li><a href="/wiki/Phantom_limb" title="Phantom limb">Phantom limb</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Alcoholic_polyneuropathy" title="Alcoholic polyneuropathy">Alcoholic polyneuropathy</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks mw-collapsible uncollapsed navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="col" class="navbox-title" colspan="2" style="padding-left: 0.5em; padding-right: 0.75em;"><div id="Other" style="font-size:114%;margin:0 4em">Other</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">General</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Complex_regional_pain_syndrome" title="Complex regional pain syndrome">Complex regional pain syndrome</a></li>
<li><a href="/wiki/Mononeuritis_multiplex" class="mw-redirect" title="Mononeuritis multiplex">Mononeuritis multiplex</a></li>
<li><a href="/wiki/Nerve_compression_syndrome" title="Nerve compression syndrome">Nerve compression syndrome</a></li>
<li><a href="/wiki/Neuralgia" title="Neuralgia">Neuralgia</a></li>
<li><a href="/wiki/Peripheral_neuropathy" title="Peripheral neuropathy">Peripheral neuropathy</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr></tbody></table></div>
<div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1061467846"></div><div role="navigation" class="navbox" aria-labelledby="Hypersensitivity_and_autoimmune_diseases" style="padding:3px"><table class="nowraplinks hlist mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1063604349"><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Hypersensitivity_disease_by_cause" title="Template:Hypersensitivity disease by cause"><abbr title="View this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Hypersensitivity_disease_by_cause" title="Template talk:Hypersensitivity disease by cause"><abbr title="Discuss this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">t</abbr></a></li><li class="nv-edit"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Template:Hypersensitivity_disease_by_cause&amp;action=edit"><abbr title="Edit this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">e</abbr></a></li></ul></div><div id="Hypersensitivity_and_autoimmune_diseases" style="font-size:114%;margin:0 4em"><a href="/wiki/Hypersensitivity" title="Hypersensitivity">Hypersensitivity</a> and <a href="/wiki/Autoimmune_disease" title="Autoimmune disease">autoimmune diseases</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Type_I_hypersensitivity" title="Type I hypersensitivity">Type I</a>/<a href="/wiki/Allergy" title="Allergy">allergy</a>/<a href="/wiki/Atopy" title="Atopy">atopy</a><br />(<a href="/wiki/Immunoglobulin_E" title="Immunoglobulin E">IgE</a>)</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Foreign</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Atopic_dermatitis" title="Atopic dermatitis">Atopic dermatitis</a></li>
<li><a href="/wiki/Allergic_urticaria" class="mw-redirect" title="Allergic urticaria">Allergic urticaria</a></li>
<li><a href="/wiki/Allergic_rhinitis" title="Allergic rhinitis">Allergic rhinitis</a> (Hay fever)</li>
<li><a href="/wiki/Allergic_asthma" class="mw-redirect" title="Allergic asthma">Allergic asthma</a></li>
<li><a href="/wiki/Anaphylaxis" title="Anaphylaxis">Anaphylaxis</a></li>
<li><a href="/wiki/Food_allergy" title="Food allergy">Food allergy</a>
<ul><li>common allergies include: <a href="/wiki/Milk_allergy" title="Milk allergy">Milk</a></li>
<li><a href="/wiki/Egg_allergy" title="Egg allergy">Egg</a></li>
<li><a href="/wiki/Peanut_allergy" title="Peanut allergy">Peanut</a></li>
<li><a href="/wiki/Tree_nut_allergy" title="Tree nut allergy">Tree nut</a></li>
<li><a href="/wiki/Seafood_allergy" class="mw-redirect" title="Seafood allergy">Seafood</a></li>
<li><a href="/wiki/Soy_allergy" title="Soy allergy">Soy</a></li>
<li><a href="/wiki/Wheat_allergy" title="Wheat allergy">Wheat</a></li></ul></li>
<li><a href="/wiki/Side_effects_of_penicillin" title="Side effects of penicillin">Penicillin allergy</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Autoimmune</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Eosinophilic_esophagitis" title="Eosinophilic esophagitis">Eosinophilic esophagitis</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Type_II_hypersensitivity" title="Type II hypersensitivity">Type II</a>/<a href="/wiki/Antibody-dependent_cellular_cytotoxicity" title="Antibody-dependent cellular cytotoxicity">ADCC</a><br />
<ul><li><ul><li><a href="/wiki/Immunoglobulin_M" title="Immunoglobulin M">IgM</a></li>
<li><a href="/wiki/Immunoglobulin_G" title="Immunoglobulin G">IgG</a></li></ul></li></ul></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Foreign</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<li><a href="/wiki/Hemolytic_disease_of_the_newborn" title="Hemolytic disease of the newborn">Hemolytic disease of the newborn</a></li>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Autoimmune</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Cytotoxicity" title="Cytotoxicity">Cytotoxic</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Autoimmune_hemolytic_anemia" title="Autoimmune hemolytic anemia">Autoimmune hemolytic anemia</a></li>
<li><a href="/wiki/Immune_thrombocytopenic_purpura" title="Immune thrombocytopenic purpura">Immune thrombocytopenic purpura</a></li>
<li><a href="/wiki/Bullous_pemphigoid" title="Bullous pemphigoid">Bullous pemphigoid</a></li>
<li><a href="/wiki/Pemphigus_vulgaris" title="Pemphigus vulgaris">Pemphigus vulgaris</a></li>
<li><a href="/wiki/Rheumatic_fever" title="Rheumatic fever">Rheumatic fever</a></li>
<li><a href="/wiki/Goodpasture_syndrome" title="Goodpasture syndrome">Goodpasture syndrome</a></li>
<li><a class="mw-selflink selflink">Guillain–Barré syndrome</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">"<a href="/wiki/Hypersensitivity#Type_V" title="Hypersensitivity">Type V</a>"/<a href="/wiki/Receptor_(biochemistry)" title="Receptor (biochemistry)">receptor</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Graves%27_disease" title="Graves&#39; disease">Graves' disease</a></li>
<li><a href="/wiki/Myasthenia_gravis" title="Myasthenia gravis">Myasthenia gravis</a></li>
<li><a href="/wiki/Pernicious_anemia" title="Pernicious anemia">Pernicious anemia</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Type_III_hypersensitivity" title="Type III hypersensitivity">Type III</a><br />(<a href="/wiki/Immune_complex" title="Immune complex">Immune complex</a>)</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Foreign</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Henoch%E2%80%93Sch%C3%B6nlein_purpura" title="Henoch–Schönlein purpura">Henoch–Schönlein purpura</a></li>
<li><a href="/wiki/Cutaneous_small-vessel_vasculitis" title="Cutaneous small-vessel vasculitis">Hypersensitivity vasculitis</a></li>
<li><a href="/wiki/Reactive_arthritis" title="Reactive arthritis">Reactive arthritis</a></li>
<li><a href="/wiki/Farmer%27s_lung" title="Farmer&#39;s lung">Farmer's lung</a></li>
<li><a href="/wiki/Acute_proliferative_glomerulonephritis" title="Acute proliferative glomerulonephritis">Post-streptococcal glomerulonephritis</a></li>
<li><a href="/wiki/Serum_sickness" title="Serum sickness">Serum sickness</a></li>
<li><a href="/wiki/Arthus_reaction" title="Arthus reaction">Arthus reaction</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Autoimmune</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Lupus" title="Lupus">Lupus</a></li>
<li><a href="/wiki/Subacute_bacterial_endocarditis" title="Subacute bacterial endocarditis">Subacute bacterial endocarditis</a></li>
<li><a href="/wiki/Rheumatoid_arthritis" title="Rheumatoid arthritis">Rheumatoid arthritis</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Type_IV_hypersensitivity" title="Type IV hypersensitivity">Type IV</a>/<a href="/wiki/Cell-mediated_immunity" title="Cell-mediated immunity">cell-mediated</a><br />(<a href="/wiki/T_cell" title="T cell">T cells</a>)</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Foreign</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Allergic_contact_dermatitis" title="Allergic contact dermatitis">Allergic contact dermatitis</a></li>
<li><a href="/wiki/Mantoux_test" title="Mantoux test">Mantoux test</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Autoimmune</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Type_1_diabetes" title="Type 1 diabetes">Type 1 diabetes</a></li>
<li><a href="/wiki/Hashimoto%27s_thyroiditis" title="Hashimoto&#39;s thyroiditis">Hashimoto's thyroiditis</a></li>
<li><a href="/wiki/Multiple_sclerosis" title="Multiple sclerosis">Multiple sclerosis</a></li>
<li><a href="/wiki/Coeliac_disease" title="Coeliac disease">Coeliac disease</a></li>
<li><a href="/wiki/Giant_cell_arteritis" title="Giant cell arteritis">Giant cell arteritis</a></li>
<li><a href="/wiki/Postorgasmic_illness_syndrome" title="Postorgasmic illness syndrome">Postorgasmic illness syndrome</a></li>
<li><a href="/wiki/Reactive_arthritis" title="Reactive arthritis">Reactive arthritis</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Graft-versus-host_disease" title="Graft-versus-host disease">GVHD</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Transfusion-associated_graft-versus-host_disease" title="Transfusion-associated graft-versus-host disease">Transfusion-associated graft-versus-host disease</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Unknown/<br />multiple</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Foreign</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Hypersensitivity_pneumonitis" title="Hypersensitivity pneumonitis">Hypersensitivity pneumonitis</a>
<ul><li><a href="/wiki/Allergic_bronchopulmonary_aspergillosis" title="Allergic bronchopulmonary aspergillosis">Allergic bronchopulmonary aspergillosis</a></li></ul></li>
<li><a href="/wiki/Transplant_rejection" title="Transplant rejection">Transplant rejection</a></li>
<li><a href="/wiki/Latex_allergy" title="Latex allergy">Latex allergy</a> (I+IV)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Autoimmune</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Sj%C3%B6gren_syndrome" title="Sjögren syndrome">Sjögren syndrome</a></li>
<li><a href="/wiki/Autoimmune_hepatitis" title="Autoimmune hepatitis">Autoimmune hepatitis</a></li>
<li><a href="/wiki/Autoimmune_polyendocrine_syndrome" title="Autoimmune polyendocrine syndrome">Autoimmune polyendocrine syndrome</a>
<ul><li><a href="/wiki/Autoimmune_polyendocrine_syndrome_type_1" title="Autoimmune polyendocrine syndrome type 1">APS1</a></li>
<li><a href="/wiki/Autoimmune_polyendocrine_syndrome_type_2" title="Autoimmune polyendocrine syndrome type 2">APS2</a></li></ul></li>
<li><a href="/wiki/Addison%27s_disease" title="Addison&#39;s disease">Autoimmune adrenalitis</a></li>
<li><a href="/wiki/Autoimmune_disease" title="Autoimmune disease">Systemic autoimmune disease</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table></div>
<!-- 
NewPP limit report
Parsed by mw1452
Cached time: 20230615210046
Cache expiry: 1814400
Reduced expiry: false
Complications: [vary‐revision‐sha1, show‐toc]
CPU time usage: 0.850 seconds
Real time usage: 0.973 seconds
Preprocessor visited node count: 6192/1000000
Post‐expand include size: 289822/2097152 bytes
Template argument size: 9655/2097152 bytes
Highest expansion depth: 13/100
Expensive parser function count: 2/500
Unstrip recursion depth: 1/20
Unstrip post‐expand size: 269280/5000000 bytes
Lua time usage: 0.490/10.000 seconds
Lua memory usage: 8817694/52428800 bytes
Number of Wikibase entities loaded: 1/400
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00%  832.504      1 -total
 51.72%  430.549      1 Template:Reflist
 32.01%  266.461     57 Template:Cite_journal
 13.84%  115.253     13 Template:Navbox
 11.34%   94.369      1 Template:Infobox_medical_condition_(new)
 10.14%   84.406      1 Template:Medical_condition_classification_and_resources
  9.75%   81.181      1 Template:Infobox
  8.62%   71.793      2 Template:Cite_book
  7.17%   59.724      2 Template:Short_description
  6.16%   51.317      2 Template:Hlist
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:12800708-0!canonical and timestamp 20230615210045 and revision id 1160020717. Rendering was triggered because: page-view
 -->
</div><!--esi <esi:include src="/esitest-fa8a495983347898/content" /> --><noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript>
<div class="printfooter" data-nosnippet="">Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Guillain–Barré_syndrome&amp;oldid=1160020717">https://en.wikipedia.org/w/index.php?title=Guillain–Barré_syndrome&amp;oldid=1160020717</a>"</div></div>
					<div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:1976_health_disasters" title="Category:1976 health disasters">1976 health disasters</a></li><li><a href="/wiki/Category:Autoimmune_diseases" title="Category:Autoimmune diseases">Autoimmune diseases</a></li><li><a href="/wiki/Category:Cytomegalovirus-associated_diseases" title="Category:Cytomegalovirus-associated diseases">Cytomegalovirus-associated diseases</a></li><li><a href="/wiki/Category:Medical_triads" title="Category:Medical triads">Medical triads</a></li><li><a href="/wiki/Category:Myelin_disorders" title="Category:Myelin disorders">Myelin disorders</a></li><li><a href="/wiki/Category:Peripheral_nervous_system_disorders" title="Category:Peripheral nervous system disorders">Peripheral nervous system disorders</a></li><li><a href="/wiki/Category:Syndromes_affecting_the_nervous_system" title="Category:Syndromes affecting the nervous system">Syndromes affecting the nervous system</a></li><li><a href="/wiki/Category:Diseases_named_for_discoverer" title="Category:Diseases named for discoverer">Diseases named for discoverer</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:CS1:_long_volume_value" title="Category:CS1: long volume value">CS1: long volume value</a></li><li><a href="/wiki/Category:CS1_errors:_missing_periodical" title="Category:CS1 errors: missing periodical">CS1 errors: missing periodical</a></li><li><a href="/wiki/Category:CS1_French-language_sources_(fr)" title="Category:CS1 French-language sources (fr)">CS1 French-language sources (fr)</a></li><li><a href="/wiki/Category:Articles_with_short_description" title="Category:Articles with short description">Articles with short description</a></li><li><a href="/wiki/Category:Short_description_is_different_from_Wikidata" title="Category:Short description is different from Wikidata">Short description is different from Wikidata</a></li><li><a href="/wiki/Category:Good_articles" title="Category:Good articles">Good articles</a></li><li><a href="/wiki/Category:Wikipedia_medicine_articles_ready_to_translate" title="Category:Wikipedia medicine articles ready to translate">Wikipedia medicine articles ready to translate</a></li><li><a href="/wiki/Category:Wikipedia_neurology_articles_ready_to_translate" title="Category:Wikipedia neurology articles ready to translate">Wikipedia neurology articles ready to translate</a></li></ul></div></div>
				</div>
			</main>
			
		</div>
		<div class="mw-footer-container">
			
<footer id="footer" class="mw-footer" role="contentinfo" >
	<ul id="footer-info">
	<li id="footer-info-lastmod"> This page was last edited on 13 June 2023, at 23:54<span class="anonymous-show">&#160;(UTC)</span>.</li>
	<li id="footer-info-copyright">Text is available under the <a rel="license" href="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons Attribution-ShareAlike License 4.0</a><a rel="license" href="//creativecommons.org/licenses/by-sa/4.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//foundation.wikimedia.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//foundation.wikimedia.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
</ul>

	<ul id="footer-places">
	<li id="footer-places-privacy"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Privacy_policy">Privacy policy</a></li>
	<li id="footer-places-about"><a href="/wiki/Wikipedia:About">About Wikipedia</a></li>
	<li id="footer-places-disclaimers"><a href="/wiki/Wikipedia:General_disclaimer">Disclaimers</a></li>
	<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
	<li id="footer-places-wm-codeofconduct"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Universal_Code_of_Conduct">Code of Conduct</a></li>
	<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Guillain%E2%80%93Barr%C3%A9_syndrome&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
	<li id="footer-places-developers"><a href="https://developer.wikimedia.org">Developers</a></li>
	<li id="footer-places-statslink"><a href="https://stats.wikimedia.org/#/en.wikipedia.org">Statistics</a></li>
	<li id="footer-places-cookiestatement"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Cookie_statement">Cookie statement</a></li>
</ul>

	<ul id="footer-icons" class="noprint">
	<li id="footer-copyrightico"><a href="https://wikimediafoundation.org/"><img src="/static/images/footer/wikimedia-button.png" srcset="/static/images/footer/wikimedia-button-1.5x.png 1.5x, /static/images/footer/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation" loading="lazy" /></a></li>
	<li id="footer-poweredbyico"><a href="https://www.mediawiki.org/"><img src="/static/images/footer/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="/static/images/footer/poweredby_mediawiki_132x47.png 1.5x, /static/images/footer/poweredby_mediawiki_176x62.png 2x" width="88" height="31" loading="lazy"></a></li>
</ul>

</footer>

		</div>
	</div> 
</div> 
<div class='vector-settings'>
	
<button
	id=""
	class="cdx-button cdx-button--icon-only vector-limited-width-toggle"
	><span class="vector-icon mw-ui-icon-fullScreen mw-ui-icon-wikimedia-fullScreen"></span>

<span>Toggle limited content width</span>

</button>

</div>
<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgHostname":"mw1385","wgBackendResponseTime":118,"wgPageParseReport":{"limitreport":{"cputime":"0.850","walltime":"0.973","ppvisitednodes":{"value":6192,"limit":1000000},"postexpandincludesize":{"value":289822,"limit":2097152},"templateargumentsize":{"value":9655,"limit":2097152},"expansiondepth":{"value":13,"limit":100},"expensivefunctioncount":{"value":2,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":269280,"limit":5000000},"entityaccesscount":{"value":1,"limit":400},"timingprofile":["100.00%  832.504      1 -total"," 51.72%  430.549      1 Template:Reflist"," 32.01%  266.461     57 Template:Cite_journal"," 13.84%  115.253     13 Template:Navbox"," 11.34%   94.369      1 Template:Infobox_medical_condition_(new)"," 10.14%   84.406      1 Template:Medical_condition_classification_and_resources","  9.75%   81.181      1 Template:Infobox","  8.62%   71.793      2 Template:Cite_book","  7.17%   59.724      2 Template:Short_description","  6.16%   51.317      2 Template:Hlist"]},"scribunto":{"limitreport-timeusage":{"value":"0.490","limit":"10.000"},"limitreport-memusage":{"value":8817694,"limit":52428800}},"cachereport":{"origin":"mw1452","timestamp":"20230615210046","ttl":1814400,"transientcontent":false}}});});</script>
<script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"Guillain\u2013Barr\u00e9 syndrome","url":"https:\/\/en.wikipedia.org\/wiki\/Guillain%E2%80%93Barr%C3%A9_syndrome","sameAs":"http:\/\/www.wikidata.org\/entity\/Q205214","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q205214","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2001-05-27T08:19:39Z","dateModified":"2023-06-13T23:54:01Z","headline":"autoimmune disease that causes the immune system to attack part of the peripheral nervous system"}</script><script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"Guillain\u2013Barr\u00e9 syndrome","url":"https:\/\/en.wikipedia.org\/wiki\/Guillain%E2%80%93Barr%C3%A9_syndrome","sameAs":"http:\/\/www.wikidata.org\/entity\/Q205214","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q205214","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2001-05-27T08:19:39Z","dateModified":"2023-06-13T23:54:01Z","headline":"autoimmune disease that causes the immune system to attack part of the peripheral nervous system"}</script>
</body>
</html>